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Abstract 
 
Anthocyanins are thought to possess significant cardio-protective properties 
and have been proposed as potent modulators of vascular disease. However, 
their true health benefits have been thrown into question, since the current 
literature poorly describes their stability in foods, metabolism and mode of 
biological activity. Therefore, this thesis aimed to evaluate (i) the stability of 
anthocyanins during commercial juice processing, (ii) the formation of 
phenolic degradation products under simulated physiological conditions and 
recovery from clinical samples, (iii) the in vitro hepatic conjugation 
(metabolism) of anthocyanins and their phenolic acid degradation products 
and (iv) the in vitro cardiovascular related bioactivities of anthocyanins and 
their free or conjugated metabolites. 
Using commercial and bench-scale processing models, no significant loss in 
anthocyanins was observed throughout blackcurrant juice processing and only 
sodium bisulphite improved anthocyanin yield in juices. Using in vitro stability 
studies, it was demonstrated that B-ring hydroxylation status mediated the 
degradation of anthocyanins to phenolic acids under simulated physiological 
and gastrointestinal conditions. Subsequently, it was shown that following 
microsomal metabolism, pelargonidin and cyanidin formed aglycone, aryl and 
acyl glucuronides of 4-hydroxybenzoic acid and protocatechuic acid, 
respectively; thus indicating that anthocyanins may be found in the systemic 
circulation as free or conjugated phenolic acids. 
Finally, it was shown that the attenuation of Ang II induced endothelial 
superoxide production by anthocyanins was enhanced following degradation 
and metabolism to phenolic acid metabolites. Furthermore, this biological 
effect was inversely associated with the number of aryl hydroxyls, which is in 
express opposition to their antioxidant potential. Therefore, it is likely that the 
biological effects of these compounds, at physiological concentrations, are not 
due to their direct radical scavenging properties. 
Overall, the findings of this thesis emphasize the importance of metabolism, 
bioavailability and structure-activity relationships when conducting or 
interpreting past and future research associated with the health benefits of 
flavonoids. 
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Chapter 1  
 
Review of the literature: Anthocyanin occurrence, stability, 
metabolism and bioactivity 
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1.1 Introduction 
 
In recent years it has been established that oxidative stress, vascular 
inflammation, and endothelial dysfunction play a central role in the 
development of cardiovascular diseases. As such, advancements in the 
knowledge of these disease processes have allowed the development of 
novel pharmaceutical and/or dietary strategies to prevent the development of 
vascular diseases. Epidemiological observations have played a significant 
part in the development of such dietary strategies and the identification of 
numerous cardio-protective phytochemicals. Of these phytochemicals, 
anthocyanins (natural polyphenols found in many purple to red coloured plant 
and fruit species; Figure 1.1) are thought to possess significant cardio-
protective properties.  
 
Anthocyanin
O
R
R
R
OH
OH
O+
O
OH
OHOH
OH
Anthocyanidin
Glycoside
A
B
C
 
 
Figure 1.1: Common anthocyanin structure. 
 
Since the 1970s, many studies have investigated the occurrence and utility of 
anthocyanins in plants and in food production, whilst research concerning 
their potential health benefits has become prominent only since the late 
1990s. In vitro, in vivo and meta-analysis studies have shown that 
anthocyanins  prevent or reduce the risk factors associated with a multitude of 
diseases, including those associated with cardiovascular (Mink, Scrafford et 
al. 2007; Hooper, Kroon et al. 2008) and inflammatory diseases (Oak, Bedoui 
et al. 2006; Xia, Ling et al. 2006; Yamamoto, Naemura et al. 2006; Sorrenti, 
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Mazza et al. 2007; Xia, Ling et al. 2007; Leblais, Krisa et al. 2008; 
Toufektsian, de Lorgeril et al. 2008), carcinogenesis (Feng, Ni et al. 2007; 
Rossi, Garavello et al. 2007; Elisia and Kitts 2008) and obesity (Tsuda, Horio 
et al. 2003; Tsuda, Ueno et al. 2004; Jayaprakasam, Olson et al. 2006; 
Sasaki, Nishimura et al. 2007). Indeed, anthocyanins are thought to act 
directly on the different cells involved in the development of vascular 
pathologies. For example, anthocyanins exert a protective effect against TNF-
α induced monocyte chemoattractant protein 1 (MCP-1; involved in the 
recruitment of marophages to sites of inflammation) secretion from the 
endothelium (Garcia-Alonso, Rimbach et al. 2004). More recently, 
anthocyanins have been shown to inhibit CD40 induced proinflamatory 
signalling and cholesterol distribution (Xia, Hou et al. 2005; Xia, Ling et al. 
2007).  
 
To date, current literature evidence poorly describes the stability and human 
metabolism of anthocyanins, with no evidence regarding the biological effect 
of their metabolites. Thus, in order to fully appreciate the health related 
benefits of ingested anthocyanins, an understanding of their occurrence, 
biochemistry, metabolism and final bioactive mechanisms is essential. Within 
this review, our current understanding of these issues is collated, with some 
narrative highlighting the gaps in our present knowledge.  
  
1.2 Anthocyanin occurrence in the diet 
 
Anthocyanins occur widely in our diets, with the average human consumption 
estimated to be 12.5 mg/person/day (Wu, Beecher et al. 2006). Of the many 
fruits and vegetables that contain anthocyanins, berry species possess the 
highest concentration of anthocyanins and thus represent a major vehicle for 
the delivery of these compounds (Maatta-Riihinen, Kamal-Eldin et al. 2004). In 
plants, anthocyanins are almost exclusively found as 3-O-glycosides of 
anthocyanidin, the aglycone form of the anthocyanin. There are approximately 
17 anthocyanidins found in plants, including the six common species (cyanidin 
(Cy), delphinidin (Dp), petunidin (Pt), peonidin (Pn), pelargonidin (Pg) and 
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malvidin (Mv) (Figure 1.2). They are characterised by their many structural 
deviations, including differences in the number and position of attached 
sugars, the number and position of hydroxyl and/or methoxyl groups on the B-
ring and the extent of sugar acylation and the identity of the acylating agent 
(Wu, Beecher et al. 2006). Furthermore, anthocyanins may exist in at least 
four different structural conformations (Figure 1.3) namely, flavylium cation, 
quinonoidal base, hemiketal and chalcone, which are pH dependant 
(Asenstorfer, Iland et al. 2003).  
 
OH
OH
OH
OH
OH O+
OH
OH
OH
OH O+
Cyanidin (Cy)
Pelargonidin (Pg)
OH
OH
OH
OH
OH
OH O+
OH
OH
OH
OH O+
O
CH3
O
CH3
OH
OH
OH
OH O+
O
CH3
OH
OH
OH
OH
OH O+
O
CH3
Delphinidin (Dp)
Peonidin (Pn)
Petunidin (Pt)
Malvidin (Mv)
 
 
Figure 1.2: Structures of common anthocyanidin species. 
 
When considering the potential health benefits of anthocyanins, an 
appreciation of their occurrence in human populations is essential. A survey 
published by the U.S. Department of Agriculture (USDA) (USDA 2006) 
showed that berries accounted for the majority of all the frozen fruit products 
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consumed in 2005 . In addition, berry fruits contain the highest concentrations 
of anthocyanins when compared with most other dietary sources (Mazza and 
Miniati 1993)(Table 1.1). Therefore, berry fruits represent the most abundant 
and feasible dietary source of anthocyanins in human populations and provide 
an excellent vehicle for the delivery of these health promoting compounds.  
 
R3
R2
R1
OOH
OH O+
O OH
OH
OH
OH
O
OH
R3
R2
R1
OOH
OH
O OH
OH
OH
OH
O
R3
R1
OOH
OH O
O OH
OH
OH
OH
OH
OOH
OH
O
R3
R2
R1
OH
O
OH
OH
OH
Flavylium ion
Hemiketals
Quinoid bases
Chalcones
 
Figure 1.3: The four most common pH dependent structural conformations of anthocyanins. 
 
Table 1.1. Anthocyanin content in berry species. 
No Data272Black berry8
39798Cranberry2-4,8
20331Strawberry2,3,8
500*385Black currant3,4,7,8
2301037Raspberry2,5,6
No Data1027Elderberry4,7,8
10411053Chokeberry2-4,7,8
12315Gooseberry1-2,7,8
Dry WeightFresh weight
Total Anthocyanin content 
(mg/100g dry/fresh weight)
Berry Species
 
Weight reported as mg anthocyanin/100g dry or fresh weight. *Anthocyanin content reported in freeze dried 
pomace. 1M. Jordheim, F. Mage, O. M. Andersen, J. Agric. Food Chem. 55, 5529 (2007). 2M. P. Kahkonen, A. 
I. Hopia, M. Heinonen, J. Agric. Food Chem. 49, 4076 (2001). 3P. G. Kapasakalidis, R. A. Rastall, M. H. 
Gordon, J. Agric. Food Chem. 54, 4016 (2006). 4K. R. Maatta-Riihinen, A. Kamal-Eldin, P. H. Mattila, A. M. 
Gonzalez-Paramas, A. R. Torronen, J. Agric. Food Chem. 52, 4477 (2004). 5R. A. Moyer, K. E. Hummer, C. E. 
Finn, B. Frei, R. E. Wrolstad, J. Agric. Food Chem. 50, 519 (2002). 6W. Mullen et al., J. Agric. Food Chem. 
50, 5197 (2002). 7X. Wu et al., J Agric Food Chem 52, 4026 (Jun 16, 2004). 8X. Wu et al., J. Agric. Food 
Chem. 54, 4069 (2006). 
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Table 1.2. Anthocyanin profiles of various berry species1-8 
+++Other
++Dp-3-Arabinose
+++Dp-3-Glucoside
+++++Dp-3-Rutinoside
Glucoside +
Pt-3(6-coumarroyl)-
+Pt-3-Rutinoside
Pg-3-glucose-rutinoside
+++++Pg-3-Rutinoside
Pg-3-sophoroside
++++++Pg-3-Glucoside
+++Pn-3-Arabinose
+++++Pn-3-Galactoside
+Pn-3-Rutinoside
+++++Pn-3-Glucoside
Glucoside +
Cy-3(6-coumarroyl)-
5-Rhamnoside ++
Cy-3-Sophoroside-
Cy-3-(2-glucosylrutinoside)
5-Glucoside ++
Cy-3-Sambudioside-
+Cy-3-dioxaloylglucoside
+Cy-3-malonylglucoside
+++++Cy-3-Sophoroside
+++++Cy-3-Sambudioside
++Cy-3-xyloside
+++++++++++Cy-3-Arabinoside
++++++++Cy-3-Galactoside
+++++++++++++Cy-3-Rutinoside
+++++++++++++++++++Cy-3-Glucoside
BlackberryStrawberryCranberryBlack current RaspberryElderberryChokeberryGooseberry
Visual Representation of Anthocyanin Abundance within each berry species*
Anthocyanin species
 
*Visual representation of anthocyanincontent from chromatographs: (Trace) +<++<+++<++++<+++++ (Abundant). 
1M. Jordheim, F. Mage, O. M. Andersen, J. Agric. Food Chem. 55, 5529 (2007). 2M. P. Kahkonen, A. I. Hopia, M. 
Heinonen, J. Agric. Food Chem. 49, 4076 (2001). 3P. G. Kapasakalidis, R. A. Rastall, M. H. Gordon, J. Agric. Food 
Chem. 54, 4016 (2006). 4K. R. Maatta-Riihinen, A. Kamal-Eldin, P. H. Mattila, A. M. Gonzalez-Paramas, A. R. 
Torronen, J. Agric. Food Chem. 52, 4477 (2004). 5R. A. Moyer, K. E. Hummer, C. E. Finn, B. Frei, R. E. Wrolstad, J. 
Agric. Food Chem. 50, 519 (2002). 6W. Mullen et al., J. Agric. Food Chem. 50, 5197 (2002). 7X. Wu et al., J Agric 
Food Chem 52, 4026 (Jun 16, 2004). 8X. Wu et al., J. Agric. Food Chem. 54, 4069 (2006). 
 
Of the many anthocyanin species that may occur in berry fruits, cy, pg and pn 
are the most abundant anthocyanidins species, with cy-3-glu, cy-3-rut, cy-3-
gal, cy-3-ara and pn-3-glu accounting for the most profuse anthocyanins 
(Table 1.2) (Maatta-Riihinen, Kamal-Eldin et al. 2004; Wu, Gu et al. 2004; 
Tian, Giusti et al. 2005; Wu and Prior 2005; Netzel, Netzel et al. 2006; 
Seeram, Adams et al. 2006; Lin and Harnly 2007). A detailed catalogue of 
anthocyanin containing foods and the respective quantities can be found in 
the recent Phenol-Explorer database (Scalbert, Neveun et al. 2010) launched 
by Scalbert et al.  
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Chokeberry, elderberry and strawberry have the smallest variation of 
anthocyanin species and structural deviations, consisting almost exclusively of 
either cy or pg derivatives (Chandra, Rana et al. 2001; Maatta-Riihinen, 
Kamal-Eldin et al. 2004; Nakajima, Tanaka et al. 2004; Wu, Gu et al. 2004). 
The most abundant anthocyanin in chokeberry is cy-3-gal, with  
concentrations up to 989.7 mg/100g fresh weight (FW) (Wu, Gu et al. 2004), 
followed by cy-3-ara, cy-3-xyl and cy-3-glu at concentrations of 399.3, 51.5 
and 37.6 mg/100g FW respectively (Wu, Gu et al. 2004), with only trace 
amounts of  pg-3-ara  (2.3 mg/100g FW) (Chandra, Rana et al. 2001; Kay, 
Mazza et al. 2004; Maatta-Riihinen, Kamal-Eldin et al. 2004; Nakajima, 
Tanaka et al. 2004; Wu, Gu et al. 2004). Elderberries contain an abundance 
of cy-3-glu and cy-3-sam (739.8 and 545.9 mg/100g FW, respectively) (Wu, 
Gu et al. 2004), with small to trace amounts of cy-3-sam-5-glu, cy-3-rut and 
cg-3-glu (82.6, 4.4 and1.8 mg/100g FW, respectively) (Chandra, Rana et al. 
2001; Nakajima, Tanaka et al. 2004; Wu, Gu et al. 2004). Strawberries 
contain predominantly pg-3-glu and pg-3-rut, with some studies identifying 
varying concentrations of cy-glycosides (Wu, Gu et al. 2004; Seeram, Adams 
et al. 2006). Interestingly, while blackberries may contain up to 9 anthocyanin 
species, cy-3-glu represents the vast majority, with only small to trace 
amounts of other cy-3-glycosides, pn-3-glycosides and pg-3-glycosides 
(Moyer, Hummer et al. 2002; Wu, Beecher et al. 2006). Of the most commonly 
occurring berry fruits, chokeberry, elderberry, strawberry and blackberry have 
the simplest anthocyanin profiles, which make them ideal candidates for 
assessing anthocyanin chemistry in fruit and their metabolism in human 
studies. However, when considering structural complexity it should be noted 
that elderberry contains a high amount of cy-3-sam (Nakajima, Tanaka et al. 
2004; Wu, Beecher et al. 2004), a disaccharide, and small amounts of cy-3-
sam-5-glu (Nakajima, Tanaka et al. 2004; Wu, Beecher et al. 2004), a 
trisaccharide, which may significantly vary in absorption and degradation 
characteristics in comparison to less complex anthocyanin-sugar moieties.  
 
In addition to the anthocyanin profile of berry fruits, it is important to consider 
their phenolic acid content, particularly those associated with anthocyanins. 
The significance of the anthocyanin:phenolics ratio (Table 1.3) becomes 
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evident when discerning the bioavailability of berry-derived anthocyanins, 
where distinguishing anthocyanin derived phenolic acids from indigenous 
berry phenolic constituents may become problematic, as misidentification is 
possible during clinical sample analysis. Furthermore, changes in berry 
anthocyanin:phenolics ratio during processing may serve as a means of 
identifying anthocyanin degradation. Therefore, it may be shown that the true 
beneficial properties of berry fruits produces are not solely related to their 
anthocyanin content, but also to their phenolic acid content. Further study is 
required to assess the stability and occurrence of anthocyanins throughout 
commercial fruit (berry) processing (which is a focus of the present thesis; 
Chapter  2). 
 
      Table 1.3. Total anthocyanin to total phenolic acid ratios 
1:0.03Black berry4
1:0.72Cranberry1,3
1:0.01Strawberry1
1:1.05Black current2,3,5
1:0.22Raspberry1,4
1:3.76Elderberry3,5
1:1.56Chokeberry1,3,5
1:0.35Gooseberry1,3,5
Total anthocyanin:phenolic ratioBerry species 
 
1M. P. Kahkonen, A. I. Hopia, M. Heinonen, J. Agric. Food Chem. 49, 4076 (2001). 2P. G. Kapasakalidis, R. A. Rastall, M. H. 
Gordon, J. Agric. Food Chem. 54, 4016 (2006). 3K. R. Maatta-Riihinen, A. Kamal-Eldin, P. H. Mattila, A. M. Gonzalez-Paramas, 
A. R. Torronen, J. Agric. Food Chem. 52, 4477 (2004). 4R. A. Moyer, K. E. Hummer, C. E. Finn, B. Frei, R. E. Wrolstad, J. 
Agric. Food Chem. 50, 519 (2002). 5X. Wu et al., J Agric Food Chem 52, 4026 (Jun 16, 2004), 
 
Whilst the anthocyanin and phenolic acid content of berry fruits is of priority 
when considering their potential health benefits, account for berry species 
most consumed in the population should also be made, as these species offer 
the greatest potential for the delivery of anthocyanins within the human diet. A 
survey published by the U.S. Department of Agriculture (USDA) (USDA 2006) 
showed that berries represent 67% of all the frozen fruit products consumed in 
the U.S. in 2005, with strawberries representing a major class of these berry 
products. However, while raspberry, cranberry and strawberry have been 
shown to have an estimated daily consumption of 0.2, 0.12 and 1.95 g, 
respectively (Wu, Beecher et al. 2006), little published data exists regarding 
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direct berry consumption statistics. The U.S. Department of Agriculture 
Economic Research Services (USDAERS) per capita food availability data 
serves as an indirect measure of trends in food use, providing an indication of 
population food consumption over time. A summary for the per capita 
cultivation of commonly consumed berry products, compiled by the USDAERS 
is shown in Table 1.4 (USDAERS 2007). Based on this data, it is evident that 
strawberries are the most highly cultivated berry species in the U.S. This trend 
may also be true for Europe, where marketing information compiled by TNS 
Worldpanel (UK) state that strawberries and raspberries represent 63% and 
19% of the European berry market, respectively (Garner 2008). 
 
Table 1.4. Per capita berry cultivation in the U.S. in 20051 
0.21*Cranberry juice
0.80Blueberry
0.10Blackberry
7.70Strawberry
0.30Raspberry
2.00Cranberry
Cultivation 
(lbs FW per capita)
Berry species
 
Data stated as lbs fresh weight per capita.  *Measured in gallons per capita. 1Data taken from USDAERS (2007) 
[www.ers.usda.gov/Data/FoodConsumption/FoodAvailFaqs.htm.]. 
 
 
1.3 Anthocyanin stability under physiological conditions  
 
On entry into the body, anthocyanins experience many physiochemical 
conditions that may lead to their structural modification. Regions of the GIT 
are characterized by their differential pH, microbial and cellular characteristics, 
each posing different molecular altering pressures. It is currently unknown 
whether the majority of anthocyanins remain intact during gastrointestinal tract 
(GIT) digestion or whether any anthocyanins pass intact to the colon, where 
further biotransformation by colonic microflora may occur. Many bioavailability 
studies, performed in vivo following the consumption of anthocyanin-rich food 
sources, have consistently shown that less than 1% of their ingested dose 
reaches the systemic circulation (Manach, Williamson et al. 2005). In addition, 
no conclusive evidence has yet accounted for their disappearance following 
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ingestion. Currently, the chemical and biological degradation and metabolism 
of anthocyanins needs to be fully characterised in order to sufficiently interpret 
the findings of in vivo bioavailability.  
       
1.3.1 Anthocyanin degradation to phenolic acids 
A number of chemical factors affect the structural nature of anthocyanins, 
including pH and temperature. As anthocyanins exist in at least four pH-
dependent structural iso-forms, anthocyanins exhibit differential chemical 
properties. More importantly, at alkaline pH’s, anthocyanins degrade to form 
free phenolic acids, where dp, cy, pg, pn and mv degrade to form gallic acid 
(GA), protocatechuic acid (PA), 4-hydroxybenzoic acid (HBA), vanillic acid 
(VA) and syringic acid (SA) respectively (Figure 1.4) (Seeram, Bourquin et al. 
2001; Keppler and Humpf 2005; Fleschhut, Kratzer et al. 2006; Sadilova, 
Stintzing et al. 2006; Kern, Fridrich et al. 2007).  
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Anthocyanin
Phenolic acidPhloroglucinol Aldehyde
Anthocyanin                 Phenolic Acid                       R1 R2
Cyanidin-3-gly Protocatechuic acid  OH    H    
Pelargonidin-3-gly 4-hydroxybenzoic acid                H                   H        
Delphinidin-3-gly Gallic Acid                        OH      OH
R2
R1
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OH O+
A
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C
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Peonidin-3-gly Vanillic Acid                         H      OCH3
Malvidin-3-gly Syringic Acid                    OCH3 OCH3
 
Figure 1.4: Degradation of anthocyanins to their corresponding phenolic acid and aldehyde 
constituents. 
 
In addition, it has been shown that anthocyanins degrade to an additional 
phenolic aldehyde, with the most commonly reported constituent being 2,4,6-
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trihydroxybenzaldehyde (PGA) (Keppler and Humpf 2005; Sadilova, Stintzing 
et al. 2006; Kern, Fridrich et al. 2007). 
 
Due to the steric demand of the glycoside structures, a distinction between 
anthocyanin and anthocyanidin stability is evident, where anthocyanins 
(glycososides) show a greater pH stability than their respective aglycons, 
(Fleschhut, Kratzer et al. 2006). However, little has been reported regarding 
the influence of B-ring hydroxylation on the stability of anthocyanins under 
experimental or biological conditions. A study by Nielsen et al. (Nielsen, Haren 
et al. 2003) investigated the stability of pure anthocyanins at different pH 
values in aqueous solutions and found that cy and dp glycosides appeared to 
be most stable at pH 2, with a 10% loss at a pH value up to 3.3. A local 
minima in stability occurred at pH 3.8, where it was proposed that a less 
stable intermediate (pseudo-base) exists between the flavylium and hemiketal 
structural forms. The stability of these anthocyanins increased between pH 
3.8-4.5, followed by an increased degradation at pH values greater than 4.5 
(Nielsen, Haren et al. 2003).  
 
A study by Keppler et al. (Keppler and Humpf 2005) suggested that ring 
fission and the formation of phenolic acids may take place at neutral pH and 
proposed that this was a minor degradation pathway, where anthocyanins 
form chalcone and coumarin glycosides as final degradation products 
(Markakis 1974). However, no studies have yet demonstrated the rate of 
anthocyanin degradation and phenolic acid formation under physiological 
conditions (which is a focus of the present thesis; Chapter 3). Nonetheless, 
some attempts have been made to determine the stability of anthocyanins 
under particular experimental conditions. Two studies by Fleschut et al. 
(Fleschhut, Kratzer et al. 2006) and Kern et al. (Kern, Fridrich et al. 2007) 
showed that at pH 7.4 and 37 oC, anthocyanidins cy, dp, pn and mv 
completely degrade within 60 minutes, with dp characterized as the least 
stable anthocyanidin, followed by mv, cy, pn and pg. This would suggest that 
the chemical breakdown of anthocyanidins increases with the number of 
methoxy and hydroxyl groups on the polyphenolic structure. It remains 
apparent that anthocyanins and anthocyanidins are greatly affected by pH 
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conditions in aqueous solutions and are unstable at physiological pH. Under 
cell culture conditions, it is reported by Keppler et al. (Keppler and Humpf 
2005) that the phenolic acid degradation products of anthocyanins appear to 
be stable, although PGA was shown to undergo extensive degradation. This 
was thought to occur due to condensation with amine groups on amino acids 
or proteins to form imines, with the nucleophilic addition of an amine to the 
aldehyde followed by the elimination of water.  
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Figure 1.5: Proposed pathway for anthocyanin degradation at pH 7. 
 
Most anthocyanin degradation studies show that the formation of phenolic 
acid degradation products do not fully account for the loss of their parent 
anthocyanidins (Keppler and Humpf 2005; Fleschhut, Kratzer et al. 2006; 
Kern, Fridrich et al. 2007). Therefore, it is postulated that anthocyanidins form 
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a more stable, intermediary such as a polymerized chalcone or α-diketone, 
which may undergo dimerisation or degradation to constituent phenolic acids 
(Figure 1.5). However, this should be the focus of future research, as the 
characterising of anthocyanin degradation intermediates may provide insights 
into the anomalous data reported during degradation and bioavailability 
studies.    
 
A number of studies have reported the thermal degradation of anthocyanin 
pigments at increased temperatures. Still, only a small number of studies have 
reported the degradation of anthocyanins and the formation of constituent 
phenolic acids over time under thermal conditions. Studies by Sadilova et al. 
(Sadilova, Stintzing et al. 2006; Sadilova, Florian et al. 2007) investigated the 
thermal degradation of acylated and non-acylated anthocyanins of strawberry, 
elderberry and blackcarrot at 95 oC over 6-7 hours. At pH 1 it was shown that 
the half life of pg-3-glu, cy-3-glu and cy-3,5-diglu was 2.12, 1.95 and 0.98 
hours respectively, with an 81%, 93% and 68% loss of anthocyanins over 7 
hours. At pH 3.5, anthocyanins were shown to be completely lost after 6 hours 
at 95 oC. In both studies, the degradation of anthocyanins correlated with the 
formation of HBA, PCA and PGA. From these studies it has been proposed 
that the first step of thermal degradation is not anthocyanin de-glycosylation, 
but opening of the pyrylium ring and chalcone glycoside formation, followed by 
cleavage of anthocyanidin in chalcone form, which may then rapidly degrade 
to phenolic acids and aldehydes, respectively (Sadilova, Florian et al. 2007). 
Furthermore, a study by Seeram et al. (Seeram, Bourquin et al. 2001) 
demonstrated that anthocyanidins are degraded in pH 7 and 10 solutions at 
ambient temperature within 1 hour.   
 
1.3.2 Degradation during GIT digestion 
To understand anthocyanin bioavailability, information regarding their 
absorption, metabolism and excretion is paramount. Although complex animal 
and human studies have been utilized to determine the digestion, metabolism 
and excretion of anthocyanins, many studies have made use of in vitro 
procedures that mimic human physiochemical conditions. These include in 
vitro digestions, microsomal incubations and cell culture studies. In vitro 
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digestions generally consist of peptic and pancreatic-bile salt digestions, 
followed by dialysis diffusion, using cellulose dialysis tubing to simulate the 
mucus membrane of the lower gastrointestinal tract (GIT) and represent 
serum (diffused) and colonic (non-diffused) compartments (Perez-Vicente, Gil-
Izquierdo et al. 2002; McDougall, Dobson et al. 2005; McDougall, Fyffe et al. 
2005). Using these in vitro models, studies by McDougall et al. (McDougall, 
Dobson et al. 2005; McDougall, Fyffe et al. 2005) showed that the recovery of 
pure phenolic acids following peptic digestion is near 100% (McDougall, 
Dobson et al. 2005), while the recovery of anthocyanins was between 70-
90%. This indicates that anthocyanins remain fairly stable during peptic 
digestion in the stomach (pH ~2) and are passed intact to the upper intestinal 
tract. Poor anthocyanin recovery is reported following pancreatic and bile salt 
digestion (pH 6-7), with only a ~38% recovery (Perez-Vicente, Gil-Izquierdo et 
al. 2002; McDougall, Dobson et al. 2005; McDougall, Fyffe et al. 2005). To 
account for this poor recovery, further characterisation of anthocyanin 
degradation during simulated digestion is necessary (and is a focus of the 
present thesis; Chapter 4), since the loss of anthocyanins has not yet been 
fully accounted for (Figure 1.6).  
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Figure 1.6: Current knowledge of anthocyanin absorption and degradation in the upper GIT. 
 
 
The absence of aglycone structures and the low recovery of anthocyanins 
following peptic and pancreatic-bile salt digestions would suggest that 
anthocyanins are de-glycosylated and degraded during digestion (Seeram, 
Bourquin et al. 2001; Keppler and Humpf 2005; Fleschhut, Kratzer et al. 2006; 
Sadilova, Stintzing et al. 2006; Kern, Fridrich et al. 2007). However, a study by 
Perez-Vicente et al. (Perez-Vicente, Gil-Izquierdo et al. 2002) demonstrated 
that glycoside hydrolysis does not occur during gastric digestion, reporting 
complete anthocyanin recovery. Thus, the enzymatic and non-enzymatic 
hydrolysis of anthocyanins under intestinal digestion should be a focus for 
further research (and is a focus of the present thesis; Chapter 4).  
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1.4 Anthocyanin metabolism and bioavailability 
 
1.4.1 Absorption 
The elucidation of xenobiotic metabolism requires information about their 
absorption, distribution, metabolism and excretion (ADME). Gastrointestinal 
metabolism and absorption of many compounds, including flavonoids, is site 
specific and under the control of numerous physiological factors. Fluid pH and 
compound ionization (pKa) alters passive diffusion across physiological 
barriers, including those of the gastrointestinal tract and mucosal surface 
area. Specialized transport systems, the permeability of macromolecules and 
glycosylation also play an important role in site specific absorption of 
xenobiotics. Aglycones, such as anthocyanidins, are predominantly more 
hydrophobic and may be absorbed via passive diffusion, while glycosides, 
such as anthocyanins, are more hydrophilic and either requires an active 
transport system or hydrolysis before absorption, suggesting the absorption 
primarily takes place in the intestine. Nevertheless, the exact mechanism of 
anthocyanin absorption is yet to be established, including whether they may 
enter the enterocyte as intact molecules or are cleaved and absorbed as 
aglycones or metabolites.  
 
Evidence from in vitro studies suggest that anthocyanins are able to cross cell 
membranes and are detectable within the cytosol, where the glycosides have 
a higher transport efficiency than the aglycones (Sichel, Corsaro et al. 1991; 
Youdim, Martin et al. 2000; Yi, Akoh et al. 2006). Initially it was believed that 
the mechanism of anthocyanin absorption was similar to that of other 
flavonoids, where transport is facilitated by either the activity of sodium 
glucose transporter co-transporter (SGLT) or extracellular hydrolysis via 
lactate phlorizin hydrolase (LPH) followed by passive diffusion. However, 
studies by Hollman et al. and Arts et al. (Hollman, Bijsman et al. 1999; Arts, 
Sesink et al. 2004) demonstrated that inhibition of both SGLT and LHP did not 
significantly reduce the absorption of cy-3-glu by jejunal tissue. Therefore, 
some other mechanism may be responsible for anthocyanin absorption.  
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Recently a plant homologue to the mammalian bilirubin transporter, 
bilitranslocase has been identified (Passamonti, Vrhovsek et al. 2002; Sabina, 
Alessandra et al. 2005).  Bilitranslocase operates as a uniporter, shown to 
catalyze the electrogenic transport of bromosulfophthalein (Sabina, 
Alessandra et al. 2005), a structural mimic of flavonoids. Indeed, the current 
body of evidence (Passamonti, Vanzo et al. ; Passamonti, Vrhovsek et al. 
2002; Sabina, Alessandra et al. 2005; Karawajczyk, Drgan et al. 2007) 
suggests that bilitranslocase is a flavonoid membrane transporter with 
phylogenetic origins. Considering the physiological implications, anthocyanin 
interactions with bilitranslocase suggests that it could promote the transport of 
anthocyanins from the lumen into the epithelial layers of the gastric mucosa. 
This potential aspect of anthocyanin absorption should be the focus of future 
research.    
   
1.4.2 Microfloral metabolism 
Colonic microflora are thought to play a major role in flavonoid metabolism, 
where heterocyclic ring fission is wholly mediated by microorganisims in the 
colon, although some studies have shown that methoxy groups on the B-ring 
structure infer resistance to bacterial ring fission (Hollman and Katan 1998). 
Ring fission of flavonoids generates phenolic acids which may subsequently 
be absorbed and excreted or further degraded. In vitro studies have shown 
that phenolic acids are susceptible to microbial metabolism, including 
dehydroxylation, demethylation, reduction and decarboxylation. Although it is 
clear that many flavonoids undergo microfloral metabolism, few studies report 
the bacterial transformations of anthocyanins. Studies investigating the 
colonic metabolism of anthocyanins show that the anthocyanins cy-3-glu, mv-
3-glu, cy-3,5-diglu, mv-3,5-diglu, cy-3-rut and pn-3-glu are hydrolysed within 
20 minutes to 2 hours of incubation with colonic fermentations and that mono-
glycosides are hydrolysed faster than di-glycosides (Aura, Martin-Lopez et al. 
2005; Keppler and Humpf 2005; Fleschhut, Kratzer et al. 2006). Interestingly, 
cy-3-rut was metabolised at a greatly decreased rate, with significant amounts 
still detectable after 2 hours, in a study by Keppler and Humpf (Keppler and 
Humpf 2005). However, the breakdown of anthocyanins and their degradation 
products (phenolics) by enteric microflora is very similar to that observed in 
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sterile incubations (Keppler and Humpf 2005), suggesting that spontaneous 
pH dependent degradation was responsible. It was shown that PGA was 
degraded to phloroglucinolate only in the presence of enteric microflora, 
suggesting that this biotransformation does not occur spontaneously. The 
microfloral biotransformation of syringic acid and vanillic acid was 
accompanied by the formation of demethylated gallic acid and protocatechuic 
acid in Keppler’s study. However, these finding are contradicted in a study by 
Fleschut et al. (Fleschhut, Kratzer et al. 2006), showing that phenolic acid 
transformation was not observed, although decarboxylation and 
dehydroxylation of protocatechuic acid was identified. Nonetheless, these 
studies have been conducted in systems which do not account for intestinal 
metabolism or absorption, and consisted of in vitro fermentation experiments.  
 
1.4.3 Phase I and II metabolism 
Absorption of most compounds from the GIT is usually associated with 
intestinal and/or hepatic metabolism, where they undergo biotransformation, 
such as hydroxylation, methylation, glucuronidation or conjugation by phase I 
and phase II enzymes in the liver. In many early studies, only un-metabolised 
anthocyanins were identified in the systemic circulation, possibly mistaking 
glucuronides for glycosides due to their similar polarities and UV-vis 
characteristics (Lapidot, Harel et al. 1998; Cao and Prior 1999; Matsumoto, 
Inaba et al. 2001). More recent studies using mass spectrometry techniques 
have identified glucuronides and sulphates of anthocyanins in plasma and 
urine samples, suggesting that anthocyanins, like other flavonoids, are 
extensively conjugated in vivo. 
 
Glucuronidation is the foremost conjugating pathway in mammals, during 
which, hydroxyl, carboxyl or amino groups are conjugated with glucuronic acid 
via UDP-glucuronyl transferase (UGT). Glucuronidation is also the principal 
conjugation pathway of many flavonoids (O-glucuronidation) in a wide range 
of tissues, including liver, lung, kidney, skin, brain and intestine. Markedly, 
glucuronides do not appear to be readily available for biliary excretion (Dutton 
1980), suggesting that intestinal glucuronidation may facilitate the rapid 
transfer of anthocyanins into the systemic circulation.  
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Methylation, another common metabolic conjugation pathway for flavonoids, 
occurs via the actions of methyltransferases, such as 
catecholmethyltransferase (COMT), found primarily in the liver and intestine. 
Studies have demonstrated that low doses of flavonoids are extensively 
methylated in humans and animals (Kuhnle, Spencer et al. 2000; Williamson, 
Day et al. 2000). Flavonoids may also undergo sulphation and amino acid 
conjugation (Williamson, Day et al. 2000). Sulphation is catalysed by the 
sulphotransferases, which are cytosolic enzymes found throughout the body. 
It should be noted that sulphation is an ATP and sulphate dependant reaction, 
and thus is highly saturatable, which yields low levels of conjugates.  
 
1.4.4 Pharmacokinetics 
Following GIT digestion and metabolism, anthocyanins and their metabolites 
may be released into the systemic circulation and eventually excreted. There 
have been many studies over the past decade investigating the serum 
recovery of anthocyanins, which all demonstrate that ingested anthocyanins 
are absorbed and excreted intact as glycosylated or glucuronidated 
compounds (Miyazawa, Nakagawa et al. 1999; Bub, Watzl et al. 2001; Cao, 
Muccitelli et al. 2001; Matsumoto, Inaba et al. 2001; Netzel, Strass et al. 2001; 
Mazza, Kay et al. 2002; Mulleder, Murkovic et al. 2002; Rechner, Kuhnle et al. 
2002; Wu, Cao et al. 2002; Felgines, Talavera et al. 2003; Nielsen, Dragsted 
et al. 2003; Bitsch, Netzel et al. 2004; Kay, Mazza et al. 2004; Kay, Mazza et 
al. 2005; Manach, Williamson et al. 2005; Tian, Giusti et al. 2006; Charron, 
Clevidence et al. 2007; Vitaglione, Donnarumma et al. 2007). In vivo 
anthocyanin bioavailability studies usually consist of volunteers consuming 
single doses of anthocyanins, ranging from 150mg to 2g, in the form of 
berries, berry extracts or concentrates. Anthocyanin absorption has been 
shown to be very low, with the total anthocyanins (parent and metabolised 
compounds) plasma recovery in the order of 1-200nmol/l (<0.1% of ingested 
dose), reaching the systemic circulation within 1.5 hours (usually between 0.7-
4 hours) of ingestion. Likewise, urine concentrations have been shown to 
reach similar levels within 2.5 hours, demonstrating rapid absorption and 
elimination (Miyazawa, Nakagawa et al. 1999; Bub, Watzl et al. 2001; Cao, 
Muccitelli et al. 2001; Matsumoto, Inaba et al. 2001; Netzel, Strass et al. 2001; 
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Mazza, Kay et al. 2002; Mulleder, Murkovic et al. 2002; Rechner, Kuhnle et al. 
2002; Wu, Cao et al. 2002; Felgines, Talavera et al. 2003; Nielsen, Dragsted 
et al. 2003; Bitsch, Netzel et al. 2004; Kay, Mazza et al. 2004; Kay, Mazza et 
al. 2005; Manach, Williamson et al. 2005; Tian, Giusti et al. 2006; Charron, 
Clevidence et al. 2007; Vitaglione, Donnarumma et al. 2007). In addition to 
the parent compounds, anthocyanins are found in the circulation and excreted 
as glucuronide, methyl and sulphate conjugates. Studies by Kay et al. (Kay, 
Mazza et al. 2004; Kay, Mazza et al. 2005) demonstrated that following the 
ingestion of anthocyanins, the parent compounds represents only 32% of the 
total anthocyanins detected in serum, with 68% identified as conjugated 
metabolites. Similar to the serum availability, only 32% of the anthocyanins 
excreted in the urine were as parent structures where 67% were shown to be 
conjugated metabolites. Of these metabolites, glucuronidation was the major 
metabolic pathway observed for anthocyanins (representing 59% and 57% of 
the total anthocyanins detected in the blood and urine, respectively), followed 
by methylation (representing 43% and 51% of the total anthocyanins detected 
in the serum and urine, respectively).  
 
Whilst these studies show that less than 1% of the ingested anthocyanin dose 
is detectable in urine or plasma, no conclusive explanation for their 
disappearance has been agreed. It remains to be shown whether this 
disappearance is due to degradation of anthocyanins to constituent phenolic 
acids and aldehydes and subsequent conjugation, or due to poor absorption. 
As the appearance of anthocyanins in serum is rapid (Hollman and Katan 
1998), it is unlikely that the disappearance of anthocyanins is due to poor 
absorption. Rather, it is likely that anthocyanins form intermediate or end 
stage degradation products during digestion, absorption and metabolism that 
have yet to be identified in vitro (this is a focus of the present thesis; Chapter 
4) or in vivo. Markedly, PCA and HBA have been identified in the plasma of 
rats following high doses of cy and pg glucosides, although very little research 
has attempted to identify these phenolic acids in the plasma of humans. 
Currently, a study by Vitaglione (Vitaglione, Donnarumma et al. 2007) was the 
first to partially account for the low systemic availability of anthocyanins in 
humans, where almost 73% of ingested cy was accounted for by the formation 
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of PCA. This suggested that ingested anthocyanins are primarily availably to 
the systemic circulation as phenolic acid derivatives. Further research is 
necessary to establish the extent to which anthocyanins are degraded and 
subsequently metabolised in humans, in order to account for their loss during 
in vivo studies (which is a focus of the present thesis; Chapter 4). 
 
1.5 Anthocyanins in the prevention of cardiovascular disease 
 
It has long been thought that diets rich in anthocyanins and flavonoids may 
confer a protective effect against cardiovascular disease and mortality. 
Indeed, this hypothesis has been driven by findings from numerous 
epidemiological and experimental studies. Whilst the epidemiological 
evidence for the protective effects of flavonoid rich diets on cardiovascular 
protection is mixed, the majority of studies are in support of their positive 
effects (Hertog, Feskens et al. 1993; Hertog, Kromhout et al. 1995; Knekt, 
Jarvinen et al. 1996; Rimm, Katan et al. 1996; Hertog, Sweetnam et al. 1997; 
Hertog, Feskens et al. 1997; Yochum, Kushi et al. 1999; Arts, Jacobs et al. 
2001; Geleijnse, Launer et al. 2002; Knekt, Kumpulainen et al. 2002; Sesso, 
Gaziano et al. 2003; Lin, Rexrode et al. 2007; Mink, Scrafford et al. 2007). 
Furthermore, a study by Mink et al. (Mink, Scrafford et al. 2007), a large 
prospective study of postmenopausal women over a 16 year period, showed 
that dietary intakes of anthocyanins were associated with a lower risk of 
mortality and cardiovascular disease. At the experimental levels, anthocyanins 
have been shown in numerous animal (and some human) studies to prevent 
or reduce factors associated with  cardiovascular and inflammatory disease 
(Oak, Bedoui et al. 2006; Xia, Ling et al. 2006; Yamamoto, Naemura et al. 
2006; Sorrenti, Mazza et al. 2007; Xia, Ling et al. 2007; Leblais, Krisa et al. 
2008; Toufektsian, de Lorgeril et al. 2008), carcinogenesis (Feng, Ni et al. 
2007; Rossi, Garavello et al. 2007; Elisia and Kitts 2008) and obesity (Tsuda, 
Horio et al. 2003; Tsuda, Ueno et al. 2004; Jayaprakasam, Olson et al. 2006; 
Sasaki, Nishimura et al. 2007).  
 
33 
 
Initially, the beneficial effects of anthocyanins had been linked to their 
antioxidant potential and radical scavenging activities. However, current 
research suggests a mechanism of action that is not related to their direct 
radical scavenging properties, where the primary mechanism for their 
observed health benefits remains unclear. The following sections of this 
review provide an account for both the antioxidant and non-radical scavenging 
mechanisms by which anthocyanins are thought to modulate the development 
of oxidative diseases, with particular focus on cardiovascular disease and 
endothelial dysfunction.  
 
1.5.1 Anthocyanins as antioxidants 
Since the 1980s, it has been thought that the partial reduction of oxygen was 
a deleterious reaction leading to the non-specific modification of biological 
molecules and toxicity. This idea later became known as the “oxidative theory 
of disease” fuelled by the production of free radicals. Free radicals are defined 
as any chemical species possessing an un-paired electron, which in a 
biological context may be considered a “fragment of a molecule”. They are 
formed via three fundamental mechanisms, namely, through the homolytic 
cleavage of a covalent bond, loss of a single electron or gain of a single 
electron. The latter is referred to as electron transfer and is the most common 
in biological systems. 
 
Radical formation by electron transfer: A + e- = A-˙   
Radical formation by homolytic fission: X:Y = X˙ + Y˙ 
 
Perhaps the most important free radicals in biology are those derived from 
oxygen, dubbed “reactive oxygen species” (ROS), where a one electron 
reduction of oxygen results in the formation of the superoxide free radical 
anions and a two-electron reduction results in the formation of hydrogen 
peroxide.  
O2 + e- = O2-˙ 
O2 + 2e- = H2O2  
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Within a biological context, hydrogen peroxide is commonly produced via 
superoxide, where two superoxide molecules may react together to form 
hydrogen peroxide and oxygen. 
 
2O2-˙+ 2H+ = H2O2 + O2 
 
Hydrogen peroxide is an important molecule in biology because it is easily 
broken down to produce the most reactive of the oxygen free radicals, the 
hydroxyl radical (OH˙). Although the production of ROS from oxygen is 
reviewed in great depth elsewhere (Cheeseman and Slater 1993), a 
description of the key ROS in human vasculature (oxygen, superoxide, 
hydrogen peroxide and the hydroxyl radical) is warranted. Superoxide may 
not, itself, be considered a particularly detrimental ROS. However, its main 
significance as a damaging ROS is as a source of hydrogen peroxide and as 
a reductant of transition metal ions. Superoxide is particularly significant in 
cardiovascular disease as a derivative reactant with nitric oxide. Once 
superoxide is converted to hydrogen peroxide, it may quickly react with 
transition metal ions to produce hydroxyl radicals. Hydroxyl radicals may then 
react with most biological molecules, at a diffusion limited rate, to cause many 
detrimental alterations to cellular mechanisms (Cheeseman and Slater 1993). 
 
It had first been proposed that anthocyanins, as with other flavonoids, exert 
their biological effects through a ROS scavenging mechanism (Kuhnau 1976; 
Bors, Heller et al. 1990; Sichel, Corsaro et al. 1991).  Although a balanced 
level of oxidation is vital for the homeostasis of living processes, it is clear that 
an excess of free radicals is detrimental to biological organisms, causing 
oxidative damage to DNA, lipids, proteins and many other organic 
components (Halliwell 1994). However, there has been considerable interest 
in the therapeutic uses of exogenous antioxidant supplementation, including 
dietary derived phytochemicals in the safeguarding of correct redox 
homeostasis. There exists some controversy in the field regarding the true 
benefit of many dietary derived antioxidants, considering the efficiency and 
abundance of endogenous antioxidants and the availability of molecules such 
as vitamin C.    
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It should be noted that, in order to balance free radical production in the 
cellular environment (redox), cells produce a number of endogenous 
antioxidants. The redox status of cells are primarily maintained by glutathione 
(GSH) and thiol redox balance. GSH is a tripeptide and major low molecular 
weight thiol in cells, which controls the cellular thiol-disulfide redox state 
(Jones 2002). A cellular redox balance is achieved through the maintenance 
of the thiol to di-sulphide status of reduced GSH and its oxidized form GSSG 
(dimerised GSH).  
 
The role of ROS generation in human pathologies is well illustrated in 
atherosclerosis. Many of the pathologies associated with cardiovascular 
disease, including coronary artery disease, hypertension, heart failure and 
stroke, are attributed to oxidative mechanisms and the formation of 
atherosclerotic plaques and plaque rupture, dubbed ‘the oxidative theory of 
atherosclerosis” (Figure 1.7) (Schissel, Tweedie-Hardman et al. 1996; Tabas 
1999; Skalen, Gustafsson et al. 2002; Medeiros, Khan et al. 2004; Stocker 
and Keaney 2004; Williams and Fisher 2005).  Briefly, it is believed that 
oxidation of LDL at the sub-endothelial level (Schissel, Tweedie-Hardman et 
al. 1996; Tabas 1999; Skalen, Gustafsson et al. 2002; Medeiros, Khan et al. 
2004; Stocker and Keaney 2004; Williams and Fisher 2005) due to ROS 
generation by major cells of the arterial wall, including endothelial cells, 
smooth muscle cells, monocytes and macrophages, is primarily responsible 
for the exacerabation of CVD. However, there is no consensus on the 
predominant mechanism of LDL oxidation, although it is known that 
superoxide anions produced by vascular and immune cells mediate the 
progression of vascular disease via a mechanism that is attenuated by 
superoxide dismutase and metal chelators (Heinecke, Baker et al. 1986). 
Enzymes such as NAD(P)H oxidase, xanthine oxidase, lipoxygenase and un-
coupled nitric oxide synthase are thought to be the major sources of 
superoxide generation in vascular tissue (discussed below).  
36 
 
LDL
LUMEN
INTIMA
MEDIA
Endothelial 
cells
Smooth 
muscle cells
Proteoglycan
LDL retention
Oxidized LDL
Macrophage 
(CD36)
Monocyte T cellAdhesion molecules
(VCAM1,ICAM1 etc.) 
Foam cell
Cytokines
Growth factors
MCP1, M-CSF, 
Cytocines
Atherosclerotic lesions
 
Figure 1.7: The oxidative theory of atherosclerosis1. 
 
Anthocyanins have consistently been shown to possess novel and potent 
antioxidant properties (Igarashi, Takanashi et al. 1989; Costanino, Albasini et 
al. 1992; Tamura and Yamagami 1994; Tsuda, Watanabe et al. 1994) where a 
number of studies have reported the antioxidant activity of berry extracts and 
pure anthocyanins by several methods, including the common total 
antioxidant activity (TAA), Trolox equivalent antioxidant activity (TEAC) (Table 
1.5), oxygen radical absorbance capacity (ORAC) and DPPH radical 
scavenging capacity assays. In 1994, the antioxidant capacity of cyanidin-3-
glucoside and cyanidin was investigated by Tsuda et al (Tsuda, Watanabe et 
al. 1994), using linoleic acid auto-oxidation, liposomes, erythrocyte 
membranes and liver microsomes. In all systems, cyanidin-3-glucoside and 
cyanidin showed antioxidant activity, where cyanidin possessed a greater 
antioxidant capacity than its glucoside. Subsequently, the antioxidant capacity 
of a number of other anthocyanin species were studied and it has been shown 
                                            
1
 Adapted from Stocker, R. and Keaney, JF. (2004). Physiol Rev 84(4):1381-1478. 
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that the scavenging effect on hydroxyl and superoxide radicals is influenced 
by their structural characteristics. For example, delphinidin and cyanidin 
glycosides have relatively strong antioxidant activities compared with other 
anthocyanins. Indeed, the structure-antioxidant activity of many flavonoids, 
including anthocyanins, has been extensively studied and is reviewed in Rice-
Evans et al. (Rice-Evans, Miller et al. 1996). In this review and in studies by 
Bors et al. (Bors, Heller et al. 1990) and Sichel et al. (Sichel, Corsaro et al. 
1991), key structural characteristics have been identified as important 
antioxidant components in aqueous phases, using the TAA and TEAC assays. 
The three polyphenolic structural criteria for effective radical scavenging 
include, 1) a O-dihydroxy structure on the B-ring, conferring stability to the 
radical form and electron delocalization, 2) a 2,3 double bond in addition to a 
4-oxo function on the C-ring, where this structure reacts with free radicals to 
produce stable phenoxyl radicals via electron delocalization from the B-ring 
and 3) where maximal radical scavenging potential is achieved when 3- and 
5-OH groups on the A-ring are found in conjunction with a 4-oxo function on 
the C-ring. The effects of these structural characteristics on antioxidant 
capacity are clearly illustrated in studies comparing cyanindin, pelargonidin, 
delphinidin and malvidin derivatives (with antioxidant activity in the order of 
dp=cy>pg), in addition to other flavonoids, including quercetin (Q), morin (M), 
kaempferol (K) and myricetin (My) (Figure 1.8 and Table 1.5) (with 
antioxidant activity in the order Q>My>M>K).  
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Figure 1.8: B-ring hydroxylation patterns of orthodiphenolic structures. 
 
In a study by Youdim et al. (Youdim, Martin et al. 2000) it was shown that 
anthocyanins are incorporated into endothelial plasma membranes and 
cytosols, where these enriched endothelial cells confer significant protection 
against oxidative stress. In addition, several human trials (Netzel, Strass et al. 
2001; Mazza, Kay et al. 2002) and epidemiological studies (Mink, Scrafford et 
al. 2007) have demonstrated the beneficial role of anthocyanins and other 
flavonoids in cardiovascular disease prevention. However, due to the low 
bioavailability of anthocyanins and the controversy regarding the failure of 
some antioxidant supplementation trials (Fruebis, Steinberg et al. 1994; 
Witting, Pettersson et al. 1999; Stocker and Keaney 2004), it remains to be 
shown whether anthocyanin associated cardiovascular protection is due to 
direct radical scavenging capacity or via some other mechanism (a focus of 
this thesis; chapter 5). 
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Table 1.5. Flavonoid structure and free radical scavenging activity* 
2.53, 5, 7, 3', 5'Morin
3.13, 5, 7, 3', 4', 5'Myricetin
4.73, 5, 7, 3', 4'Quercetin
1.33, 5, 7, 4'Kaempferol
4.43, 5, 7, 3', 4', 5'Delphinidin
4.43, 5, 7, 3', 4'Cyanidin
1.33, 5, 7, 4'Pelargonidin
Antioxidant activity 
(TEAC**)
OH-SubstitutionFlavonoid
 
*Data taken from Rice-Evans et al. (1996). Free Rad. Biol. Med. 20(7): 933-956. **Measured in mM. Bold text refers to 
B-ring hydroxylated carbons.  TEAC, Trolox equivalent antioxidant activity. 
 
 
1.5.2 Vascular dysfunction, reactive oxygen generation and 
anthocyanins. 
 
Early researchers of cardiovascular disease observed that the rupture of the 
atherosclerotic plaque led to, or was preceded by, the recruitment of 
inflammatory cells (monocytes/macrophages), suggesting that cardiovascular 
disease and inflammation were inextricably linked and that atherosclerosis 
was not simply a degradative disease of the elderly. Subsequent work has 
sought to more precisely define the pathways involved in the development of 
cardiovascular disease and vascular inflammation. To date, an overwhelming 
body of evidence now clearly indicates that cardiovascular disease and more 
particularly, atherosclerosis, is a multi-factorial disease that may commence 
from childhood and clinically manifest later in life. These inflammatory 
diseases therefore represent viable targets for therapeutic intervention and 
are particularly amenable to low cost, long term and sustainable dietary 
interventions, through the actions of biologically active phytochemicals. 
Therefore it remains crucial that the cardiovascular effects of dietary 
phytochemicals, including anthocyanins, are established. 
 
Although the development of atherosclerosis is a multifactorial process, there 
is accumulating evidence that suggests the vascular production of reactive 
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oxygen species plays an important role in disease development, particularly 
since vascular superoxide production has been demonstrated to be 
associated with atherosclerotic risk factors. Although vascular superoxide may 
affect the vasculture in many different ways, perhaps their most significant 
effect occurs through their rapid reactivity with nitric oxide. Indeed, the 
bioactivity of eNOS is dependent on vascular levels of superoxide and other 
ROS. In particular, the rapid reaction of superoxide with NO results in the 
formation of peroxynitrite anions and loss of NO function. Furthermore, 
increased vascular superoxide promotes the oxidative degradation of 
tetrahydrobiopterin (BH4), leading to eNOS “un-coupling” and the increased 
production of superoxide. Nonetheless, there are many alternative sources of 
superoxide within the human vasculature, some of which have been 
implicated in endothelial associated pathologies. These superoxide 
generation systems include the mitochondria, xanthine/xanthine oxidase 
couple, uncoupled nitric oxide synthases, endothelial cytochrome P450 
enzymes, lipoxygenases and NADPH oxidases (Droge 2002). 
 
Numerous studies have recently suggested that anthocyanins could modulate 
oxidative diseases through mechanisms auxiliary to radical scavenging. The 
redox status of cells is an important factor in cellular homeostasis. This is 
illustrated by the induction of cells from quiescent states to proliferative or 
apoptotic states by sub-toxic levels of oxidative stress and mild shifts in 
cellular redox state. Furthermore, oxidants have been shown to trigger 
phosphorylation cascades that lead to the activation of mitogen activated 
protein kinases (MAPKs) and nuclear factor kB (NF-kB). Existing evidence 
suggests a possible link between cellular thiol redox status and NF-kB 
mediated gene expression, where altered GSH to GSSG ratio have been 
shown to activate NF-kB (Kokura, Wolf et al. 1999). Recent studies by Xia et 
al (Xia, Ling et al. 2003; Xia, Hou et al. 2005; Xia, Ling et al. 2006; Xia, Ling et 
al. 2007), have reported novel mechanisms by which plant pigments, including 
anthocyanins, may attenuate atherosclerosis development through the 
modulation of various redox sensitive signalling pathways. It was shown that 
in the absence of anthocyanins, ligation of the CD40 receptor by CD40L 
triggers the recruitment of TRAF-2 to lipid rafts and binding to CD40. This then 
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led to the activation of NFκB, which in turn initiated the transcription of IL-6, IL-
8 and MCP-1 (Frolov and Hui 2007). The significance of these pathways is 
demonstrated through the link between cholesterol metabolism and 
inflammatory response, where evidence suggests that the activation of CD40L 
and TLR are significantly involved in the cholesterol dependant development 
of atherosclerosis. Xia et al. (Xia, Ling et al. 2007) demonstrate that cy-3-glu 
and pn-3-glu renders the CD40-CD40L inflammatory pathway inactive through 
the inhibition of TRAF-2 recruitment and up regulates ABCA1-mediated 
cholesterol efflux to ApoA-1, reducing raft cholesterol content (Figure 1.9). 
 
CD40L
CD40
TRAF-2
NF-κB
Pro-atherogenic Transcription
Intracellular 
Cholesterol
Apo A-1
HDL
Pro-atherogenic
cytokines and 
chemokines
IL-6, IL-8, MCP-1
Cy-3-glu
 
Figure 1.9: Anthocyanin regulation of CD40-CD40L inflammatory pathway2. 
 
Heme catabolism to carbon monoxide, Fe2+ and biliverdin (converted to 
bilirubin by biliverdin reductase) is catalyzed by heme-oxygenase-1 (HO-1). 
These reaction products have been shown to modulate cell signal 
transduction pathways relevant to inflammation (Stocker, Yamamoto et al. 
1987), where Fe2+ induces ferritin expression and ATPase Fe2+ secreting 
pumps to decrease oxidation, increase vasodilatation and inhibit platelet 
aggregation. Similar to HO-1, It has been shown that flavonoids are able to 
inhibit the activity of NADPH oxidases (Tsuda, Ueno et al. 2006; Steffen, 
                                            
2
 Adapted from Xia et al. (2007). Arterioscler. Thromb. Vasc. Biol. 27(3): 519-524. 
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Gruber et al. 2008) (discussed below), although no conclusive evidence has 
been presented regarding the effects of anthocyanins on NADPH oxidase 
activity or expression.  
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Figure 1.10: Anthocyanin regulation of FasL, P38 and P53 mediated atherogenesis in vascular smooth 
muscle cells3. 
 
Ultimately, the many signal transduction pathways already described, lead not 
only to the development of atherosclerotic plaques, but also to the abnormal 
proliferation of vascular smooth muscle cells which play an important role in 
the pathogenesis of atherosclerosis and restenosis (Rivard and Andres 2000). 
In a study by Lo et al. (Lo, Huang et al. 2007), it has been demonstrated that 
anthocyanin rich berry extracts may induce apoptosis in proliferating smooth 
muscle cells, where it was suggested that anthocyanins promote smooth 
muscle cell apoptosis through the FasL mediated pathway, by inducing the 
expression of FasL and tBid (components of the mitochondrial associated 
apoptotic pathway) on the activation of p38 MAP kinase and phosphorylation 
of target c-Jun proteins, cleaving caspase-3 and 8 and releasing cytochrome c 
from the mitochondria (Figure 1.10).  However, a study by Oak et al. (Oak, 
                                            
3
 Adapted from Oak et al. (2006). Br. J. Pharmacol. 149(3):283-290. 
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Bedoui et al. 2006), contradicts these findings, where it was shown that 
anthocyanins with a 3’ hydroxyl are able to inhibit platelet derived growth 
factor (PDGF) induced vascular endothelial growth factor (VEGF) expression 
by preventing the activation of p38 MAPK and JNK in vascular smooth muscle 
cells. In addition, a study by Martin et al. (Martin, Favot et al. 2003) showed 
that Dp exerted anti-proliferative effects on basal and VEGF induced 
proliferation of bovine aortic endothelial cells through the transient activation 
of ERK 1 and 2.  
 
Overall, it is clear that whilst anthocyanins do possess significant radical 
scavenging capacities, they may also act via additional, or even superior, 
mechanisms not directly associated with their antioxidant activity. Therefore, 
the observed effects of anthocyanins on inflammation and cardiovascular 
disease may be due to their potential duality, both inhibiting inflammation and 
preventing its induction via free radical damage. Whilst anthocyanins may 
exert many biological affects associated with cardiovascular disease, few 
studies have investigated the effect of anthocyanin metabolites  on human 
health (investigated here in chapter 5), despite one study by Rechner and 
Kroner (Rechner and Kroner 2005) which showed that anthocyanins and their 
colonic metabolites effect various aspects of platelet function and aggregation. 
Therefore, the study of anthocyanin metabolism and its effects on human 
disease is of great importance to this research field.  
 
1.5.3 Endothelial Nitric oxide (NO) and vascular function/dysfunction 
While many risk factors affect endothelial phenotype, a consistently identified 
and defining determinant of endothelial dysfunction is insufficiency of nitric 
oxide (NO). NO functions as a profound vasodilator that is produced within the 
endothelium by type II (cytokine inducible) and type III (endothelial) nitric 
oxide synthase (eNOS/NOS3), reviewed extensively by Moncada et al. and 
Bredt et al. (Moncada, Palmer et al. 1991; Bredt and Snyder 1994) and 
described here in brief.  
 
NOS enzymes catalyze the conversion of L-arginine to nitric oxide that 
subsequently perform vasodilatory functions. Pro-inflammatory cytokines also 
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increase the activity of GTP-cyclohydrolase, the rate limiting enzyme in tetra-
hydrobiopterin production, which is a cofactor for NOS. Interestingly, NFκB, a 
redox sensitive transcription factor which regulates the expression of many 
pro-inflammatory cytokines, is stabilized by constitutively expressed NO 
through the maintenance of the NFκB subunit IκB, thereby attenuating pro-
inflammatory responses. Over the past three decades, NO has been identified 
as a principle mediator of vaso-protection by controlling vasodilatation, 
suppressing inflammatory cytokine and adhesion molecule release and 
limiting vascular smooth muscle proliferation, intimal fibrosis and platelet 
aggregation. Thus, its synthesis in appropriate amounts sustains vascular 
health and its loss is characteristic in atherothrombogenesis.  
 
The eNOS enzyme is constitutively expressed by the gene NOS3 and post-
transcriptional modification of target eNOS to the plasma membrane of 
vascular endothelial cells. The enzyme is rapidly activated by a number of 
antagonists, including acetylcholine, bradykinin, vascular endothelial growth 
factor (VEGF), shear stress and estrogens. A number of co-factors are also 
required for NOS generation of NO, including tetrahydrobiopterin (BH4), 
NADPH and flavins. Once produced, NO diffuses into the vessel lumen and 
underlying smooth muscle tissue. Platelet activity and smooth muscle 
relaxation occurs as NO activates guanylyl cyclase and raises cyclic 
guanosine monophosphate (cGMP) levels. NO also causes smooth muscle 
relaxation through calcium dependent potassium channels.  
 
Unfortunately, many potential sites for NO dysregulation exist. While many 
pathological situations may alter the amount, activity and cellular localization 
of eNOS or the availability of NO and its cofactors, this thesis was particularly 
focused on the mechanism of NO dysregulation through the excess 
production of ROS, particularly via the actions of endothelial NOX activity 
(described below).  
  
Many lines of evidence support a critical role for increased oxidative stress in 
atherosclerosis associated endothelial dysfunction. Furthermore, it has now 
been well established that endothelial dependent vasodilatation is impaired by 
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superoxide production, which is reversible with specific superoxide 
scavengers. However, it remains important to consider that endothelial 
dysfunction is not always reversible with short-term antioxidant infusion. For 
example, a study by Widlandsky et al. (Widlansky, Biegelsen et al. 2004) 
showed no effect of high concentration ascorbic acid on endothelial 
dysfunction in atherosclerotic coronary arteries. This, and other findings, is 
consistent with the understanding that ROS have complex effects on 
endothelial cell function beyond the direct inactivation of NO and oxidation of 
LDL and explain the failure of simple antioxidant strategies to reduce 
cardiovascular disease risk in many studies. Therefore, it remains essential to 
evaluate the effect of many potential dietary therapeutics, such as flavonoids, 
for biological actions beyond their simple radical scavenging capacity. Many 
studies have thus focused on strategies that act to reduce oxidative stress in 
the vasculature by inhibiting cellular sources of ROS, such as the NADPH 
oxidases (NOX).     
 
1.5.4 NADPH oxidases, vascular oxidation and flavonoids 
NAD(P)H oxidases (NOX) were first thought to be a superoxide generating 
enzymes found only in phagocytic cells. However, in recent years it has been 
established that endothelial cells express a superoxide generating enzyme 
analogous to phagocytic NADPH oxidase. Specifically, endothelial and 
vascular smooth muscle cell NADPH oxidase expression has been implicated 
as a major contributor to CVD development and has been extensively 
reviewed by Bedard et al. (Bedard and Krause 2007), described here in brief. 
 
Endothelial NADPH oxidases, like many other enzymes, are proteins that 
transfer electrons across biological membranes. However, in the case of 
NOX, the primary electron acceptor is oxygen which subsequently is reduced 
to form super oxide. It may therefore be said that NOX enzymes are potent 
generators of vascular superoxide. All NOX family members are trans-
membrane proteins which usually possess an NADPH binding site, a FAD 
binding site, six conserved trans-membrane regions and heme-binding 
histidines. Currently, seven NOX family members have been identified (NOX 
1, 2, 3, 4 and 5, DUOX 1 and 2) which each possesses slightly different 
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structures, tissue distributions and cellular localizations. NOX 2, otherwise 
known as gp91phox, was the first NOX enzyme identified in phagocytes and 
was later identified in endothelial cells. The activation of NOX2 is reliant on a 
number of complex protein/protein interactions with membrane and cytosolic 
subunits. Functionally, NOX2, as with many NOX enzymes, are unstable in 
the absence of the membrane subunit p22phox. Furthermore, activation of 
NOX2 requires the translocation of cytosolic factors to the NOX2/p22phox 
complex (also known as flavocytrochrome b558). Current evidence suggests 
that the phosphorylation of p47phox (the ‘organizer’ subunit) allows for the 
interaction with p22phox which promotes the recruitment of an ‘activator’ 
subunit, called p67phox, to the NOX2 complex. This in turn allows for the 
recruitment of p40phox. Finally, NOX interaction with GTPase RAC, via a two 
step mechanism, allows the transport of electrons from NADPH in the cytosol, 
across the NOX2 complex, to oxygen on the luminal or extracellular space. Of 
note, the NOX isoform, NOX4, found in kidney, endothelial and vascular 
smooth muscle cells, is the most abundantly expressed isoform in vascular 
endothelial cells and is the primary catalytic unit for vascular ROS generation.  
 
At present, there is mounting evidence that dietary derived polyphenolic 
compound may modulate the production of vascular superoxide by NOX 
enzymes. Recent studies by Davalos et al. (Davalos, de la Pea et al. 2009) 
and Sarr et al. (Sarr, Chataigneau et al. 2006) have demonstrated that red 
grape polyphenols decrease phagocyte NOX expression and superoxide 
overproduction in humans and rats. However, their remains no published data 
regarding anthocyanins and vascular NOX expression or activity (a focus of 
this thesis; chapter 5). This should be a primary focus for future research, 
since the proposed anthocyanin metabolites (described in chapter 4) bare a 
striking resemblance to the well established NOX inhibitor, apocynin (review 
at length in Stefanska et al. (Stefanska and Pawliczak 2008)). Indeed, it has 
been demonstrated that apocynin undergoes dimerization under physiological 
conditions, which allows it to inhibit p47phox binding to gp91phox (NOX2) in a 
dose dependent manner. Further evidence for the potential role of dietary 
polyphenols and NOX enzyme modulation may be observed in quercetin and 
ursolic acid. To date, there have been numerous studies investigating the 
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effect of quercetin on NOX enzyme superoxide production and vascular 
health. Overall these studies indicate that quercetin and other similar 
compounds (e.g. 3,4-dihydroxyflavonol, chrysin and isorhamnetin), prevent 
vascular superoxide production by reducing overexpression of p47phox and 
subsequent loss of NO production though eNOS “uncoupling” (Sanchez, 
Galisteo et al. 2006; Sanchez, Lodi et al. 2007; Romero, Jiménez et al. 2009). 
Some suggest that this effect is related to protein kinase C (PKC) inhibition 
(which is necessary for p47phox phosphorylation and activation). In a study by 
Steinkamp-Fenske et al. (Steinkamp-Fenske, Bollinger et al. 2007) it was 
shown that ursolic acid from the Chinese herb Danshen down regulated 
NOX4 and increased eNOS promoter activity in human endothelial cells. 
 
Since it is evident that phenolic acids may modulate NOX activity, flavonoids 
and their metabolites should be the focus of future research in the flavonoids 
field. To this end, little published data exists regarding the effects and 
flavonoid metabolites on NOX and/or eNOS activity. However, research 
conducted by Steffen et al. (Steffen, Schewe et al. 2007; Steffen, Gruber et al. 
2008) suggest that the methylated metabolites of (-)-epichatechin mediates 
the activity of endothelial NOX superoxide production and downstream NO 
availability. Future work should thus include structure-activity relationship 
studies for flavonoids, their metabolites and NOX activity (investigated in 
chapter 5).  
 
Overall, our understanding of vascular NADPH oxidases and its impact on 
vascular dysfunction and NO activity has increased substantially in recent 
years. However, much remains to be learned, not only about the function and 
stimuli of these enzyme systems, but also the elucidation of targeted 
therapeutic agents. The discovery of specific inhibitors of NOX-based 
oxidases, particularly deriving from the diet, could provide invaluable tools for 
the prevention and treatment of a broad range of oxidative diseases. Indeed it 
may be found that anthocyanins and their metabolites represent viable agents 
for the dietary prevention or treatment of cardiovascular and oxidative 
diseases. However, before this claim can be made, further knowledge of 
anthocyanin stability, metabolism and mechanisms of action is required.      
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1.6 Analytical methods for assessing anthocyanins 
  
1.6.1 Analytical analysis of anthocyanins 
As berry fruits represent an important dietary source of anthocyanins, they 
have been used in many studies of assessing anthocyanin metabolism and 
bioactivity. This usually requires the extraction of anthocyanins from raw fruit 
matrixes and subsequent purification. Initially, berry samples are 
homogenized (Gao and Mazza 1994) or frozen with subsequent grinding in 
liquid nitrogen (Labarbe, Cheynier et al. 1999). Following homogenization, 
centrifugation may be employed to recover juices, whilst solid phase 
extraction (SPE) (Dugo, Mondello et al. 2001) and/or liquid-liquid extractions 
(LLE) (Rodriguez-Saona, Giusti et al. 1998) may be used to isolate 
anthocyanins from sample homogenates or juices. However, it should be 
noted that due to the unstable nature of anthocyanin, these common 
extraction techniques are usually conducted under acidified conditions, in 
order to prevent the degradation of anthocyanins. To avoid chemical 
modification during extraction with solvents (commonly methanol, ethanol or 
acetone), mixtures should be acidified with organic acids (e.g. acetic of formic 
acid) (Goto 1987). In addition, high temperatures should be avoided during 
the extraction of anthocyanins as anthocyanins are known to be unstable in 
temperature exceeding 30 °C (Goto 1987). Various so lvent-to-sample ratios 
have been used for the extraction of anthocyanin from plant material, where 
two or more re-extractions of solid residues may be required in order to 
achieve maximum anthocyanin recovery.  
 
SPE has been extensively used for the purification of anthocyanins from crude 
extracts, allowing for the removal of large amount of undesirable products, 
such as sugars, acids, amino acids and proteins. Usually, pre-conditioned 
SPE cartridges (C18 cartridges conditioned with methanol) are washed with 
several column volumes of acidified water (commonly 0.01% HCl or 3% formic 
acid) (Garcia-Viguera, Zafrilla et al. 1998; Wang, Kalt et al. 2000; Kahkonen, 
Hopia et al. 2001), followed by elution with acidified solvents. Furthermore, 
improved sample purity and reduced interference with less polar 
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polyphenolics may be achieved by washing with ethyl-acetate (Kondo, 
Ohnishi et al. 1999). Besides SPE, paper, thin layer and column 
chromatography have been used for the purification of anthocyanins. 
Preparative liquid chromatography (prep-LC) is also a widely used technique 
for the isolation of anthocyanins from a variety of plant matrices.  
 
No standard method for the isolation of anthocyanins from biological fluids 
have been established; although there are several important factors that 
should be considered. As anthocyanins are polar structures, they should be 
extracted in polar solvents, such as water, methanol or ethanol. Due to their 
poor stability, it is recommended that temperatures during extraction remain 
below 30 °C and that the pH be maintained at 1-2 (M azza, Cacace et al. 
2004). The most common extraction procedures include filtration, 
centrifugation and collection of the subsequent supernatants or reversed-
phase SPE using C8 or C18 cartridges (Mazza, Cacace et al. 2004). 
Following these procedures, samples may be directly injected onto an LC 
column for quantification.    
 
The most widely employed method for the quantification of anthocyanins is 
UV-Vis spectroscopy, as anthocyanins possess unique UV absorption 
spectra, with maximum absorbance at about 520 nm. Since the 1960s, a pH 
differential method has been employed for the rapid, non-specific, 
quantification of anthocyanins, and does not require the use of any elaborate 
analytical equipment. This method is normally used to quantify the total 
anthocyanin content of a fluid and takes advantage of the anthocyanins ability 
to shift in colour, moving from deep red/blue, at pH 1, to near colourless, at pH 
4.5. The total monomeric anthocyanin content may be calculated based on 
their extinction coefficients and difference in optical densities at pH 1 and pH 
4.5 (Markham 1982). However, more specific methods are required to identify 
and characterise the anthocyanin profiles of complex solutions. 
 
Liquid chromatography (LC) is the most widely used technique for 
anthocyanin quantification today, with many different methods having been 
developed (Markham 1982; Doerge, Chang et al. 2000; Wang, Kalt et al. 
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2000; Chandra, Rana et al. 2001; Nyman and Kumpulainen 2001; Nielsen, 
Haren et al. 2003; Nakajima, Tanaka et al. 2004; Wu and Prior 2005; Aaby, 
Ekeberg et al. 2007; Cristina Alcalde-Eon 2007). Briefly, reversed-phase 
columns with binary aqueous acidified solvents (water, methanol or 
acetonitrile acidified with acetic, trifluoracetic or formic acid) are commonly 
used, with detection on a photo-diode array detector (DAD) recording at 
280nm, 320nm and 520nm. Anthocyanin analytical standards are commonly 
used as references for identification and quantification. However, the limited 
availability of many anthocyanin standards is a significant factor hindering the 
characterisation of anthocyanin metabolism and bioavailability. In the absence 
of relevant analytical standards, anthocyanin quantification requires 
extraction, isolation, purification, and identification using LC-MS and NMR 
techniques. Recently, capillary zone electrophoresis (CZE) has been 
employed for the analysis of anthocyanins. This technique combines aspects 
of chromatography and electrophoresis, separating compounds based on their 
electrophoretic motility (Issaq 1999; Issaq, Chan et al. 1999; Ichiyanagi, 
Tateyama et al. 2000). However, this technique cannot offer the separation of 
complex mixtures that can be achieved with LC-DAD (da Costa, Horton et al. 
2000).  
Although LC is a reliable and relatively simple technique for the quantification 
of anthocyanins, the identification and quantification of anthocyanin and their 
metabolites in biological fluids is inherently difficult. The instability of 
anthocyanins at higher pH values makes the identification and quantification 
of metabolites via enzymatic methods particularly problematic. In addition, the 
liberation of aglycone products greatly increases the rate of degradation. For 
this reason, identification of anthocyanins is not always possible by enzymatic 
methods and requires further methods of identification.   
 
Several methods are employed for the identification and characterisation of 
anthocyanins, exploiting various aspects of their physical and chemical 
properties. UV-vis spectroscopy is extensively used to identify anthocyanins 
based on their unique spectral characteristics, described at length in reviews 
by Harboune (Harborne 1958) and Markham (Markham 1982). Cleaving of 
glycosides by acid hydrolysis with subsequent identification and quantification 
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of resultant aglycone structures and individual sugars is a common means of 
identifying anthocyanins. In addition, enzyme hydrolysis, mass spectrometry 
(MS) and nuclear magnetic resonance spectroscopy (NMR) have been 
extensively used for the identification of anthocyanins and their biological 
constituents and metabolites (Markham 1982; Doerge, Chang et al. 2000; 
Wang, Kalt et al. 2000; Chandra, Rana et al. 2001; Nyman and Kumpulainen 
2001; Nielsen, Haren et al. 2003; Nakajima, Tanaka et al. 2004; Wu and Prior 
2005; Aaby, Ekeberg et al. 2007; Cristina Alcalde-Eon 2007).   However, 
whilst the qualitative and quantitative analysis of anthocyanins have 
successfully been achieved using the methods described above, little or no 
reported data exists regarding many aspects of anthocyanin analysis, 
including robust techniques for the identification of metabolites and their 
stability or recovery under analytical conditions, such as extraction, isolation 
or purification (a focus in this thesis; chapter 3).  
 
1.7 Concluding remarks 
 
It has here been illustrated that anthocyanins potentially possess significant 
biological activities that could prove beneficial to human health. However, it 
has been highlighted that their true health benefits are unclear; due to gaps in 
the current literature. The most important of these gaps include a full account 
for the very poor bioavailability of anthocyanins and the incorporation of this 
information into bioactivity studies (i.e. use of appropriate metabolites and 
physiological concentration in in vitro studies). Therefore, in order to fully 
appreciate the health related benefits of ingested anthocyanins, an 
understanding of their occurrence, biochemistry, metabolism and final 
bioactive mechanisms is essential, and was the focus of the current thesis. By 
enhancing our knowledge of the afore mentioned gaps in our knowledge, a 
fuller appreciation for the importance of investigating the health related 
benefits of flavonoid consumption and the significance of metabolism and 
structural characterisation in elucidating their mechanisms of action might be 
achieved.
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Chapter 2 
 
Anthocyanin occurrence in blackcurrants and their stability 
during juice processing 
 
This study fulfilled the Collaborative Awards in Science and Engineering 
(CASE) portion of this BBSRC-CASE studentship 
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2.1 Introduction 
 
Within the food industry anthocyanins play an important role in food quality, 
where they are extensively used as “natural” food colorants (Robert L, Rickey 
Y et al. 1987). In addition to this role, it has been shown in numerous studies 
(both epidemiologically and experimentally) that anthocyanins may be 
protective against chronic diseases, including cardiovascular disease and 
cancer (Galvano, La Fauci et al. 2004; Hooper, Kroon et al. 2008). Berry fruits 
generally contain high concentrations of anthocyanins; however, their 
consumption as fresh produce is restricted due to their short seasonal 
availability and relatively high cost. Therefore, only small proportions of 
berries are consumed fresh, with most of their intake coming from processed 
foods, such as frozen products, juices, jams, jellies etc (Caswell 2009). 
Understanding the potential health benefits of anthocyanins therefore requires 
the establishment of their degradation or alteration during commercial 
processing, which will ultimately impact the final polyphenolic profile of 
processed foods.  
 
The processing of fresh berries to juice concentrates requires many 
processing stages, including milling, pressing, pasteurization, filtration, 
clarification and concentration. In addition, enzymatic depectinization is often 
employed to facilitate the pressing process, since endogenous sugars readily 
form pectin based gels at low pH levels (Buchert, Koponen et al. 2005; Wang, 
Xu et al. 2008), which may severely influence pressing efficiency and final 
product yields. As these enzymes possess glycosidase activities, they may 
represent an important influence on anthocyanin stability, since the hydrolysis 
of anthocyanins to aglycones severely decreases their stability in aqueous 
media (Markakis 1974). Sodium bisulphite is also frequently added during fruit 
processing to minimize the oxidation of colour components (such as 
anthocyanins), flavour and ascorbic acid (Markakis 1974). In addition, in order 
to bring thermally sensitive colloidal substances out of solution, pressed juices 
are commonly heated to a holding temperature in excess of 100 °C, known as 
a ‘hot break’ which is thought to improve final juice yields during pressing and 
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aid depectinization and pasteurization (Goodman, Fawcett et al. 2002). 
Currently, the influences of many of these processes on anthocyanins 
throughout commercial juice processing are unknown. 
 
Prior studies have assessed the recovery of anthocyanins during bench scale 
(pilot) processing (Skrede, Wrolstad et al. 2000; Lee, Durst et al. 2002; 
Zhongxiang, Min et al. 2005), however, data on ‘large-scale’ commercial 
processing is limited. Previous reports have thus far failed to establish if 
losses of anthocyanins are the result of poor recovery of parent compounds 
during processing or degradation, although two studies by Landbo and Meyer 
et al have described the loss of anthocyanins and phenols during different 
enzyme treatments (Landbo and Meyer 2001; Landbo and Meyer 2004 ). 
Establishing the amounts of anthocyanins and their degradation products 
throughout the manufacturing of commercial products remains important for 
ascertaining their dietary occurrence and potential health benefits.  
 
In the present investigation we established the recovery and stability of 
anthocyanins throughout the commercial processing of blackcurrants to 
blackcurrant juice concentrate using an industrial scale process. Furthermore, 
several modifiable processing factors were assessed for their influence on 
anthocyanin yield in final concentrated juice, using a “bench-scale” processing 
model to simulate industrial processes. The modifiable factors assessed 
included milling, depectinaze enzyme treatment, sodium bisulphite 
concentration and evaporation temperature and were investigated using a full-
factorial Design of Experiment (DOE) analysis.  
 
2.2 Materials and Methods 
 
Sodium bisulphite, 4-hydroxybenzoate methyl ester and methyl 3,4-
dimethoxybenzoate were purchased from Sigma-Aldrich (UK). Cyanidin-3-
glucoside and delphinidin-3-glucoside were purchased from Extrasynthese 
(Genay, France). A mixed blackcurrant analytical standard (containing 
cyanidin-3-glucoside, cyanidin-3-rutinoside, delphinidin-3-glucoside and 
55 
 
delphinidin-3-rutinoside) was provided by Nutritional Healthcare R&D, 
GlaxoSmithKline. (Coleford, UK). Pectinase enzymes were provided by 
GlaxoSmithKline. (Proprietary information). Blackcurrants (spp. Ribes nigrum 
cv. ‘Ben Hope’ and ‘Ben Gairn’) were harvested in the UK and used within 24 
h for industrial processing experiments or were frozen within 24 h and stored 
at -18 °C until use in bench-scale processing. All other chemicals and 
reagents were from Sigma-Aldrich (UK) and all solvents were of HPLC grade. 
 
2.2.1 Commercial blackcurrant processing and sampling (scheme 2.1) 
To evaluate the influence of industrial processing on the anthocyanin content 
of blackcurrant juice concentrate, representative samples were taken at 
different stages throughout commercial blackcurrant processing. Briefly, 
freshly harvested blackcurrants (Ribes nigrum ‘Ben Hope’ and ‘Ben Gairn’) 
were milled by roller mills and the comminute fed directly into temperature 
controlled mash heaters. The mash was heated to a controlled temperature of 
50°C for pectolytic enzyme hydrolysis. Sodium bisul phite was added as an 
aqueous solution to achieve a sulphur dioxide level to 600 mg/kg. Once the 
enzyme and sodium bisulphite was added, the mash was maintained at 50°C 
for three hours. Juice was extracted from the enzyme treated mash by 
pressing with a Bucher HPX5005i hydraulic press using Bucher berry socks 
on the press tubular elements. On completion of the initial press, subsequent 
leaching was performed with evaporator condensate at 60 °C. Pressed juice 
was then heated through a tubular pasteurizer at a holding temperature of 
103°C for 30-45 sec, and then cooled to 35°C. Paste urised juice was then 
clarified by sedicantation and filtration (Flottweg sedicanter S4D -3/408 and 
Flottweg decanter centrifuge Z4D). The clarified juice was filtered through a 
Keiselguhr filter aid (Filtrox FILTROjet 1100/1850 candle filter and Securox B 
40/16 cartridge filters). Clarified and filtered juice was passed through a Velo 
evaporator (Velo TSE4000) and chilled to approximately 10 °C for storage. 
Samples were taken throughout the processing procedure (whole berry, post-
milling, post-depectinization, post-pressing, post-pasteurization, post-
clarification, post-filtration and post-concentration) and stored at -18°C until 
extraction and UPLC analysis for anthocyanins and their degradation 
products, including protocatechuic acid and gallic acid, using authentic 
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analytical standards. The final analyte concentrations were normalized to a 
total soluble solids ratio of the initial pressed juice to account for any intrinsic 
dilutions.  
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Scheme 2.1. Representation of industrial blackcurrant juice processing with indicated sampling points. 
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2.2.2. Simulated ‘bench-scale’ blackcurrant processing (scheme 2.2 and 
2.3) 
In order to evaluate the commercial processing line under more controlled 
conditions, a ‘bench-scale’ processing model was developed. Briefly, 250 g 
portions of fresh blackcurrants (Ribes nigrum ‘Ben Hope’) were milled using a 
bench top blender and incubated for 3 h at 45 °C in  the presence of pectolytic 
enzyme and sodium bisulphite. Following enzyme treatment, the blackcurrant 
mash was pressed through a muslin cloth under vertical pressure by hand, 
washed with 150 ml water to simulate leaching and re-pressed. To ensure all 
the juice was extracted, the muslin cloth was tightly twisted several times into 
a beaker until the resulting pomace was free of residual liquid. The pressed 
blackcurrant juice was spiked with 500 mg p-hydroxybenzoate methyl ester 
(dissolved in 10 mL methanol) as an internal dilution control. The juice was 
then passed though a pasteurizer, comprising a heated (101 °C) copper coil 
attached to a peristaltic pump which emptied into an ice-cooled beaker, 
allowing the juice to be heated to 100°C and cooled  to 40°C within 2.5 min. 
Following pasteurization, the juice was filtered through a finely sintered glass 
funnel and concentrated to a total soluble solids ratio of 65 °Brix by rotary 
evaporation (90°C in vacuo). The blackcurrant concentrate was diluted to its 
initial internal standard concentration (which corresponded to their initial total 
soluble solids ratio) prior to extraction. Samples were taken throughout this 
process and stored at -18 °C until analysis for ant hocyanins and their 
degradation products (protocatechuic acid and gallic acid). 
 
The relationship between anthocyanin concentration and various processing 
factors (milling, enzyme treatment, SO2 and evaporation) was assessed using 
a full-factorial Design of Experiment analysis (see appendix A for further 
details). Blackcurrants were processed as described above (‘bench-scale’) 
with the following alterations: berries were coarsely or finely milled using a 
bench top blender (altering blending time and speed); enzyme concentrations 
were varied from 0.1 to 1.5 ml/kg fruit; enzyme incubation times were varied 
from 0.5-6 h; sodium bisulphite concentrations were varied from 0 to 300 
mg/kg fruit; evaporation temperatures were varied from 40 to 90 °C. The final 
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concentrate anthocyanin concentration was analysed by Ultra-Performance 
Liquid Chromatography (UPLC).    
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Scheme 2.2. Representation of “bench scale” blackcurrant juice processing with indicated sampling 
points. 
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Scheme 2.3. Representation of a novel “bench scale” pasteuriser developed for “bench scale” 
blackcurrant juice processing. 
 
2.2.3 Sample extraction  
Whole blackcurrants and processed samples were stored in the dark at -18 °C 
until extraction. Frozen blackcurrants and pre-press samples were milled in 
liquid nitrogen with a pestle and mortar to form a homogonous powder. 
Subsequently, 1 g fresh weight (FW) of the frozen powder was accurately 
weighed and extracted in 5 ml 5% formic acid in methanol with ultrasound 
assistance (sonication at 40 °C for 15 min) and cen trifuged at 4000 rpm for 20 
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min. The pellet was re-extracted in an additional 5 ml of 5% formic acid in 
80% aqueous methanol with ultrasound assistance and centrifuged at 4000 
rpm for 20 min. The combined supernatants were concentrated by rotary 
evaporation to a 1 ml volume and spiked with 0.5 mg methyl 3,4-
dimethoxybenzoate as an internal volume adjuster and filtered through a 0.45 
µm syringe filter. All post-press samples and concentrates were diluted 1:1 or 
1:3 (post-press samples and final concentrates, respectively) in acidified 
methanol (5% formic acid), spiked with 0.5 mg methyl 3,4-dimethoxybenzoate 
as an internal standard and filtered through a 0.45 µm syringe filter. 
 
2.2.4 UPLC analysis  
Extracted samples were analysed by UPLC using a Waters Acquity UPLC 
equipped with an Acquity BEH C18 1.7 µm (2.1 x 50mm) column (Waters) 
and Van guard BEH C18 guard column (Waters). The column temperature 
was set to 40°C and the mobile phase consisted of 5 % aqueous formic acid 
(A) and acetonitrile (B). The flow rate was 0.49 ml/min and solvent gradient 
was as follows: 0% B at 0 min, 1% B at 0.26 min, 2.5% B at 2.85 min, 3% B at 
3-4 min, 4% B at 4.5 min, 6% B at 5.1 min 8% B at 6 min, 20% B at 7-8 min, 
50% B at 8.5 min and 100% B at 9 min. The injection volume was 2 µL. The 
weak wash consisted of water:acetonitile (95:5) and the strong wash 
consisted of acetonitrile:iosopropanol:water (7:2:1). Absorbance was recorded 
at 260nm, 320nm and 500nm. Refer to appendix A for further 
chromatographic data on juice samples. 
 
2.2.5 Total soluble solids, specific gravity and acidity analysis  
For the determination of total soluble solids ratio (°Brix) of the processed 
blackcurrant samples, 1 mL of processed blackcurrant juice was directly 
analysed on a auto-refractometer (Bellingham and Stanley Ltd., RFM 90) 
calibrated for sugar quantification at 24 °C. The s pecific gravity was 
established by applying 2 mL of processed blackcurrant juice to a density 
meter (Anton Paar, DMA 4500 M) at a cell temperature of 20°C. To measure 
acidity, 1-3 g of sample was titrated to pH 8.15 with 0.1M NaOH and acidity 
was calculated as % w/v citric acid mono-hydrate (CAMH) using the following 
formulae: [Titre volume (ml) x 0.7 x SG]/sample weight = % w/v CAMH] 
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2.2.6 Statistical analysis  
Differences in anthocyanin concentrations in processed samples were 
evaluated by one-way repeated measures analysis of variance (Windows 
SPSS, version 14). Significance was determined at p<0.05. For commercial 
scale processing, sample replicates (4 independent experimental replicates) 
consisted of samples taken at each processing step (i.e. milling, pressing, 
pasteurisation, clarification and concentration). For bench-scale processing, 
independent experiments were performed in triplicate. The relationship 
between processing factors (milling, enzyme treatment and time, SO2 and 
evaporation condition) and final concentrate anthocyanin content was 
assessed using a full-factorial Design of Experiment (DOE) model using 
Design Expert® Software (Stat-Ease, Inc., Minneapolis). Twenty two 
independent experimental runs were performed for the DOE analysis and five 
factors assessed. All analytical procedures were performed in duplicate for 
each sample (i.e., technical replicates). 
 
2.3 Results and Discussion 
 
2.3.1 Characterization of anthocyanins in whole blackcurrants and juices  
Two cultivars of blackcurrants were used in the commercial processing, Ribes 
nigrum cv. ‘Ben Gairn’ and ‘Ben Hope’. The total anthocyanin content of Ribes 
nigrum cv. ‘Ben Gairn’ was 164±3.4 mg/100 g and for Ribes nigrum cv. ‘Ben 
Hope’ was 220±8 mg/100 g. These concentrations were consistent with 
previously reported data for blackcurrants (Mazza and Miniati 1993). The 
separation of blackcurrant anthocyanins by UPLC is shown in Figure 1.1. 
Peak assignments and identification were made according to UV-vis spectra 
and retention time in comparison to authentic analytical standards. There 
were four major anthocyanin species identified in the blackcurrants, namely, 
cyanidin-3-rutinoside (57±1 and 74±3 mg/100 g FW), cyanidin-3-glucoside 
(8±0.3 and 11±0.3 mg/100 g FW), delphinidin-3-rutinoside (79±1.1 and 
108±3.9 mg/100 g FW) and delphinidin-3-glucoside (18±0.5 and 25±0.6 
mg/100 g FW)(for Ben Gairn and Ben Hope, respectively). Although previous 
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studies have identified low levels of other anthocyanins in blackcurrants, 
namely pelargonidin, peonidin and malvidin glycosides (Slimestad and 
Solheim 2002), the present study focused only on establishing the stability 
and recovery of the major anthocyanins present; namely dephinidin-
rutinoside, delphinidin-glucosinde, cyanidin-rutinoside and cyanidin-glucoside. 
Following commercial processing the raw pressed juice had an anthocyanin 
concentration of 96±12 mg/100 ml juice and the final juice concentrate had a 
total anthocyanin concentration of 80±3 mg/100 ml (when re-diluted to their 
initial raw-pressed juice total soluble solids levels).   
 
Table 2.1. Chemical profile of blackcurrant juice during processing 
Processing step 
 
Soluble solids 
(°Brix)  
Specific Gravity 
 
Acidity 
(% w/v CAMH) 
pH 
 
Pressed Juice 10.1±4.4 1.0387±0.0217 2.6±1.1 2.84 
Pasteurized Juice 9.8±4.1 1.0402±0.0164 2.5±1.0 2.91 
Clarified Juice 7.3±3.8 1.0299±0.0157 2.0±1.0 2.91 
Concentrated Juice 66.6±1.5 1.3322±0.0103 18.5±9.0 2.55 
Data represented as mean±SD (n=4). CAMH, citric acid mono-hydrate. 
 
1
2
3
4
0 9 min
AU
 
(50
0n
m
)
87654321
 
Figure 2.1. Representative chromatograph of blackcurrant anthocyanins at 500nm. AU, absorbance 
units; 1, delphinidin-3-glucoside; 2, delphinidin-3-rutinoside; 3, cyanidin-3-glucoside; 4, cyanidin-3-
rutinoside. 
 
2.3.2 Anthocyanin stability during commercial juice processing  
For extraction and analysis purposes, the processing experiments were 
separated into two phases consisting of pre-press (whole berry, berry mash, 
pectinaze and sodium bisulphite treatment) and post-press (pasteurized, 
decanted, filtered and concentrate) juice samples. The relative anthocyanin 
62 
 
content of blackcurrants during the two phases of commercial processing is 
illustrated in Figure 2.2, while chemical and physical characteristics (i.e. pH, 
specific gravity, acidity and total soluble solids ratio) are described in Table 
2.1.  
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Figure 2.2. Recovery of anthocyanins during commercial juice processing. A, anthocyanin extraction 
from whole berries (i.e., pre-press). B, anthocyanins during juice processing (i.e., post-press). Data 
represented as mean±SD (n=4). Significance was assessed by repeated measures ANOVA (p<0.05). 
1Refers to initial whole berry anthocyanin content prior to pre-press berry processing. 2Refers to initial 
raw pressed juice anthocyanin content prior to post-press juice processing. 
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Pre-press processing. The pre-press blackcurrant processing (i.e., solid 
matrix) did not contribute to a significant loss in total anthocyanins (n=4, 
sampled over four days), from whole berry through milling (p=0.7) to pectin 
hydrolysis and sodium bisulphite addition (p=1.0), with less than 13% loss 
across the pre-press processing stages as compared with the initial whole 
berry (Figure 2.2A). No anthocyanin degradation products (anthocyanin 
derived protocatechuic acid or gallic acid aglycones) were detected during 
commercial blackcurrant juice pre-press processing samples. 
 
Post-press juice processing. Following pressing, the subsequent processing 
of the pressed juice did not contribute to a significant loss in total 
anthocyanins, through pasteurization (p=1.0), decantation (p=1.0), filtration 
(p=0.9) and concentration (p=1.0); with 17% total anthocyanin lose across the 
post-press processing steps (Figure 2.2B). It should be emphasised that all 
samples were normalized to their initial raw pressed juice total soluble solids 
value in order to account for dilutions throughout commercial juice processing. 
Overall, this study demonstrated that no significant anthocyanin degradation 
occurred during commercial scale blackcurrant pre and post-press 
processing. However, it should be noted that there was a significant loss of 
anthocyanins between the pre-press mash and the post-press juice samples 
which was likely due to sub-optimal extraction from the berry pomace, as 
some anthocyanins will remain in the post press berry skins, as reported by 
Fang et al. (Fang, Zhang et al. 2006). Losses were minimal at all other stages 
of commercial processing. This is consistent with previously reported data, 
where a study by Skrede et al. (Skrede, Wrolstad et al. 2000) showed no 
losses of anthocyanins during milling and pectin hydrolysis (pre-press 
processing) using a bench-scale method.  
 
2.3.3 Assessing the impact of processing on anthocyanins using a 
bench-scale processing model   
In order to assess and modulate the potential impact of commercial juice 
processing factors/steps on blackcurrant juice anthocyanin content, a “bench-
scale” method was developed to simulate the commercial process. The 
development of a bench-scale model allowed for the alteration of experimental 
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variables in order to perform factorial analysis of various processing factors. 
Furthermore, the development of a bench-scale model allowed for greater 
control over inherent processing dynamics, such as uncontrolled intrinsic 
dilutions or sample losses that occur throughout industrial scale processes. 
These dynamics were controlled for by spiking juice samples with p-
hydroxybenzoic acid methyl ester prior to post press processing and using this 
as an internal control standard to back-calculate processing volumes post-
hoc.  
0
20
40
60
80
100
120
Wh
ole
 
be
rry
1
Po
st-
En
zy
m
e
%
 
o
f I
n
iti
al
0
20
40
60
80
100
120
%
 
o
f I
n
iti
al
Po
st-
Pa
ste
ur
ize
r
Po
st-
Fil
ter
Po
st-
Co
nc
en
tra
tor
Ra
w
 
pre
ss
ed
 
juic
e
2
a
b
A)
B)
 
Figure 2.3. Recovery of anthocyanins during bench-scale juice processing. A, anthocyanin extraction 
from whole berries (i.e, pre-press). B, anthocyanins during juice processing (i.e., post-press). Data 
represented as mean±SD (n=3). Significance was assessed by repeated measures ANOVA (n=3, 
p<0.05). Like letters (a and b) represent statistical similarity. 1Refers to initial whole berry anthocyanin 
content prior to pre-press berry processing. 2Refers to initial raw pressed juice anthocyanin content 
prior to post-press juice processing. 
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Similar to the commercial scale process, the bench-scale model showed no 
significant losses in anthocyanin content following sequential milling and 
enzyme treatment (Figure 2.3A). In general, post-press juice processing 
showed no significant anthocyanin losses, which is also consistent with the 
commercial scale observations (Figure 2.3B). However, unlike the 
commercial scale processing, a significant loss of 22±0.7% anthocyanins 
(P<0.001) was observed during pasteurization. This was likely a result of the 
difference in pasteurization holding time, since the commercial process 
consisted of a 30 sec heating period, while the bench scale process took 2.5 
min to reach 100 °C and lower down to 40 °C. This o bservation is consistent 
with the findings of  Rubinskiene et al. (Rubinskiene, Viskelis et al. 2005), who 
assessed the effect of pasteurization times on aqueous anthocyanins 
concentrations. No phenolic acid degradation products were observed. 
 
As with commercial scale processing, it was shown that the post-press juice 
contained a lower concentration of anthocyanins than the pre-press mash (or 
whole berry) as some anthocyanins remain in the post press berry skins 
(pomace), as reported by others (Fang, Zhang et al. 2006). This previously 
identified aspect of juice processing was not the focus of the present 
investigation which aimed to establish the degradation of anthocyanins during 
juice processing and not the extraction efficiency of anthocyanins from berry 
skins, which is a known limitation in the processing of berry juice. 
 
Factorial analysis of processing and anthocyanin yield. The association 
between juice processing stages (i.e. milling, enzyme concentration and 
incubation time, sodium bisulphite concentration and evaporation conditions) 
and final juice anthocyanin yield was assessed using a factorial DOE model. A 
DOE model approach was chosen in order to assess the multi-factor 
interactions between various processing factors and final juice anthocyanin 
yield (synergistic effects). An overview of the association between final 
anthocyanin yield and various common processing influences is shown in 
Figure 2.4, displayed as a two factor interaction plot. The only processing 
event which had an impact on anthocyanin recovery in this analysis was the 
concentration of sodium bisulphite used.  Sodium bisulphite concentration 
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produced a marked increase (p<0.001) in final anthocyanin concentration 
(Figure 2.4a-c) when altered in conjunction with other processing factors: 
pectinase incubation time, pectinase concentration, evaporation time or milling 
method. This would indicate that sodium bisulphite concentration may be an 
important factor to consider during commercial blackcurrant juice processing, 
where it is likely that sodium bisulphite improves the extraction of 
anthocyanins from the fruit skin, as previously described (Cacace and Mazza 
2002).   
 
Throughout commercial blackcurrant processing, no significant anthocyanin 
degradation was observed and no anthocyanin derived degradation products 
(protocatechuic acid and gallic acid aglycones) were identified. This would 
suggest that anthocyanins are not degraded to any significant extent during 
commercial processing, most likely as a result of the short residence times at 
high temperature and low pH of blackcurrant fruits and juice concentrate (pH 
2-3), which would have a stabilizing effect on the anthocyanin flavylium iso-
form (Markakis 1974). Losses of anthocyanins were observed following 
pressing which was likely due to incomplete anthocyanin recovery from the 
pressed berries/pomace as described above and by others previously (add 
references from above).  
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Figure 2.4. Two factor relationship plots of various juice processing factors on final anthocyanin 
content in blackcurrant juice concentrate. A, the effect of pectinase enzyme concentration and sodium 
bisulphite concentration on juice anthocyanin content; B, the effect of pectinase enzyme incubation 
time and sodium bisulphite concentration on juice anthocyanin content; C, the effect of evaporation 
temperature and sodium bisulphite concentration on juice anthocyanin content. Sodium bisulphate 
concentration significantly effected anthocyanin concentration (p<0.001). *Pectinase concentration, 
pectinase incubation time and evaporator temperature did not demonstrate a significant effect on 
anthocyanin concentration (p>0.05). FW, fresh weight. 
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It has been reported that under the described processing conditions, 
anthocyanin condensation may occur, where anthocyanin species may be 
conjugated to other flavonoids and aldehyde structures (17, 18). It may 
therefore be hypothesised that anthocyanins may form protein bound or 
condensation products during commercial processing. This represents a 
potential area for future research, where novel anthocyanin condensation 
products could be targets for bioactivity studies examining the health benefits 
of processed berry products. However, this is merely speculation; as there 
was no significant loss of anthocyanins observed in the present study except 
during the pressing step.   
  
In a recent study by Hollands et al. (Hollands, Brett et al. 2008) the 
anthocyanin content of several processed blackcurrant products was 
assessed. The study reported that the total anthocyanin level in commercial 
blackcurrant products was substantially lower (0.05–10.3% of the levels in 
fresh fruit) than that found in fresh fruits. This would indicate that processed 
blackcurrant products are not rich sources of anthocyanins in the diet, when 
compared to fresh produce. We propose that the apparent loss of anthocyanin 
content in processed juices is not likely the result of processing, but rather due 
to degradation during product storage. This was confirmed in a pilot study in 
which the anthocyanin concentration was monitored in various commercial 
juice preparations over twelve weeks under different storage conditions (some 
pilot data is represented in Figures 2.5, 2.6 and 2.7).  Briefly, commercial 
black currant juices were formulated (with/without sugar; with/without 
ascorbate; with/without SBS;–formulation was proprietry to GlaxoSmithKline) 
and stored at 4 °C and 21 °C (representing storage in a fridge or ambient 
temperature) for 12 weeks. At 0, 6 and 12 weeks aliquots of the stored 
formulations were analysed by HPLC for anthocyanins and the degradation 
products gallic acid and protocatechuic acid. From this pilot data it is evident 
that anthocyanins are rapidly degraded during storage (both at 4 °C and 21 
°C) although the formation of phenolic acid degrada tion products was not 
consistent.  
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Figure 2.5. Total anthocyanin loss in different blackcurrant juice preparations when stored at 21 °C 
over 12 weeks. A, full sugar formulation (proprietary to GSK) without SBS and vitamin C; B, full 
sugar formulation (proprietary to GSK) without SBS but with vitamin C; C, full sugar formulation 
(proprietary to GSK) with SBS but without vitamin C; D, full sugar formulation (proprietary to GSK) 
with SBS and vitamin C. SBS, sodium bisulphite; Vit C, vitamin C/ascorbate.   
 
 
 
 
 
 
 
 
 
 
 
70 
 
 
 
 
 
 
 
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
0 6 12
µg
/1
00
m
l G
al
lic
 
Ac
id
m
g/
10
0m
l A
n
th
o
cy
an
in
s
Weeks at 21°C
Formulation: Low Sugar, SBS, Vit C
Anthocyanins
Free Gallic acid
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
0 6 12
µg
/1
00
m
l G
al
lic
 
Ac
id
m
g/
10
0m
l A
n
th
o
cy
an
in
s
Weeks at 21°C
Formulation: Low sugar, SBS, no Vit C
Anthocyanins
Free Gallic acid
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
0 6 12
µg
/1
00
m
l G
al
lic
 
Ac
id
m
g/
10
0m
l A
n
th
o
cy
an
in
s
Weeks at 21°C
Formulation: Low sugar, no SBS, Vit C
Anthocyanins
Free Gallic acid
A B
C
 
Figure 2.6. Total anthocyanin loss in different blackcurrant juice preparations when stored at 21 °C 
over 12 weeks. A, low sugar formulation (proprietary to GSK) without SBS but with vitamin C; B, low 
sugar formulation (proprietary to GSK) with SBS and vitamin C; C, low sugar formulation (proprietary 
to GSK) without SBS but with vitamin C. SBS, sodium bisulphite; Vit C, vitamin C/ascorbate.   
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Figure 2.7. Total anthocyanin loss in different blackcurrant juice preparations when stored at 4 °C over 
12 weeks. A, full sugar formulation (proprietary to GSK) with SBS and vitamin C; B, full sugar 
formulation (proprietary to GSK) with SBS but without vitamin C; C, low sugar formulation 
(proprietary to GSK) with SBS and vitamin C; D, low sugar formulation (proprietary to GSK) with 
SBS but without vitamin C; E, low sugar formulation (proprietary to GSK) without SBS and vitamin C; 
F, low sugar formulation (proprietary to GSK) without SBS but with vitamin C. SBS, sodium 
bisulphite; Vit C, vitamin C/ascorbate.   
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In conclusion, the results of this study demonstrated that of the five 
processing factors assessed only sodium bisulphite had any significant impact 
on the final anthocyanin yield of the blackcurrant juice. This study also 
showed that during commercial processing no significant anthocyanin 
degradation was observed and anthocyanins were not fully recovered from 
the press pomace. Further study should be conducted to establish the 
degradation characteristics of anthocyanins during processed juice storage. 
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Chapter 3  
 
 
Anthocyanin stability and recovery under simulated 
physiochemical conditions 
 
 
Data published in J. Agric. Food Chem. (2009) 57: 12, 5271-5278. 
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3.1 Introduction 
Over the past decade, interest in anthocyanins has grown considerably, as 
evidence of their beneficial effects on health continues to increase, particularly 
regarding their role in reducing cardiovascular disease risk (Xia, Ling et al. 
2006; Mink, Scrafford et al. 2007; Xia, Ling et al. 2007), cancer (Feng, Ni et al. 
2007; Rossi, Garavello et al. 2007) and obesity (Tsuda, Horio et al. 2003). In 
plants, anthocyanins are almost exclusively found as glycosides of the 
aglycone form (anthocyanidins) (Figure 3.1), where three common structures, 
cyanidin, delphinidin and pelargonidin exist, differing only in the number and 
position of hydroxyl groups on their B-ring. Anthocyanins may exist in at least 
four different pH-dependent structural isoforms, namely, flavylium anion, 
hemiketals, quinoid bases and chalcones, arising at pH 1-3, 4-5, 6-8 and 7-8, 
respectively (Markakis 1974). At more alkaline pH values, anthocyanins have 
consistently been shown to degrade to their constituent phenolic acids, where 
delphinidin, cyanidin and pelargonidin degrade to form gallic acid, 
protocatechuic acid and 4-hydroxybenzoic acid, respectively (Seeram, 
Bourquin et al. 2001; Fleschhut, Kratzer et al. 2006) (Figure 3.1). In addition, 
it is known that all species of anthocyanins degrade to a common phenolic 
aldehyde, with the most frequently reported constituent being phloroglucinol 
aldehyde (Keppler and Humpf 2005; Sadilova, Stintzing et al. 2006).  
 
Since the 1970s, many studies have investigated the occurrence and utility of 
anthocyanins in plants and in food production, whilst research concerning 
their potential health related benefits has become prominent only since the 
late 1990s. It has since been established that anthocyanins are poorly 
available to the systemic circulation (Kay, Mazza et al. 2004; Kay, Mazza et 
al. 2005; Vitaglione, Donnarumma et al. 2007). We postulate that this is a 
result of their reported instability, as it has been shown that, under certain 
conditions (e.g. food processing (Hollands, Brett et al. 2008)), anthocyanins 
are subject to significant degradation (McDougall, Fyffe et al. 2005; Fleschhut, 
Kratzer et al. 2006; Sadilova, Florian et al. 2007). Therefore, it is paramount 
that the chemical stability of anthocyanins is assessed under physiological 
and experimental conditions in order to determine the contribution of 
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degradation to their reported bioavailability. Whilst a great deal of studies 
have reported on aspects of anthocyanin stability, there is no single 
investigation fully describing their recovery and degradation following the 
routine extraction, pre-analytical preparation, and storage of clinically and 
experimentally derived samples. Thus, the aim of this study was to assess the 
degradation and recovery of selected anthocyanins (aglycones and mono-
glucosides), with mono-, di- and tri-hydroxylated B-rings, under simulated (in 
vitro) physiological conditions (i.e., in vitro models designed to simulate 
aspects of in vivo conditions) and routine experimental conditions. 
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Figure 3.1. Structure of anthocyanidins and their respective phenolic acid and aldehyde constituents. 
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3.2 Materials and Methods 
 
Cyanidin-3-glucoside (kuromanin chloride), delphinidin-3-glucoside (myrtillin 
chloride), pelargonidin-3-glucoside (callistephin chloride), cyanidin chloride, 
delphinidin chloride, pelargonidin chloride and 4-hydroxybenzoic acid were 
purchased from Extrasynthese (Genay, France) and dissolved in DMSO. 
Protocatechuic acid, gallic acid, trans-cinnamic acid, 4-hydroxycinnamic acid 
and phloroglucinol aldehyde were purchased from Sigma-Adlrich (UK) and 
dissolved in DMSO. Phenol free Dulbecco's Modified Eagle's Medium 
(DMEM) and bovine calf serum were purchased from Invitrogen (UK). All 
water used was 18MΩ/cm milliQ water and solvents were of HPLC grade.  
 
3.2.1 Influence of B-ring hydroxylation on the rate of anthocyanin 
degradation and the formation of phenolic acids 
To assess the effect of B-ring hydroxylation on anthocyanin degradation and 
the formation of phenolic acid and aldehyde constituents under physiological 
conditions, pelargonidin-3-glucoside, cyanidin-3-glucoside, delphinidin-3-
glucoside, pelargonidin, cyanidin and delphinidin were individually made up to 
150 µM in pre-incubated physiological buffer (10 mM Na/K phosphate, pH 7.4) 
or water (titrated to pH 7 with the drop wise addition of dilute NaOH) and 
incubated at 37 °C (final DMSO concentration was 1. 5%). After 0, 2, 6, 12 and 
24 h, 150 µL aliquots were acidified with HCl (2% final concentration) and 
injected onto an HPLC-DAD system. Control samples consisted of acidified 
(2% HCl) buffer matrices that were filtered and then spiked with anthocyanins 
and anthocyanidins to a final concentration of 150 µM. An automated method 
was utilised to further assess the rate of anthocyanin degradation in the buffer 
matrix, where samples were incubated in an HPLC auto-sampler at 37 °C with 
injections at 0, 2, 4, 8 and 12 h, using the same conditions as above.  
 
3.2.2 Anthocyanin recovery following routine pre-analytical treatments  
Sample preparation: To determine the recovery of anthocyanins with different 
B-ring hydroxyl moieties under common experimental conditions, 0.5 M Na/K 
phosphate buffer, foetal calf serum (Invitorogen, UK) and cell culture media 
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(phenol free DMEM) were acidified to pH ~2 with the drop wise addition of HCl 
and spiked to a final concentration of 25 µg/mL with either pelargonidin-3-
glucoside, cyanidin-3-glucoside or delphinidin-3-glucoside. The final serum 
and cell culture medium concentrations were 99.5% in a 1 mL volume. In 
addition, to establish the recovery of anthocyanin degradation products, 
protocatechuic acid, 4-hydroxybenzoic acid, gallic acid and phloroglucinol 
aldehyde were spiked to 100 µM in buffer and serum samples. Recoveries 
were established following filtration, centrifugation and SPE (as outlined 
below) and were quantified using HPLC/DAD.  
 
Filtration: Sample preparations (1 mL) were filtered through 17mm Cronus 
PVDF 0.45 µm syringe filters (SMI-Labhut Ltd, Maisemore, UK). The 
subsequent filtrates were stored at -80 °C until HPLC analysis. Control 
samples consisted of pre-filtered, acidified, buffer matrices, spiked to 25 
µg/mL with either pelargonidin-3-glucoside, cyanidin-3-glucoside or 
delphinidin-3-glucoside, respectively (1 mL final volume) and exposed to the 
same thermal conditions as the extracted samples.  
 
Centrifugation. Sample preparations were centrifuged at 10,000 rpm for 20 
min and the supernatants stored at -80 °C until HPL C analysis. Sample 
controls consisted of spiked buffer preparations, exposed to the same thermal 
conditions as the extracted samples, but not exposed to centrifugation.  
 
Solid phase extraction method 1: Solid phase extraction (SPE) was adapted 
from previously reviewed methods (Mazza, Cacace et al. 2004). Briefly, 
Strata-X 6 mL/500 mg solid phase extraction cartridges (Phenomenex, 
Macclesfield, UK) were preconditioned with 1 column volume (6 mL) of 
methanol followed by 1 column volume of 0.5% HCl in water. Prior to 
extraction, samples and controls were spiked with 25 µg/mL tran-cinnamic 
acid as an internal standard. The recovery of the internal standard was 
established to be 94±3%. SPE cartridges were loaded with 1 mL of 0.5% HCl 
followed by 1mL of spiked sample preparation. Sample tubes were further 
rinsed with 1 mL 0.5% HCl and loaded onto the SPE cartridges. Samples 
were eluted using a peristaltic pump at approximately 1 drop/s, washed with 2 
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column volumes of 0.5% HCl under a stream of nitrogen. Extraction cartridges 
were then loaded with 3 ml 0.5% HCl in methanol and allowed to soak for 10 
min. Samples were eluted with 7 mL 0.5% HCl in methanol and the eluate 
evaporated to dryness on a rotary evaporator, re-dissolved in 1 mL initial 
HPLC mobile phase (details below) and stored at -80 °C until HPLC analysis. 
Sample controls consisted of spiked buffer preparations, exposed to the same 
thermal conditions as the extracted samples, but not subjected to SPE.  
 
Solid phase extraction method 2 (minimalised-evaporation method). Solid 
phase extraction was performed as previously stated, with the following 
alterations; prior to extraction, samples and controls were spiked to 25 µg/mL 
with 4-hydroxycinamic acid as an internal standard. Samples were eluted with 
8 mL acidified methanol and the eluate evaporated to approximately 500 µL 
on a rotary evaporator. Sample eluates were spiked to 25 µL with 1 mg/mL 
trans-cinnamic acid as a second internal standard. Sample volumes were 
adjusted to 1 mL with 0.5% HCl. Actual sample volumes were calculated from 
the two internal standard concentrations determined by HPLC-DAD.  
 
3.2.3 Anthocyanin freeze-thaw stability  
To determine the storage stability of various anthocyanins, acidified buffer 
solutions (10 mM Na/K phosphate buffer in 2% HCl) were spiked with 150 µM 
delphinidin-3-glucoside, cyanidin-3-glucoside, pelargonidin-3-glucoside, 
delphinidin, cyanidin or pelargonidin (individually). Samples were immediately 
injected onto an HPLC system and subsequently frozen at -80 °C. Samples 
were re-analysed sequentially for six freeze-thaw cycles. One freeze-thaw 
cycle consisted of a 24 h storage at -80 °C followed by a 20 min defrost at 
ambient room temperature prior to HPLC analysis.   
 
3.2.4 HPLC/DAD/MS conditions  
HPLC analysis was performed on an Agilent 1100 series HPLC equipped with 
a diode array detector (DAD) and a 4 µm, 250 x 4.6 mm Synergi Max-RP 
reverse phase column (Phenomenex, Macclesfield, UK) with a SecurityGuard 
guard cartridge (Phenomenex AJO-6074) for samples from anthocyanin 
recovery and freeze-thaw experiments and a 4 µm, 250 x 4.6 mm Synergi 
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Polar-RP (polar-N-capped) reverse phase column (Phenomenex, 
Macclesfield, UK ) with a SecurityGuard guard cartridge (Phenomenex AJO-
6074) for samples from anthocyanin degradation experiments. The column 
temperature was set at 37 °C with an injection volu me of 50 µL and mobile 
phases consisting of 5% formic acid (v/v) in water (solvent A) and 5% formic 
acid (v/v) in acetonitrile (solvent B). For anthocyanin recovery and freeze-thaw 
stability experiments the solvent gradient consisted of 2.5% B at 0 min, 25% B 
at 15 min, 45% B at 20 min and 100% B at 25-30 min; at a flow rate of 1 
mL/min. For anthocyanin degradation experiments, the solvent gradient 
consisted of 0% B at 0 min 0.5% B at 5 min, 8% B at 20 min, 8% B at 28 min, 
10% B at 39 min, 13% B at 40 min, 20% B at 44 min, 25% B at 50 min, 50% B 
at 65 min and 100% B at 75-80 min; at a flow rate of 1 ml/min. Absorbance 
was recorded at 520, 360 and 280 nm for both HPLC methods.  
 
3.2.4 LC-MS conditions. Following HPLC/DAD analysis, a subset of samples 
were then injected onto an HPLC-ESI-MS system for structural elucidation, 
using an Agilent 1100 series HPLC-DAD coupled to an Agilent 1100 series 
LC/MSD SL single quadrupole mass spectrometer. Electrospray ionization 
was performed in full scan mode (Mass range: 100-1000 Da) with the 
following spray chamber conditions: drying gas flow of 13 L/min; nebulizer 
pressure of 50 Psi; drying gas temperature of 350 °C. Positive mode 
ionization was used to analyse all anthocyanin species at a capillary voltage 
of 4000v and a fragmentor setting of 100. Negative mode ionization was used 
to analyse phenolic acids, aldehyde and anthocyanin intermediates at a 
capillary voltage of -3000v and a fragmentor setting of 70. HPLC conditions 
were as stated above with the following alterations. Levels of formic acid in 
the mobile phases were reduced to prevent ion suppression. Solvent A 
consisting of 0.1% formic acid in water and solvent B consisting of 0.1% 
formic acid in acetonitrile. Anthocyanins, phenolic acids and PGA were 
identified by retention times, optical density ratios (λ440/λmax for anthocyanins 
and λ280/λmax for phenolic acids)  and UV/mass spectra in comparison to 
analytical standards and previously reported data (Harborne 1958; Markham 
1982; Mazza and Miniati 1993). Quantification was by HPLC-DAD using 
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standard curves generated from pure analytical standards with R2 values 
greater than 0.98.  
 
3.2.5 Statistical analysis  
Differences within anthocyanin species were evaluated by one way ANOVA 
with Tukey post-hoc tests (Windows SPSS, version 15) on concentration data 
derived from standard curves. Significance was determined at P<0.05. In 
order to evaluate significant differences between species, all recovery and 
degradation data were transformed to percent of control values and analysed 
using one-way ANOVA with Tukey post hoc tests. Differences between 
anthocyanin degradation within water and buffer matrices were analysed by 
independent Student’s t-Tests with a significance threshold of P<0.05. All 
treatments were performed in triplicate, and data were obtained from three 
independent experiments.   
 
3.3 Results and Discussion 
 
3.3.1 Influence of B-ring hydroxylation on anthocyanidin (aglycone) 
stability  
Anthocyanidin degradation: To assess anthocyanidin stability under simulated 
physiological conditions, their degradation was determined in both water and 
in buffered matrices (Figure 3.2 and 3.3). In both matrices an instantaneous 
loss of >50% of the initial anthocyanidins was observed, with 100% 
degradation occurring by the first time point measurement (2 h); therefore 
rates of degradation were not established. The loss of anthocyanidins over 24 
h was associated with the formation of their respective phenolic acids.  
  
Phenolic acid formation: In water the formation of phenolic acids accounted 
for 30-40% of initial anthocyanidin molar concentrations, while in buffer the 
phenolic acid formation accounted for only 8-18% of initial anthocyanidin 
molar concentrations. In water, pelargonidin [λmax 512nm; m/z 271], cyanidin 
[λmax 524nm; m/z 287] and  delphinidin [λmax 528nm; m/z 303] degraded to 
yield 53±4.2 µM 4-hydroxybenzoic acid [λmax 254nm; m/z 138] (accounting for 
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38±0.1% pelargonidin loss), 58±1.2 µM protocatechuic acid [λmax 260nm, 
294nm; m/z 154]  (accounting for 39±0.0% of  cyanidin loss) and 53±2.0 µM 
gallic acid [λmax 270nm; m/z 170] (accounting for 31±0.0% of delphinidin loss), 
respectively.  
  
In buffered samples, pelargonidin,  cyanidin and delphinidin degraded to yield 
25±0.7 µM 4-hydroxybenzoic acid (accounting for 18±0.0% of pelargonidin 
loss), 32±0.3 µM protocatechuic acid (accounting for 21±0.0% of cyanidin 
loss) and 14±0.3 µM gallic acid (accounting for 8±0.0% of delphinidin loss), 
respectively. It should be noted that the formation of gallic acid (associated 
with delphinidin degradation) increased linearly in water, while in buffer gallic 
acid showed first an increase in formation followed by a decrease (loss) in 
concentration between 6-24 h. 
 
Phenolic aldehyde formation: All anthocyanin species degraded to their 
common A-ring constituent, tentatively identified as phloroglucinol aldehyde 
[λmax 294nm; m/z 154]. After 24 h, phloroglucinol aldehyde formation was 
46±1.6 µM in water and 5±1.2 µM in buffered samples (±SD for pelargonidin, 
cyanidin and delphinidin) accounting for 30% and 3% of initial anthocyanin 
concentrations, respectively. 
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Figure 3.2. Representative chromatograph of anthocyanins and the phenolic degradation products 
following 24 h incubations at pH 7.4 and 37 °C. A, pelargonidin degradation to 4-hydroxybenzoic acid 
and phlorogluceraldehyde; B, cyanidin degradation to protocatechuic acid and phlorogluceraldehyde; 
C, delphinidin degradation to gallic acid and phlorogluceraldehyde.   
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Figure 3.3. Anthocyanidin degradation over 24 h at 37 °C in water (pH 7 with dilute NaOH) and in 
physiological buffer (10 mM Na/K phosphate buffer, pH 7.4). (A) pelargonidin degradation in water; 
(B) pelargonidin degradation in buffer; (C) cyanindin degradation in water; (D) cyanidin degradation in 
buffer; (E) delphinidin degradation in water; (F) delphinidin degradation in buffer.  Results expressed 
as mean±SD (n=3). *Significance from controls (P<0.05), which consisted of analytical standards 
spiked directly into acidified water or buffer matrices at t=0. †Significant difference (P<0.05) between 
samples incubated in water and buffer matrices within a given anthocyanin species and incubation 
time. 
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3.3.2 Influence of B-ring hydroxylation on anthocyanin (glycoside) 
stability  
Anthocyanin degradation: The influence of B-ring hydroxylation on the rate of 
anthocyanin degradation and the degree of phenolic acid formation was 
assessed under simulated physiological conditions (Figure 3.4). The 
anthocyanins were shown to degrade at a rate of between 3-11 µM per h over 
the first 12 h, representing a total loss of 20%, 40% and 100% for 
pelargonidin-3-glucoside [λmax 502nm; m/z 433],  cyanidin-3-glucoside [λmax 
514nm; m/z 449] and delphinidin-3-glucoside [λmax 524nm; m/z 465], 
respectively. Individual rates of degradation were 3.3 µM/h for pelargonidin-3-
glucoside, 4.5 µM/h for cyanidin-3-glucoside and 11.4 µM/h for delphinidin-3-
glucoside.  
 
Phenolic acid formation: In water, the loss of anthocyanins over 24 h was 
associated with the formation of their respective phenolic acids, which 
accounted for 12%, 8% and 0% of the initial cyanidin-3-glucoside,  
delphinidin-3-glucoside and pelargonidin-3-glucoside concentrations, 
respectively.  cyanidin-3-glucoside degraded to yield 15±14.4 µM 
protocatechuic acid (accounting for 65±27.3% of cyanidin-3-glucoside loss) 
and delphinidin-3-glucoside degraded to yield 12±9.5 µM gallic acid 
(accounting for 56±41.7% of delphinidin-3-glucoside loss). There was no 
significant degradation of pelargonidin-3-glucoside or respective formation of 
phlorogucinol aldehyde over the 24 h incubation. 
 
In buffer, the appearance of phenolic acids accounted for 10%, 8% and 2% of 
initial pelargonidin-3-glucoside, cyanidin-3-glucoside and delphinidin-3-
glucoside concentrations, respectively. pelargonidin-3-glucoside,  cyanidin-3-
glucoside and delphinidin-3-glucoside degraded to yield 16±2.5 µM 4-
hydroxybenzoic acid (accounting for 12±1.8% of pelargonidin-3-glucoside 
loss), 11±1.8 µM protocatechuic acid (accounting for 9±1.3% of cyanidin-3-
glucoside loss) and 3±0.4 µM gallic acid (accounting for 2±0.0% of 
delphinidin-3-glucoside loss), respectively.  
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Figure 3.4. Anthocyanin degradation over 24 h at 37 °C in water (pH 7 with dilute NaOH) and in 
physiological buffer (10 mM Na/K phosphate buffer, pH 7.4). (A) pelargonidin-3-glucoside 
degradation in water; (B) pelargonidin-3-glucoside degradation in buffer; (C) cyanindin-3-glucoside 
degradation in water; (D) cyanidin-3-glucoside degradation in buffer; (E) delphinidin-3-glucoside 
degradation in water; (F) delphinidin-3-glucoside degradation in buffer.  Results expressed as 
mean±SD (n=3). *Significance from controls (P<0.05), which consisted of analytical standards spiked 
directly into acidified water or buffer matrices at t=0. †Significant difference (P<0.05) between samples 
incubated in water and buffer matrices within a given anthocyanin species and incubation time. 
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Phenolic aldehyde formation: The degradation of cyanidin-3-glucoside, 
delphinidin-3-glucoside and pelargonidin-3-glucoside was associated with the 
appearance of a common constituent in buffered matrices, however, its 
formation was not significant in pelargonidin-3-glucoside samples. The 
maximum phloroglucinol aldehyde formation was 5±1.1 µM for cyanidin-3-
glucoside and 1±0.1 µM for delphinidin-3-glucoside, accounting for 3% and 
0.6% of initial anthocyanin concentrations. No significant phloroglucinol 
aldehyde formation was observed for any of the anthocyanin species in water.  
 
The degradation of the three anthocyanin species as described above was 
associated with the appearance of a common constituent, which was 
identified as phloroglucinol aldehyde, based on its retention time, UV-vis and 
MS characteristics. It is to be noted that phloroglucinol aldehyde appeared as 
a split peak, which could have been the result of the ionization characteristic 
of the aldehyde structure under acidic aqueous conditions, where the dynamic 
equilibrium of the hydrated form and hetero-dimmers are likely to occur (Bell 
and McDougall 1960; King, Woodside et al. 1974).  
 
The degradation of all anthocyanin aglycone and glucoside species was also 
associated with the appearance of three unidentified compounds, eluting at 
similar retention times. Since these compounds were common to all 
anthocyanin species in this study, they are likely to be derived from the 
common anthocyanin A-ring. However, mass fragmentation ions could only be 
obtained for one of the three unidentified compounds [Rt 6.6 min; m/z 198], 
since the remaining two unidentified compounds showed no ion fragments in 
both positive and negative ionization modes.   
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Figure 3.5. Anthocyanin recovery (%) and the formation of their respective phenolic acid constituents 
following filtration, centrifugation and SPE in phosphate buffer (pH 2), foetal calf serum (pH 2) and 
cell culture media (pH 2). Values expressed as means±SD (n=3). *Significance from controls (P<0.05). 
a-e Like letters represent statistically similar recoveries between anthocyanin species within a given 
preparation technique and matrix. α,β,γLike symbols represent statistically similar recoveries between 
preparation techniques for a given anthocyanin species within a given matrix. 1Solid phase extraction 
method with complete evaporation. 2Solid phase extraction method with minimalised-evaporation. 
Controls consisted of anthocyanins spiked into pre-extracted buffer matrices. 
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3.3.3 Anthocyanin recovery following routine sample preparation 
techniques  
To assess the effects of B-ring hydroxylation on the recovery of anthocyanins 
during routine pre-analytical sample preparation, pelargonidin-3-glucoside, 
cyanidin-3-glucoside and delphinidin-3-glucoside recovery and degradation 
was measured following filtration, centrifugation and SPE in buffer, serum and 
cell culture matrices (Figure 3.5). No significant differences in recovery were 
observed between pelargonidin-3-glucoside and delphinidin-3-glucoside 
following filtration and centrifugation, although cyanidin-3-glucoside did show 
significantly lower recovery (relative to pelargonidin-3-glucoside and 
delphinidin-3-glucoside) in serum and cell media matrices. No significant 
difference in anthocyanin recovery was observed between filtered and 
centrifuged samples, for a given anthocyanin species. All anthocyanin species 
showed significant loss following routine SPE, while SPE with an incomplete 
concentration/evaporation step (i.e. not taken to dryness) significantly 
improved their stability by 32%, 29% and 18% for pelargonidin-3-glucoside (in 
buffer, serum and cell media, respectively), and 14%, 19% and 0% for 
delphinidin-3-glucoside (in buffer, serum and cell media, respectively).  
Cyanidin-3-glucoside did not show an improvement in recovery. We speculate 
that this is likely due to the chelating and/or protein binding properties of the 
catechol group on the anthocyanin B-ring (Ito, Kato et al. 1988). 
 
The losses of anthocyanins following sample preparation were accounted for 
by a stoichiometric appearance of their respective phenolic acid constituents, 
where pelargonidin-3-glucoside and cyanidin-3-glucoside were recovered as 
4-hydroxybenzoic acid and protocatechuic acid, respectively (Figure 3.4).  
delphinidin-3-glucoside degradation to gallic acid was not observed following 
SPE. To assess the recovery of the phenolic acids following SPE, buffer and 
serum samples were spiked with 100 µM standards of protocatechuic acid,  4-
hydroxybenzoic acid and phloroglucinol aldehyde, respectively. The recovery 
of protocatechuic acid, 4-hydroxybenzoic acid and phloroglucinol aldehyde 
standards were established to be 92±2.8%, 92±2.5% and 78±2.6% in buffered 
samples and 89±2.3%, 115±2.5% and 68±2.8% in serum samples, 
respectively. Note that the recovery of 4-hydroxybenzoic acid in serum was 
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>100%, which may have resulted from additional endogenous 4-
hydroxybenzoic acid liberated from serum samples following methanol 
treatment during SPE, as recoveries were compared to spiked buffer controls. 
 
Whilst the loss of anthocyanins could be accounted for by the recovery of their 
respective B-ring phenolic acid constituents, phloroglucinol aldehyde (the A-
ring constituent) was not consistently identified in post-extraction samples 
(i.e., post SPE). In addition, the disappearance of anthocyanins was 
associated with the formation of an additional unidentified peak [λmax 272nm; 
Rt 21.5 min; m/z 189, 226.9, 248.8] which was similar to the compound 
formed when phloroglucinol aldehyde was incubated in the presence of 
acidified methanol [λmax 272 nm; TR 22.4 min; m/z 187,189 ] (Figures 3.6 and 
scheme 3.1).  
 
Phlorogluceraldehyde
Internal STD
Unknown
(Possible acetal)
Phlorogluceraldehyde
Internal STD
Unknown
(Possible acetals)
A
B
 
 
Figure 3.6. Representative chromatograph for the formation of additional phlorogluceraldehyde 
derived peaks under non-acidified (A; water:methanol) and acidified (B; 1% formic acid in 
water:methanol) SPE extraction conditions (post-SPE chromatographs). SPE, solid phase extraction. 
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Scheme 3.1. Proposed scheme for the formation of phlorogluceraldehyde derived hemiacetals and 
acetals under acidified solvent extraction conditions.  
 
3.3.4 Anthocyanin and anthocyanidin freeze-thaw stability 
To assess the influence of B-ring hydroxylation on anthocyanin freeze-thaw 
stability, anthocyanin species, with mono-, di- and tri-hyroxylated B-rings were 
frozen and thawed six times and their degradation assessed by HPLC/DAD 
(Figure 3.7). It was found that anthocyanin glucosides were stable during 
storage and freeze-thaw treatment, with no significant losses observed. Of the 
three aglycone species, both pelargonidin (P=0.001) and cyanidin (P=0.026) 
showed a significant loss following freeze-thaw cycling, while Del remained 
stable. pelargonidin showed a linear rate of degradation, with significant 
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losses demonstrated at four freeze-thaw cycles and a total reduction of 17 µM 
(11±0.0%) at six freeze-thaw cycles (representing an average loss of 1.8% 
per cycle). cyanidin also showed a linear rate of degradation, with a maximum 
reduction of 10 µM (6±0.0%) at six freeze thaw cycles (representing an 
average loss of 1.2% per cycle). 
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Figure 3.7. Anthocyanin (A) and anthocyanidin (B) freeze thaw stability. * represents significance 
(p<0.05) with respect to control. Data represents mean±SD (n=3).  
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On the whole, anthocyanins have consistently been shown to possess a very 
low bioavailability (Mazza, Kay et al. 2002; Kay, Mazza et al. 2004; Kay, 
Mazza et al. 2005; Vitaglione, Donnarumma et al. 2007). We propose that the 
poor systemic availability of anthocyanins is due to their instability and physio-
chemical degradation in vivo or during routine clinical and laboratory sample 
processing. Therefore this study aimed to quantitatively investigate the effect 
of structure on the degradation of anthocyanins under simulated (in vitro) 
physiological conditions and assess the degradation and recovery of selected 
anthocyanins following pre-analytical sample treatment and storage.   
 
Evidence presented here shows that under simulated (in vitro) physiological 
conditions (pH and temperature), anthocyanidins degraded at much higher 
rates than their glucoside counterparts; which was consistent with previously 
reported data (Markakis 1974; Seeram, Bourquin et al. 2001; Keppler and 
Humpf 2005; Fleschhut, Kratzer et al. 2006). Indeed, the rate of degradation 
varied according to the B-ring hydroxylation pattern such that an increase in 
hydroxylation was associated with a decrease in stability. Furthermore, this 
study demonstrates that anthocyanin degradation under physiological 
conditions is associated with the stoichiometric formation of phenolic acid 
constituents. As the observed rates of anthocyanidin degradation to phenolic 
acids was rapid, it is likely that these compounds are present at far higher 
concentrations than anthocyanidins/anthocyanins in processed foods, the gut 
and the systemic circulation. Although it is likely that pH and temperature are 
the chief contributors to anthocyanin degradation under biological conditions, 
the extent to which other physiological forces, such as protein interactions and 
enzymatic or microbial transformation, contribute to anthocyanin degradation 
is yet to be fully elucidated.  
 
Phloroglucinol aldehyde represented the A-ring constituent of anthocyanins in 
the present investigation; however, phloroglucinol aldehyde may also 
represent the A-ring of other similarly structured flavonoids, although their 
occurrence in human-flavonoid studies is yet to be determined. Due to the 
instability of anthocyanins relative to other flavonoids in the diet, it is likely that 
the majority of phloroglucinol aldehyde in clinically derived samples would be 
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derived from anthocyanins. Further study is however required to fully establish 
the extent to which phloroglucinol aldehyde formation is derived from the 
degradation of anthocyanins and other flavonoids within the diet. 
 
An apparent lack of appreciation for the rate and extent of anthocyanin 
degradation under physiological conditions may explain the almost complete 
absence of data aimed at quantifying anthocyanin breakdown products in 
human samples (tissue, urine, plasma) and the current lack of reports 
concerned with the biological activities of these compounds and their impact, 
as dietary constituents on human health. We contend that anthocyanins may 
be regarded as “pro-drugs” for the delivery of bioactive phenolic intermediates 
and this should be a focus for future research. 
 
In this report we provide evidence to show that anthocyanins degrade at a 
faster rate in buffered solution than in water. However, the rate of end stage 
degradation product (phenolic acids) formation was relatively slower in 
buffered solution than in water. These observations imply that the buffered 
environment confers a greater stability to the pH dependent anthocyanin 
isoforms (including chalcone, hemiketal and α-diketone intermediate 
structures). However, it is possible that slight differences in sample pH could 
account for some of the differences in anthocyanin stability as observed in the 
present investigation. As biological samples (i.e. serum, urine, and cell culture 
media) possess a degree of buffering agents, the degradation characteristics 
of anthocyanins in these matrices should be considered in light of the current 
finding, where anthocyanins may demonstrate differential degradation rates in 
other matrices such as foods, which will be dependent on their individual 
buffering characteristics.    
 
The data presented here show that B-ring hydroxylation significantly affected 
the recovery of anthocyanins following routine SPE. This observation 
suggests that an underestimation of anthocyanin levels in clinically derived 
samples is possible when employing SPE. Further, we observed that the 
disappearance of anthocyanins was accompanied by the stoichiometric 
formation of their respective phenolic acid breakdown products, demonstrating 
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that degradation rather than poor recovery was the foremost cause of 
anthocyanin loss following SPE, particularly in the case of cyanidin-3-
glucoside. This highlights the importance of establishing method accuracy and 
precision when estimating anthocyanin levels in clinical studies. Our data 
suggested that the degradation of anthocyanins observed during SPE may be 
the result of sample evaporation. We provide direct evidence that evaporation 
of SPE eluents to dryness contributes significantly to loss of anthocyanins, 
and that recoveries can be substantially improved by partially evaporating 
SPE eluents. This may be the result of acid concentration and eventual 
hydrolysis in non-neutralized samples during post-SPE evaporation. Thus, it is 
clear that both sample preparation technique and anthocyanin structure 
contribute to their experimental recovery. Consequently, these factors should 
be considered when analysing clinical or biological samples (such as cell 
culture medium, serum/plasma or urine) in order to avoid the underestimation 
of anthocyanin bioavailability.  
 
Table 3.1. Summary of Anthocyanin stability and recovery characteristics.   
Compound Structure Physiological 
stabilitya,d 
Freeze/Thaw 
stabilitya,e Recovery
b
 Extraction method Degradation products Clinical implications 
Pelargonidin-3-O-
glucoside 
OH
OH
OGlc
OH
O+
 
++++ +++++ 
+++++ Filtration 4-Hydroxybenzoic acid 
Phloroglucinol aldehyde 1. Degrades to phenolic acids in 
clinical samples prior 
to acidification.  
2. Risk of 
underestimating 
bioavailability 
following SPE.  
+++++ Centrifugation 
++++ SPEc 
Cyanidin-3-O-
glucoside 
OH
OH
OH
OGlc
OH
O+
 
+++ +++++ 
+++ Filtration 
Protocatechuic acid 
Phloroglucinol aldehyde 
++++ Centrifugation 
+++ SPEc 
Delphinidin-3-O-
glucoside OH
OH
OH
OH
OGlc
OH
O+
 
+ +++++ 
+++++ Filtration 
Gallic acid 
Phloroglucinol aldehyde 
++++ Centrifugation 
+++ SPEc 
Pelargonidin OH
OH
OH
OH
O+
 
+ +++ 
 __
   Filtration 4-Hydroxybenzoic acid 
Phloroglucinol aldehyde 
1. Quickly degrades 
to phenolic acids in 
clinical samples prior 
to acidification.  
2. Care required 
during 
extraction/analysis to 
avoid phenolic acid 
clinical samples  
__ Centrifugation 
__ SPEc 
Cyanidin 
OH
OH
OH
OH
OH
O+
 
+ ++++ 
__ Filtration 
Protocatechuic acid 
Phloroglucinol aldehyde 
__ Centrifugation 
__ SPEc 
Delphinidin OH
OH
OH
OH
OH
OH
O+
 
+ +++++ 
__ Filtration 
Gallic acid 
Phloroglucinol aldehyde 
__ Centrifugation 
__ SPEc 
 
 
aRepresentation of stability: (unstable) +<++<+++<++++<++++ (stable). bRepresentation of 
compound recovery from serum following pre-analytical extraction techniques: (low recovery) 
+<++<+++<++++<+++++ (high recovery). cSolid phase extraction method 2. dStability 
determined at 37ºC and pH 7.4. eStability determined following 6 freeze/thaw cycles (-80ºC and pH 2). 
(__), not determined. Refer to results section for further details. 
 
Whilst some studies have evaluated the storage stability of anthocyanins in 
various food matrices (Kalt, Forney et al. 1999; de Ancos, Ibanez et al. 2000; 
Eiro and Heinonen 2002), no studies have formally reported their storage 
stability under clinically relevant conditions. Thus, this study has shown that 
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anthocyanins are stable when stored at -80 °C and ≤pH 2, whilst 
anthocyanidins are relatively less stable. This indicates that the poor recovery 
of anthocyanins following clinical feeding trials is not likely to be the result of 
degradation in stored samples but the result of degradation in vivo or during 
initial sample processing. 
 
In conclusion, this report demonstrates that anthocyanins are rapidly 
degraded to their phenolic acid and aldehyde constituents under simulated (in 
vitro) physiological conditions and that increased anthocyanin B-ring 
hydroxylation is associated with a decrease in stability; these observations 
have major implications for the design and interpretation of dietary 
intervention studies utilising anthocyanins (Table 3.1). Furthermore, 
anthocyanin losses during sample preparation were accounted for by the 
stoichiometric appearance of their phenolic acid degradation products, 
particularly during SPE. Hence we suggest that the degradation of 
anthocyanins and the representative formation of their phenolic acid 
constituents be of important consideration when investigating anthocyanins 
within clinical and laboratory settings, and that these degradation products be 
targeted in future bioavailability and bioactivity studies in order to establish 
their true occurrence and influence on human health and disease. 
 
 
 
 
96 
 
 
 
 
 
 
Chapter 4  
 
 
Anthocyanin derived phenolic acids form glucuronides 
following simulated gastrointestinal digestion and 
microsomal glucuronidation 
 
 
Data published in Mol. Nutr. Food Res. (in press). 
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4.1 Introduction 
 
In recent years it has been accepted that inflammation plays a central role in 
the development of chronic diseases. As such, novel pharmaceutical and 
dietary strategies are being developed to prevent the progression of chronic 
inflammatory conditions, such as atherosclerosis. Among these strategies, 
dietary polyphenols, including anthocyanins, have been shown to be 
associated with reduced chronic disease risk and mortality (Rimm, Katan et al. 
1996; Lin, Rexrode et al. 2007; Mink, Scrafford et al. 2007). However, current 
evidence in the literature poorly describes the human metabolism of 
anthocyanins, with no information on the biological effects of their metabolites. 
Thus, a full appreciation of the health-related benefits of ingested 
anthocyanins has yet to be achieved and requires a greater understanding of 
their metabolism and associated mechanisms of action.  
 
It has been demonstrated that less than 1% of ingested anthocyanins are 
detectable in urine or plasma (Kay, Mazza et al. 2004) and it has been 
suggested that anthocyanins form intermediate or end stage degradation 
products during digestion, absorption and metabolism that have yet to be 
sufficiently established in vitro or in vivo (Kay, Kroon et al. 2009). To this end 
the anthocyanin degradation products, protocatechuic acid and 4-
hydroxybenzoic acid (Tsuda, Horio et al. 1999; Ichiyanagi, Rahman et al. 
2004) (Figure 4.1), have been identified in the plasma of rats following high 
dose consumption of cyanidin and pelargonidin (Figure 4.1). Furthermore, 
data from a recent study by Vitaglione et al. explains the low systemic 
presence of anthocyanins in humans, as almost 73% of ingested cyanidin was 
accounted for by the formation of protocatechuic acid. This suggests that 
ingested anthocyanins are primarily available to the systemic circulation as 
phenolic acid derivatives. However, the fate of these derivatives remains 
unknown. Indeed, current opinion suggests that anthocyanins are likely 
metabolised to their phenolic acid constituents (Tsuda, Horio et al. 1999; 
Vitaglione, Donnarumma et al. 2007; Han, Ryu et al. 2009; Kay, Kroon et al. 
2009). We propose that the low recovery of anthocyanins post-consumption 
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may not only be accounted for by the formation of free phenolic acids but also 
their conjugated metabolites following absorption and/or first pass 
metabolism. Human studies have yet to demonstrate the phase II conjugation 
of the anthocyanin derived phenolic acids, protocatechuic acid and 4-
hydroxybenzoic acid, but a recent study has reported the in vivo metabolic 
conjugation of protocatechuic acid to monoglucuronide, methyl-
monoglucuronide and methyl-monoglycine conjugates in rats (Cao, Zhang et 
al. 2009).  
 
 
Figure 4.1. Chemical structures of anthocyanins and their potential metabolites. 1, pelargonidin-3-
glucoside; 2, cyanidin-3-glucoside; 3, pelargonidin; 4, cyanidin; 5, 4-hydroxybenzoic acid; 6, 
protocatechuic acid; 7, 4-(1-carboxyphenyl) β-D-glucuronic acid; 8, 4-(1-carboxy-3-hydroxyphenyl) β-
D-glucuronic acid; 9, 3-(1-carboxy-4-hydroxyphenyl) β-D-glucuronic acid. 
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In the current study the potential degradation of anthocyanins (pelargonidin, 
cyanidin, pelargonidin-3-glucoside and cyanidin-3-glucoside) during the early 
stages of gastro-intestinal digestion was explored using a simulated in vitro 
GIT digestion model. The potential for anthocyanin derived degradation 
products, 4-hydroxybenzoic acid and protocatechuic acid, to undergo hepatic 
glucuronidation, both as free phenolic acids and as constituents of their 
precursor anthocyanidin structures was also evaluated.  Furthermore, in order 
to assess the conjugation position of the phenolic acid metabolites, the 
glucuronide derivatives of protocatechuic acid and 4-hydroxybenzoic acid, 
namely 4-(1-carboxyphenyl) β-D-glucuronic acid, 4-(1-carboxy-3-
hydroxyphenyl) β-D-glucuronic acid and 3-(1-carboxy-4-hydroxyphenyl) β-D-
glucuronic acid (Figure 4.1), were chemically synthesised and compared to 
the biologically derived metabolites. 
 
The focus of the present study was to establish the potential sites of metabolic 
conjugation of anthocyanins and their products of degradation. Therefore, the 
utilised experimental system was designed and optimised for maximal 
conjugation efficiency of each of the phenolic substrates. The system was not 
designed to mimic in vivo situations, but to establish potential targets for 
searching for biological metabolites of anthocyanins in future human trials 
and/or cell studies aimed at unravelling the mechanisms behind anthocyanins’ 
proposed bioactivity. 
 
4.2 Materials and Methods 
 
For metabolism and digestion studies, pooled human liver microsomes (male), 
pepsin, panceatin, bile extract, alamethicin, saccharolactone and 4-uridine 5′-
diphosphoglucuronic acid trisodium salt (UDP-GA) were purchased from 
Sigma Aldrich (UK). The phenolic compounds 4-hydroxybenzoic acid, 
protocatechuic acid, kaempferol, cyanidin chloride, pelargonidin chloride, 
cyanidin-3-glucoside chloride and pelargonidin-3-glucoside chloride were 
purchased from Extrasynthese (France) or Sigma Aldrich (UK). For chemical 
synthesis, methyl 2,3,4-tri-O-acetyl-β-D-glucopyranosylurate bromide was 
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purchased from Apollo Scientific Ltd. (UK) and methyl 4-hydroxybenzoate and 
methyl 3,4-dihydroxybenzoic acid was purchased from Alfa Aesar (UK). All 
water used was 18MΩ/cm milliQ water and solvents were of HPLC grade.  
 
4.2.1 Anthocyanin degradation during simulated gastrointestinal 
digestion 
To assess the degradation of anthocyanins during gastrointestinal digestion, 
cyanidin-3-glucoside, pelargonidin-3-glucoside, cyanidin and pelargonidin 
were, individually, subjected to a simulated gastro-intestinal digestion.  
Simulated digestions were based on previously established methods with 
modifications (Glahn, Lee et al. 1999). Briefly, to purify pepsin for gastric 
phase digestion, 0.1 g of pepsin was made up to 2.5 ml in 0.1 M HCl, added 
to 1.25 g Chelex-100 and shaken gently on a platform tabletop shaker (EMLI, 
Sky Line) for 30 min to remove any residual iron that may chelate the catechol 
anthocyanins. The solution was then poured into a 1.6 cm diameter glass 
column (acid washed) and the eluent collected. A further 2.5 ml of 0.1 M HCl 
was added to the column and the filtrate collected. The final pepsin solution 
(filtrate) was 20 mg/mL pepsin. To purify pancreatin for duodenal (intestinal) 
digestion, 0.0125 g of pancreatin and 0.075 g of bile extract was made up to 
6.25 ml with 0.1 M NaHCO3 and shaken gently with 3.125 g Chelex-100 for 30 
min. The pancreatin/bile solution was then poured into a 1.6 cm diameter 
glass column to filter out the chelex. An additional 2.5 ml of 0.1 M NaHCO3 
was added to the column and the eluent collected. The final pancreatin/bile 
solution contained 1.4 mg/mL pancreatin and 8.6 mg/mL bile extract. Both 
enzyme solutions were stored at 4 °C and used within 24 hours.  
 
To simulate gastric phase digestion, the individual anthocyanins (final 
concentrations of 200 µM) were added to a 140 mM NaCl, 5 mM KCl buffer 
solution (pH 2) containing 0.15 ml pepsin solution and 25 µg trans-cinnamic 
acid as an internal standard (3.15 ml final volume). The individual solutions 
were incubated at 37 °C for 30 min on a platform oscillating tabletop shaker 
(EMLI, Sky Line) and at 0, 15 and 30 min, 500 µl aliquots were taken, acidified 
with 0.2 M HCl in ethanol (1:1 v/v final sample dilution) and stored at -80 °C 
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until HPLC analysis. To simulate duodenal (intestinal) digestion, the pH of the 
gastric phase digest was titrated to pH 6.7 by the addition of 1 M NaHCO3, 
followed by the addition of 0.417 ml pancreatin/bile solution (0.6 mg 
pancreatin and 3.6 mg bile extract). The digest was made up to a final volume 
of 2.5 ml with 140 mM NaCl, 5 mM KCl buffer solution (pH 6.7, degassed 
under vacuum for 30 min prior to use) and incubated for 120 min at 37 °C on 
a platform oscillating tabletop shaker. At 0, 60 and 120 min, 500 µl aliquots 
were removed from the incubation mixture and acidified with 0.2 M HCl in 
ethanol (1:1 v/v final sample dilution) and stored at -80 °C until HPLC 
analysis. Control samples consisted of initial samples (0 min) spiked with 0.1 
M HCl and stored at -80 °C until HPLC analysis. Sample concentrations were 
normalised to the final incubation volumes for the gastric and intestinal phases 
respectively. For quantification, samples were thawed at room temperature, 
vortexed and centrifuged at 10,000 rpm for 20 min at room temperature and 
the supernatants analysed by HPLC.  
 
4.2.2 Microsomal conjugation of anthocyanidins and phenolic acids  
Microsomal conjugation was performed as previously described (Day, Bao et 
al. 2000; Oliveira and Watson 2000) with some adjustments. Substrate 
concentration and incubation times were optimized for each respective 
compound (cyanidin, pelargonidin, 4-hydroxybenzoic acids and 
protocatechuic acid) to achieve optimal concentrations and chromatographic 
clarity of phenolic acid glucuronides. Briefly, within a 0.1 M potassium 
phosphate buffer (pH 7.4), 0.25 mg human liver microsomes and 12.5 µg 
alamethicin were vortexed and placed on ice for 15 min. MgCl2 (1mM), 
saccharolactone (5 mM) and the respective test compounds (1-2.5 mM) were 
added (as individual treatments) and each mixture was pre-incubated for 3 
min at 37 °C. To initiate the reaction, uridine 5 ′-diphosphoglucuronic acid 
(UDP-GA; 5 mM) was added to give a final incubation volume of 0.1 mL. The 
reaction mixtures were then incubated at 37 °C for 4-12 h. Control incubations 
were performed without the addition of UDP-GA. Incubations were also 
performed with 0.3 mM kaempferol under the above stated conditions as a 
reaction control, since its microsomal conjugation has previously been 
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characterized. The reactions were stopped with the addition of 100 µL ice cold 
1% HCl in acetonitrile. After equilibration on ice for 15 min, stopped reaction 
mixtures were centrifuged (13,000 rpm for 15 min at room temperature) to 
pellet precipitate proteins and the supernatants analysed by HPLC.  
 
4.2.3 Chemical synthesis of phenolic acid glucuronides  
In general, all solvents were dried over freshly activated 3Å molecular sieves. 
Evaporations were performed in vacuo at 50°C and solids were dried 
overnight in vacuo over P2O5 before use. TLC was performed on Macherey-
Nagel Silica Gel 60/UV254 plates using UV light, or 50% sulphuric acid and 
charring for visualisation. Flash chromatography used pre-packed silica 
cartridges (Isolute Flash Si, BiotageTechnologies) and UV detection. The final 
reaction products were characterised by 1H NMR, run on a JEOL GX-400 
spectrometer at room temperature. NMR data interpretation was conducted by 
Dr. Paul Needs (Institute of Food Research, Norwich, UK). 
 
4-(1-Carboxy-3-hydroxyphenyl) β-D-glucuronic acid synthesis (Scheme 4.1). 
Briefly, methyl 3,4-dihydroxybenzoate (3 g, 17.8 mmol) was stirred in acetic 
anhydride (50 ml) at room temperature and H2SO4 (5 ml) was added drop 
wise. After 40 min the mixture was poured into ice-water (250 ml) and 
extracted with EtOAc (2 x 200 ml). The combined organic extracts were 
washed with water (2 x 100 ml) and dried (MgSO4). Evaporation, followed by 
co-evaporation with toluene produced methyl 3,4-diacetoxybenzoate [1H 
NMR: (CDCl3) 2.30 (6H, s, 2 x COCH3), 3.90 (3H, s, OCH3), 7.29 (1H, d, J 
=10.4 Hz, H-5), 7.87 (1H, d, J = 1.8 Hz, H-2), 7.94 (1H, dd, H-6)]. 
Subsequently, methyl 3,4-diacetoxybenzoate (1 g, 3.96 mmol) was dissolved  
in a mixture of THF (50 ml) and imidazolium hydrochloride (pH 7; 50 ml) at 
room temperature. After 30 min the mixture was extracted with CH2Cl2 (2 x 
200 ml) and the combined extracts were washed with water (100 ml), 
NaHCO3 (100 ml) and water (100 ml), dried (MgSO4) and evaporated. 
Purification by flash chromatography (100 % CH2Cl2 to 5% MeOH in CH2Cl2) 
gave pure
 
methyl 3-acetoxy-4-hydroxybenzoate [1H nmr: (CDCl3) 2.37 (3H, s, 
COCH3), 3.87 (3H, s, OCH3), 7.02 (1H, d, J =8.6 Hz, H-5), 7.82 (1H, d, J = 1.8 
Hz, H-2), 7.84 (1H, dd, H-6)]. Methyl 3-acetoxy-4-hydroxybenzoate (0.50 g, 
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2.38 mmol) was dissolved in dry CH2Cl2 (25 ml) under Ar gas at room 
temperature. Subsequently, powdered 3Å molecular sieves (0.5 g), methyl 
2,3,4-tri-O-acetyl-α-D-glucopyranosyluronate bromide (1.04 g, 1.1 eq.), silver 
(I) carbonate (0.72 g, 1.1 eq.) and collidine (0.34 ml, 1.1 eq.) were added to 
the methyl 3-acetoxy-4-hydroxybenzoate solution. The reaction was stirred for 
7 d in the dark and then filtered through filter aid powder. The latter was 
washed with acetone (30 ml) and CH2Cl2 (30 ml) and the combined organics 
evaporated. The resulting red oil was dissolved in CH2Cl2 (50 ml) and washed 
with 1 M HCl aq. (2 x 50 ml), and water (1 x 50 ml), and dried (MgSO4). Flash 
chromatography (100 % CH2Cl2 to 4% MeOH in CH2Cl2) produced 4-(1-
methoxycarboxy-3-acetoxyhydroxyphenyl)-2,3,4-tri-O-acetyl-β-D-
glucopyranosyluronate methyl ester, which was de-protected as previously 
described (Needs and Kroon 2006; He, Shi et al. 2008) and purified  by 
preparative HPLC to yield 4-(1-carboxy-3-hydroxyphenyl) β-D-glucuronic acid 
[1H nmr (dmso-d6)- 3.34-3.40 (m, partially obscured by HOD peak, H-2’, H-3’, 
H-4’), 3.92(1H,d, J = 9.8 Hz, H-5’), 5.06 (1H, J = 7.3 Hz, 1H’), 7.09 (1H, d, J = 
9.2 Hz,  H-5), 7.36 - 7.38 (2H, m, H-2, H-6)]. Refer to appendix B for purity 
data and NMR spectrum. 
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Scheme 4.1. Synthesis of 4-(1-Carboxy-3-hydroxyphenyl) β-D-glucuronic acid. 
104 
 
 
4-(1-carboxyphenyl) β-D-glucuronic acid synthesis (Scheme 4.2). 4-(1-
carboxyphenyl) β-D-glucuronic acid was synthesised as described previously 
(Ghosh and Farquhar 1997) for the glucuronidation of 4-
hydroxybenzaldehyde. Briefly, methyl 4-hydroxybenzoate (100 mg), methyl 
2,3,4-tri-O-acetyl-β-D-glucopyranosylurate bromide (234 mg, 1 equiv.), Ag2O 
(200mg, 2 equiv.) and acetonitrile (0.66 ml)  were stirred in the dark under Ar 
gas. After 16 h the reaction product was purified by MPLC (20g silica, 60% 
ethylactetate/40% hexane isocratic elution) and de-protected as previously 
described (Needs and Kroon 2006). The final product was precipitated in 50% 
MeOH aq at 4 °C to yield 4-(1-carboxyphenyl) β-D-glucuronic acid as a yellow 
powder [1H NMR (dmso d6)- [δH  7.89 (2H, d, J=8.4Hz, H-2, H-6), 7.09 (2H, d, 
J= 8.4Hz, H-3, H-5), 4.97 (1H, d, J=7.2Hz, H-1'), 3.48 (1H, d, J=10.0Hz, H-5'), 
3.15- 3.40 (3H, m, H-2, H-3, H-4)]. Refer to appendix B for purity data and 
NMR spectrum. 
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Scheme 4.2. Synthesis of 3-hydroxy-4-O-glucuronosylbenzoate. 
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3-(1-Carboxy-4-hydroxyphenyl) β-D-glucuronic acid synthesis (Scheme 4.3). 
The reaction precursor, methyl 4-benzyloxy-3-hydroxybenzoate was 
synthesised as previously described [14]. Subsequently, methyl 4-benzyloxy-
3-hydroxybenzoate (100 mg), methyl 2,3,4-tri-O-acetyl-β-D-
glucopyranosylurate bromide (153 mg, 1 equiv.), acetonitrile (1 ml) and Ag2O 
(179 mg, 2 equiv.) were stirred continually for 24 h on ice under Ar gas. The 
mixture was then purified by MPLC (20g silica, 20% ethylactetate/80% hexane 
isocratic elution) and the main reaction product de-protected as previously 
described (Needs and Kroon 2006; He, Shi et al. 2008). Due to poor reaction 
yields, synthesised metabolite, 4-hydroxy-3-O-glucuronosyl benzoic acid was 
tentatively identified based on ESI-MS and UV-vis spectral data following 
comparison with biologically chemically derived glucuronide conjugates. Refer 
to appendix B for purity data. 
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Scheme 4.3. Synthesis of 3-(1-Carboxy-4-hydroxyphenyl) β-D-glucuronic acid. 
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4.2.4 HPLC conditions  
HPLC analysis was performed on an Agilent 1100 series HPLC equipped with 
a diode array detector (DAD). Simulated GIT digestion samples were 
analysed on a 4 µm, 250 x 4.6 mm Synergi Max-RP reverse phase column 
(Phenomenex, Macclesfield, UK) with a SecurityGuard guard cartridge 
(Phenomenex AJO-6074) and microsmal samples on a 5 µm, 250 x 4.6 mm 
Lunar C18 column (Phenomenex, Macclesfield, UK) with a SecurityGuard 
guard cartridge (Phenomenex AJO-6074) at a column temperature of 37 °C. 
The mobile phase consisted of 1% formic acid (v/v) in water (A) and 1% 
formic acid (v/v) in methanol (B). The solvent gradient consisted of 2.5% B at 
0 min, 25% B at 15 min, 45% B at 20 min and 100% B at 25-30 min for 
simulated GI digestion samples and 0% B at 0 min, 3% B at 4 min, 3% B at 10 
min, 15% B at 20 min, 18% B at 25 min, 35% B at 30 min, 40% B at 35 min, 
50% B at 40 min and 100% B at 45-50 min for microsomal samples. The flow 
rate was 1 mL/min and absorbance was recorded at 520, 360, 280 and 
265nm. Quantification and identification of known compounds was performed 
using authentic analytical standards.  
 
4.2.5 ESI-MS and MS/MS conditions  
Full scan LC/MS analysis of all microsomal samples and synthesised 
metabolites was conducted on an Agilent 1100 series LC/MSD SL single 
quadrupole mass spectrometer coupled to an Agilent 1100 series HPLC with 
DAD detector (refer to appendix B for ESI-MS method development data). 
Electrospray ionization was performed in full scan mode (Mass range: 100-
1000Da) with the following spray chamber conditions: drying gas flow 13 
l/min; nebulizer pressure 50 psi; drying gas temperature 350 °C. Negative 
mode ionization was performed at a capillary voltage of -3000 V and a 
fragmentor setting of 100. For further structural elucidation of a selected 
number of samples MS/MS analysis was conducted on an Applied 
Biosystems 3200 Q-Trap LC/MS/MS system coupled to an Agilent 1200 
series HPLC with DAD detector. Source parameters were as follows: 
electrospray flow rate 1 mL/min, source temperature 500 °C, ion spray voltage 
-3500 V, curtain gas 10 psi, collision gas medium, ion source gas 1, 65 psi 
and ion source gas 2, 65 psi. For 4-hydroxybenzoic acid glucuronide 
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metabolites negative mode product ion scanning parameters were as follows: 
Q1 mass 313.3, declustering potential -61 V, entrance potential -4 V, collision 
energy -19 V and collision cell exit potential -2 V. For protocatechuic acid 
glucuronide metabolites: Q1 mass 329.2, declustering potential -55 V, 
entrance potential -3 V, collision energy -18 V and collision cell exit potential -
2 V. HPLC conditions were as previously described.  
 
 
4.2.6 Statistical Analysis  
Simulated GIT digestion samples were compared by one-way analysis of 
variance (ANOVA) with Tukey post-hoc tests (Windows SPSS, version 15) on 
concentration data derived from standard curves of authentic analytical 
standards. Significance was determined at p<0.05 across triplicate 
experiments.  
 
4.3 Results and Discussion 
 
4.3.1 In vitro gastrointestinal digestion of anthocyanins. To assess the 
degradation of pelargonidin-3-glucoside, cyanidin-3-glucoside, pelargonidin 
and cyanidin during GIT digestion, the anthocyanins were exposed to 
simulated gastric and duodenal digestion (Figures 4.2 and 4.3). During the 
simulated gastric digestion (0-30 min; Figure 4.2A) no significant anthocyanin 
degradation was observed. However, significant loss of anthocyanin 
aglycones was observed following 15 min of gastric digestion (p<0.05; Figure 
4.3A). During post-gastric duodenal digestion (0-120 min), a significant loss of 
cyanidin-3-glucoside was observed (Figure 4.2B), while significant losses of 
both anthocyanin aglycones were observed across 0-120 min (p<0.05; Figure 
4.3B) with complete loss of the aglycones within 60 min of digestion. No 
phenolic acid degradation products were identified within the 120 min 
digestion.  
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Figure 4.2. Anthocyanin (glycoside) loss during in vitro gastrointestinal digestion. A) Gastric phase 
digestion in the presence of pepsin (pH 2). B) Duodenal phase digestion in the presence of pancreatin 
and bile salts (pH 6.7). *Significance from control (initial anthocyanin spiked samples maintained at 
pH 2 (0.1 M HCl) throughout digestion; t=0; p<0.05). Pg-3-Glc, pelargonidin-3-glucoside; Cy-3-Glc, 
cyanidin-3-glucoside. Data represents mean±SD (n=3). 
 
 
 
Figure 4.3. Anthocyanidin (aglycone) loss during in vitro gastrointestinal digestion. A) Gastric phase 
digestion in the presence of pepsin (pH 2). B) Duodenal phase digestion in the presence of pancreatin 
and bile salts (pH 6.7). *Significance from control (initial anthocyanin spiked samples maintained at 
pH 2 (0.1 M HCl) throughout digestion; t=0; p<0.05). Pg, pelargonidin; Cy, cyanidin. Data represents 
mean±SD (n=3). 
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4.3.2 Microsomal glucuronidation of anthocyanin derived phenoic acids. 
To assess the potential for anthocyanins to form glucuronidated phenolic acid 
metabolites, pelargonidin and cyanidin; and their reported degradation 
products, 4-hydroxybenzoic acid and protocatechuic acid, were incubated with 
human liver microsomes in the presence of UDP-GA. As a reaction control, 
kaempferol was subjected to the incubation conditions described for 
anthocyanins and phenolic acids. Following 30 min, kaempferol demonstrated 
complete conjugation to form two glucuronide metabolites in a manner 
consistent with previously reported data (Oliveira and Watson 2000) (Figure 
4.4). Following microsomal metabolism, pelargonidin formed two phenolic acid 
metabolite peaks (Figure 4.5A) which were identified as 4-hydroxybenzoic 
acid (138 m/z) and its monoglucuronide metabolite M1 (314 m/z; 
demonstrating a loss of 176 m/z under ESI-MS and MS/MS conditions). In 
addition cyanidin formed one phenolic acid metabolite peak (Figure 4.6B) 
which was identified as protocatechuic acid (154 m/z). No protocatechuic acid 
glucuronide metabolites were observed using UV-vis, however, LC/MS/MS 
analysis using product ion scanning parameters optimised for the synthesised 
standards revealed (based on MS2 fragmentation patterns) the presence of 
multiple protocatechuic acid glucuronides (Table 1; M4-7).  
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Figure 4.4. Kaempferol glucuronidation by liver microsomes. Chromatograph showing 
kaempferol (1) and its microsomal glucuronide metabolites (2 and 3).  
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Figure 4.5. Representative chromatograms of pelargonidin and 4-hydroxybenzoic acid post incubation 
with human liver microsomes in the presence of UDP-GA. A) Individual incubations with pelargonidin 
(Pg) or its degradation product 4-hydroxybenzoic acid (HBA) (with chromatograms overlaid). B) 
Incubations with 4-hydroxybenzoic acid overlaid with the chromatogram of the chemically synthesised 
metabolite, 4-(1-carboxyphenyl) β-D-glucuronic acid (4GBA). M1 and M2 refers to microsomal 
metabolites 1 (4-hydroxybenzoyl glucuronide) and 2 (4GBA). For metabolite and synthetic standard 
spectral data refer to Table 1. 
 
 
 
 
Figure 4.6. Representative chromatographs of cyanidin and protocatechuic acid post incubation with 
human liver microsomes in the presence of UDP-GA. A) Incubation with cyanidin (Cy) overlaid with 
the chromatogram of the commercial standard protocatechuic acid (PCA). B) Incubation with PCA 
overlaid with the chromatograms of the chemically synthesised metabolites, 3-(1-carboxy-4-
hydroxyphenyl) β-D-glucuronic acid (4OH3GBA) and 4-(1-carboxy-3-hydroxyphenyl) β-D-glucuronic 
acid (3OH4GBA). M3-5 refers to microsomal metabolites 3 (protocatecuic acid-acyl-glucuronide), 4 
(protocatechuic acid-3’-glucuronide) and 5 (protocatechuic acid-4’-glucuronide). For metabolite and 
synthetic or commercial standard spectral data refer to Table 1. 
 
 
Following microsomal incubations, the pelargonidin degradation product 4-
hydroxybenzoic acid (138 m/z) was metabolised to form two glucuronide 
conjugates (M1 and M2; 314 m/z; Figure 4.5B) which both demonstrated a 
loss of 176 m/z under ESI-MS and MS/MS conditions. It should be noted that 
the microsomal metabolite M1 was observed during the incubation of both 
pelargonidin and 4-hydroxybenzoic acid (individually). Protocatechuic acid 
(154 m/z), when incubated in the presence of liver microsomes, was 
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metabolised to form three glucuronide conjugates (M3, M4 and M5; 330 m/z; 
Figure 4.6B) which all demonstrated a loss of 176 m/z under ESI-MS and 
MS/MS conditions. The spectral and chromatographic data for metabolites 
M1-5 are described in Table 4.1 and were confirmed using synthetic 
standards. 
 
Table 4.1. Summary of HPLC-MS/MS characteristics of phenolic acid metabolitesa 
Compound
Rt                
(min)
Mass ion spectrum [M-H]-, (m/z)b     
UV maximum 
(nm)
Relative 
abundancec                                   
(% peak area)
Identificationd
Precursor Fragment (product)
Metabolites
M1e 21.8 313 193, 175, 137, 113 262 99±18 HBA-acyl-GlcAf
M2e 16.9 313 175, 137, 113 248 1±1 HBA-4'-GlcA
M3e 16.3 329 193, 175, 153, 113 266, 298 81±3 PCA-acyl-GlcAf
M4e 17.8 329 193, 175, 153, 113 252, 292 3±0 PCA-3'-GlcA
M5e 22.5 329 175, 153, 113 258, 288 15±0 PCA-4'-GlcA
M6g 27.5 329 193, 175, 153, 113 - - Unknown
M7g 28.8 329 193, 175, 153, 113 - - Unknown
Commercial Standards
HBA 27.9 137 93, 75, 65 254 - -
4GBA 16.9 313 175, 137, 113 248 - -
PCA 20.7 153 109, 91, 65 260, 294 - -
Synthesised Standards
4OH3GBA 17.8 329 175, 153, 113 252, 292 - -
3OH4GBA 22.5 329 175, 153, 113 258, 288 - -
 
aSpectral and chromatographic data for phenolic metabolites derived following microsomal incubations 
in the presence of UDP-GA. bMass fragmentation patterns as determined by full scan MS analysis and 
confirmed by product ion MS/MS scanning (refer to methods section).  cTentative abundance based on 
peak areas relative to controls. dTentative identification based on comparisons with synthesised and 
commercial standards.  eM1-5, microsomal metabolites 1-5 as illustrated in figures 4 and 5. fMetabolite 
identification based on plausible remaining conjugation site and indirect comparisons with aryl-
synthetic standards and HPLC-MS/MS data. gMicrosomal metabolites 6 and 7 were identified in 
cyanidin microsomal  incubations based on product ion HPLC-MS/MS scans only. Rt, retention time; 
HBA, 4-hydroxybenzoic acid; 4GBA, synthesised 4-(1-carboxyphenyl) β-D-glucuronic acid; HBA-
acyl-GlcA, acyl glucuronide of 4-hydrocybenzoic acid; HBA-4’-GlcA, 4’ glucuronide of 4-
hydroxybenzoic acid; PCA, protocatechuic acid; 4OH3GBA, synthesised 3-(1-carboxy-4-
hydroxyphenyl) β-D-glucuronic acid; 3OH4GBA, synthesised 4-(1-carboxy-3-hydroxyphenyl) β-D-
glucuronic acid; PCA-acyl-GlcA, acyl glucuronide of protocatechuic acid; PCA-3’-GlcA, 3’ 
glucuronide of protocatechuic acid; PCA-4’-GlcA, 4’ glucuronide of protocatechuic acid; GlcA, 
glucuronic acid; UDP-GA, uridine 5′-diphosphoglucuronic acid. 
 
4.3.3 Structural elucidation of phenoic acid metabolites. To aid structural 
elucidation, the synthesised glucuronide conjugates of 4-hydroxybenzoic acid 
and protocatechuic acid were chemically synthesised and compared with the 
biologically derived anthocyanin and phenolic acid metabolites. It was 
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confirmed that the synthesised metabolite 4-(1-carboxyphenyl) β-D-glucuronic 
acid had the same retention time, UV maxima and mass fragmentation pattern 
as 4-hydroxybenzoic acid’s microsomal derived metabolite M2 (Figure 4.5B). 
Synthesised metabolites 4-(1-carboxy-3-hydroxyphenyl) β-D-glucuronic acid 
and 3-(1-carboxy-4-hydroxyphenyl) β-D-glucuronic acid were also confirmed 
to have the same retention time, UV maxima and mass fragmentation pattern 
as protocatechuic acid’s microsomal derived metabolites M4 and M5, 
respectively (Figure 4.6B).  
 
Although anthocyanins possess a number of beneficial bioactivities (Mazza 
2007), their apparent systemic bioavailability has been shown to be very low 
(Manach, Williamson et al. 2005). Previous studies have suggested that this is 
likely due to spontaneous degradation under physiological conditions 
(Woodward, Kroon et al. 2009) or following microbial metabolism (Keppler and 
Humpf 2005; Han, Ryu et al. 2009). In this study the aim was to identify the 
plausible alternative occurrences of anthocyanins following metabolism and it 
was hypothesised that anthocyanins are degraded to form phenolic acids and 
subsequently conjugated via phase II metabolism.  
 
Here it was observed that anthocyanins were stable during gastric digestion, 
but were degraded during intestinal digestion. Although this is consistent with 
previous studies (Perez-Vicente, Gil-Izquierdo et al. 2002; McDougall, Dobson 
et al. 2005; McDougall, Fyffe et al. 2005), little account for phenolic acid 
formation or spontaneous degradation has been previously given. Importantly, 
the loss of anthocyanins and anthocyanidins during GIT digestion in this study 
did not result in the formation of their representative phenolic acid degradation 
products. This was likely due to the short incubation time (2h) at neutral pH 
(Keppler and Humpf 2005; Woodward, Kroon et al. 2009), where we have 
previously described an initial lag in phenolic acid formation following 
anthocyanin degradation at neutral pH and 37 °C; po tentially as a result of the 
formation of relatively stable ‘ring-open’ transition products (Woodward, Kroon 
et al. 2009).  
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Degradation of anthocyanins was similar both in the presence and absence of 
digestive enzymes, which was consistent with previous observations 
regarding anthocyanin degradation under simulated physiological conditions 
and suggests that anthocyanin degradation during digestion occurred 
spontaneously. It remains to be established the extent to which anthocyanins 
are hydrolysed in vivo by the human intestinal brush-boarder enzymes (Day, 
DuPont et al. 1998; Day, Cañada et al. 2000), however the efficient 
deglucosylation of pelargonidin has been previously reported (Kroon, Clifford 
et al. 2004); suggesting significant degradation following deglycosylation 
should occur in vivo.  
 
This study demonstrated that both the degradation products of anthocyanins 
(pelargonidin and cyanidin) 4-hydroxybenzoic acid and protocatechuic acid 
were efficiently metabolised by human liver microsomes to form 
monoglucuronide conjugates. Indeed, 4-hydroxybenzoic acid was metabolised 
to form two monoglucuronide species and protocatechuic acid was 
metabolised to form three monoglucuronide species. This pattern of mono-
glucuronidation is similar to that demonstrated by Cao et al. [10] in rats and is 
consistent with the number of free hydroxyl groups present on these phenolic 
structures. Comparison of the microsomal metabolites for 4-hydroxybenzoic 
acid with the chemically synthesised glucuronides confirmed that metabolite 
M2 was the 4’-glucuronide conjugate of 4-hydroxybenzoic acid. This evidence 
suggests that pelargonidin and its 4-hydroxybenzoic acid metabolite M1 is an 
acyl glucuronide. Similarly, comparison of the protocatechuic acid microsomal 
metabolites with the chemically synthesised glucuronides confirmed that 
metabolites M4 and M5 were the 4’ and 3’ glucuronide conjugate of 
protocatechuic acid. This indicates that the protocatechuic acid metabolite M3 
is an acyl glucuronide. Interestingly, the fragmentation of these phenolic acyl 
glucuronides gives a characteristic mass fragmentation ion at 193 m/z, which 
may prove useful in distinguishing these conjugation sits (acyl vs aryl) in 
future human studies (Scheme 4.4).  
 
Herein we provide evidence that suggests acyl and aryl mono-glucuronides of 
4-hydroxybenzoic acid and protocatecuic acid may be common in vivo 
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biological conjugates following anthocyanin consumption. Further research 
should be conducted to evaluate the extent to which acyl glucuronide 
products of anthocyanin derived carboxylates are formed in vivo. Indeed, the 
occurrence of acyl glucuronides may be of particular biological interest, since 
they may cause covalent modifications to endogenous proteins and other 
macromolecules (Boelsterli 2002) and may impact pharmaceutical drug 
metabolism/bioactivity (Boelsterli 2002). In addition, future work is needed to 
establish the sites of methyl and glycine conjugation as indicated in recent 
rodent studies (Cao, Zhang et al. 2009).   
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Scheme 4.4. Proposed mechanism for phenolic glucuronide MS fragmentation under the current MS 
conditions where acyl glucuronides (A) may yield a characteristic mass ion at 193 m/z in comparison to 
its aryl glucuronide counterparts (B and C). 
 
It should be noted that the focus of the utilised experimental system in this 
study was developed to establish potential sites of metabolic conjugation and 
therefore the methods were developed to produce a system optimised for 
conjugation efficiency of each of the phenolic substrates. Consequently, the 
results cannot be implied or translated relative to physiological events such as 
systemic absorption, bioavailability, or excretion.  Therefore, future research 
should aim to identify these metabolic target in vivo, in order to determine their 
systemic absorption, bioavailability and excretion.  
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In conclusion, evidence is presented to suggest that anthocyanins can be 
degraded during gastrointestinal digestion and hepatic metabolism to form 
several mono-glucuronide metabolites. Hence, it is proposed that 
anthocyanins may additionally be found in the systemic circulation as free or 
conjugated phenolic acids. 
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Chapter 5  
Structure-activity relationship study: Modulation of 
endothelial superoxide production by anthocyanins 
and their phenolic metabolites 
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5.1 Introduction 
 
The endothelial generation of reactive oxygen species (ROS) is important 
both for normal physiology and in the progression of cardiovascular diseases 
(Droge 2002). ROS generated by the endothelium include superoxide, 
hydrogen peroxide, nitric oxide (NO), peroxynitrite and hydroxyl radicals 
(Droge 2002). Superoxide radicals, the focus of the current investigation, may 
have several effects on the vasculature, either directly or indirectly. These 
effects include rapid inactivation of the potent signalling molecule and 
endothelial vasodilator, NO, leading to endothelial dysfunction, the mediation 
of oxidative signal transduction (“redox signalling”) and oxidative damage 
(Munzel and Harrison 1999; Cai and Harrison 2000). Multiple enzyme 
systems are responsible for the generation of superoxide within the 
endothelium; notably, xanthine oxidase, un-coupled nitric oxide synthase and 
the mitochondria. Recent studies have indicated that the major source of 
endothelial superoxide is a multi-component NADPH oxidase or NOX 
(particularly NOX4) that is subject to specific regulatory stimuli such as 
oscillatory shear stress, hypoxia, angiotensin II, cytokine, growth factors and 
hyperlipidaemia (Ago, Kitazono et al. 2004; Bedard and Krause 2007). 
Depending on the level of oxidants generated and the relative balance 
between pro- and antioxidant systems, ROS may be involved in the 
progression and modulation of cardiovascular diseases such as 
atherosclerosis (Kojda and Harrison 1999; Taniyama and Griendling 2003).  
 
Of particular interest, the rennin-angiotensin system is a central component of 
the physiological and pathological responses of the vasculature (Dzau 1988; 
Brasier, Recinos et al. 2002). Its primary effector hormone, angiotensin II (Ang 
II), not only mediates its acute haemo-dynamic effects through the renal 
system, but is also implicated in inflammation, endothelial dysfunction and 
atherosclerosis through its chronic exposure to the endothelium (Mehta and 
Griendling 2007). The effect of Ang II on the vasculature is dependent on time 
(chronic vs. acute) and cell/tissue specific factors. In addition to G protein and 
non-G protein related signalling pathways, Ang II acting via the angiotensin II 
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receptor 1 (AT1R) carries out its functions through the MAP kinases (ERK1/2, 
JNK, p38MAPK), receptor tyrosine kinases (PDGF, EGFR) and non-receptor 
tyrosine kinases (Src, JAK/STAT). Importantly, AT1R stimulation also leads to 
the activation of NOX in the endothelium and subsequent generation of 
superoxide and other ROS (Rueckschloss, Quinn et al. 2002).   
 
Perhaps the most documented role of superoxide in the development of 
vascular disease is its ability to disable endothelial nitric oxide synthase 
(eNOS also known as ecNOS or NOS3) generated NO (Munzel and Harrison 
1999; Cai and Harrison 2000). eNOS is a calcium-dependent flavoprotein that 
generates NO in a process that involves the oxidation of L-arginine by the 
reduction of molecular oxygen (Moncada, Palmer et al. 1991; Bredt and 
Snyder 1994). The essential eNOS cofactor tetrahydroxybiopterin (BH4) 
appears to have a key role in regulating NOS function by “coupling” the 
reduction of oxygen to L-arginine oxidation, as well as maintaining the stability 
of NOS dimmers. BH4 is itself highly susceptible to oxidative degradation and 
the initial oxidative loss of BH4 in response to increased ROS production has 
been shown to amplify oxidative stress through the resulting loss of NO 
production and increased NOS-dependent superoxide production (eNOS “un-
coupling”) (Moncada, Palmer et al. 1991; Bredt and Snyder 1994). 
Furthermore, the rapid reaction of superoxide with NO results in the formation 
of peroxynitrite anions and loss of NO function. This appears to play an 
important role in cardiovascular disease development.  
 
It has long been thought that diets rich in anthocyanins and other flavonoids 
may confer protection against cardiovascular disease and mortality. Indeed, 
this hypothesis has been driven by finding from numerous epidemiological, 
clinical and experimental studies (Hertog, Feskens et al. 1993; Hertog, 
Kromhout et al. 1995; Knekt, Jarvinen et al. 1996; Rimm, Katan et al. 1996; 
Hertog, Sweetnam et al. 1997; Hertog, Feskens et al. 1997; Yochum, Kushi et 
al. 1999; Arts, Jacobs et al. 2001; Geleijnse, Launer et al. 2002; Knekt, 
Kumpulainen et al. 2002; Sesso, Gaziano et al. 2003; Tsuda, Horio et al. 
2003; Xia, Ling et al. 2003; Lin, Rexrode et al. 2007; Mink, Scrafford et al. 
2007; Sasaki, Nishimura et al. 2007; Xia, Ling et al. 2007; Hooper, Kroon et 
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al. 2008; Leblais, Krisa et al. 2008; Toufektsian, de Lorgeril et al. 2008). Whilst 
the epidemiological evidence for the protective effects of flavonoid rich diets, 
including anthocyanins, on cardiovascular protection are mixed, the majority 
of clinical and animal studies are in support of their positive effects 
(Andriambeloson, Magnier et al. 1998; Benito, Lopez et al. 2002; Mendes, 
Desgranges et al. 2003; Serraino, Dugo et al. 2003; Matsubara, Kaneyuki et 
al. 2005; Mink, Scrafford et al. 2007). Although early research did not attribute 
the beneficial effects of anthocyanins to their antioxidant potential and radical 
scavenging activities, considerable research has described the antioxidant 
properties of anthocyanins (Vinson, Dabbagh et al. 1995; Prior, Cao et al. 
1998; Wang, Nair et al. 1999; Kalt, McDonald et al. 2000; Mazza, Kay et al. 
2002; Zafra-Stone, Yasmin et al. 2007). Recent research suggests a 
mechanism of action that is un-related to their direct radical scavenging 
properties (Zhang, Lian et al. ; Martin, Favot et al. 2003; Lamy, Blanchette et 
al. 2006; Oak, Bedoui et al. 2006; Xia, Ling et al. 2007; Guo, Ling et al. 2008; 
Williams, El Mohsen et al. 2008; Min, Ryu et al. 2010), however, the primary 
mechanism for this observation  still remains unclear. To this end, the present 
study aimed to assess the effect of different anthocyanin derived structures 
(anthocyanins and their phenolic metabolites as determined in chapter 4) on 
the production of superoxide in the endothelium.  
 
In order to evaluate the structure-activity relationship of several hydroxylated 
and conjugated anthocyanin derived compounds (mono-hydroxyl derivatives: 
pelargonidin-3-glucoside, 4-hydroxybenzoic acid and the 4’ glucuronide of 4-
hydroxybenzoic acid; catechol derivatives:  cyanidin-3-glucoside, 
protocatechuic acid, vanillic acid, 3-hydroxy-4-methoxybenzoic acid and the 4’ 
glucuronide of protocatechuic acid; tri-hydroxyl derivatives: delphinidin-3-
glucoside, gallic acid and 2,4,6-trihydroxybenzaldehyde 
(phlorogluceraldehyde)), a number of experimental methods were developed 
and optimised based on previously reported techniques. Using these 
developed assays, structure-activity studies were sequentially conducted to 
assess both the antioxidant and non-antioxidant properties of anthocyanins, 
pertaining specifically to superoxide production. 
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Firstly, the effect of anthocyanins and their metabolites and cell treatment 
medium conditions on endothelial cell viability was assessed in order to 
ascertain the correct treatment dose and conditions. Secondly, the reduction 
of cytochrome c by anthocyanins and their metabolites was investigated, 
since it has been suggested that the ability for compounds to reduce 
cytochrome c is associated with their direct iron-ion reducing/electron 
donation capacity. It remained essential to determine the ability for 
anthocyanins and their metabolites to reduce cytochrome c, since cytochrome 
c was used as an indicator for superoxide production in subsequent structure-
bioactivity assays. Thirdly, the structure-activity relationship of anthocyanins 
and their metabolites as inhibitors of xanthine oxidase was investigated. In 
order to measure the inhibition of xanthine oxidase, a cytochrome c reduction 
assay was developed and optimised. Subsequently, the ability for 
anthocyanins and their metabolites to modulate superoxide release from intact 
endothelial cells was investigated under Ang II stimulated conditions. To 
achieve this, a cytochrome c reduction assay was developed and optimised 
for incubation time, cell treatment medium conditions, Ang II concentration 
and cytochrome c concentration. Lastly, the structure-activity effects of 
anthocyanins and their metabolites on endothelial NO production was 
assessed. Thus, the findings of these studies may provide some evidence in 
support of current epidemiological and animal study observations, and provide 
us with mechanistic insights that might be taken forward in human trials.    
 
5.2 Materials and Methods 
 
Large vessel endothelial basal medium, endothelial supplementation pack 
and trypsin/EDTA solution were purchased from TCS Cellworks, UK. Foetal 
calf serum, Medium 199 and phenol free Medium 199 were purchased from 
Invitrogen, UK. Bovine serum albumin (BSA) was purchased from Sigma-
Aldrich, UK. Equine cytochrome c, xanthine, xanthine oxidase, superoxide 
dismutase and human angiotensin II (Ang II) were purchased from Sigma-
Aldrich, UK. Rabbit anti-NOX4 was purchased from Abcam, UK, goat anti-β-
actin was purchased from Santa Cruz Biotechnologies, USA and donkey anti-
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rabbit, donkey anti-goat, instant blue staining solution and Odyssey blocking 
buffer were purchased from Li-Corr Biosciences, UK. Protease inhibitor 
cocktail and PCR nucleotide mix were purchased from Roche, UK. Random 
hexamers and BioScript were purchased from Promega, UK. PCR reaction 
buffer was purchased from Bioline, UK. Rnase out ribonuclease inhibitor was 
purchased from Invitrogen, UK. All PCR primers and probes were purchased 
from Sigma-Aldrich, UK. Precision MasterMix was purchased from Primer 
Design, UK. Cyanidin-3-glucoside (kuromanin chloride), delphinidin-3-
glucoside (myrtillin chloride), pelargonidin-3-glucoside (callistephin chloride), 
and 4-hydroxybenzoic acid were purchased from Extrasynthese, France and 
dissolved in DMSO at an initial concentration of 40 mM. Protocatechuic acid, 
gallic acid, vanillic acid, 3-hydroxy-4-methoxybenzoic acid and 2,4,5-
trihydroxybenzaldehyde were purchased from Sigma-Adlrich (UK) and 
dissolved in DMSO. All water used was 18MΩ/cm milliQ water. 
 
5.2.1 General cell culture 
 
Human umbilical vein endothelial cells (HUVECs) were purchased from TCS 
Cellworks (UK) and used between passages 2-4. The cells were cultured in a 
humidified atmosphere at 37 °C and 5% CO 2 in large vessel endothelial cell 
basal medium supplemented with hydrocortisone, human epidermal growth 
factor, human fibroblast growth factor with heparin, foetal calf serum (FCS; 
2% v/v) and an antibiotic supplement containing 25 mg/ml gentamicin and 50 
µg/ml amphotericin B (final supplement concentrations were proprietary to 
TCS Cellworks, UK). Typically, cells were cultured on Cell+™ 75 cm2 culture 
flasks (Sarstedt, UK) and subcultured at 80% confluence using a 0.025% 
trypsin/0.01% EDTA solution.   
 
5.2.2 Method development and optimisations 
 
Cell viability under different treatment conditions: To determine the 
viability of HUVECs under different treatment media conditions, endothelial 
cell viability was assessed using the WST-1 cell proliferation reagent. Briefly, 
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Cells were seeded into 96-well plates (Nunclon∆ surface, Nunc, UK) at 5000 
cells.cm-2 in 200 µL culture medium and incubated at 37 °C under a 
humidified atmosphere containing 5% CO2. At confluence, the medium was 
removed and replaced with 100 µL cell treatment medium (phenol free 
Medium 199); medium optimisation was tested with 0, 1, 5 and 10% FCS 
supplementation and 0.1, 0.2 and 0.4% BSA supplementation. Control 
incubations consisted of cells cultured in growth medium as previously 
described. Negative control consisted of cell incubated in PBS. Cell viability 
was determined after 24 and 48 h using WST-1 cell proliferation reagent as 
described below. 
 
Effect of treatment compounds on cellular viability: To assess the effect 
of different anthocyanin derived treatment compounds and DMSO vehicle 
controls (0.05% DMSO) on HUVEC cell viability and to determine optimal 
treatment ranges, WST-1 cell proliferation reagent was used to assess cellular 
respiration under different treatment condition. Cells were seeded into 96-well 
plates (Nunclon∆ surface, Nunc, UK) at 5000 cells.cm-2 in 200 µL culture 
medium and incubated at 37 °C under a humidified at mosphere containing 
5% CO2 until confluence. The medium was removed and replaced with 100 µL 
Medium 199 containing 1% FCS and 0, 0.5, 1, 10, 50 and 100 µM of 
structure-activity test compounds (mono-hydroxyl derivatives: pelargonidin-3-
glucoside, 4-hydroxybenzoic acid and the 4’ glucuronide of 4-hydroxybenzoic 
acid; catechol derivatives:  cyanidin-3-glucoside, protocatechuic acid, vanillic 
acid, 3-hydroxy-4-methoxybenzoic acid and the 4’ glucuronide of 
protocatechuic acid; tri-hydroxyl derivatives: delphinidin-3-glucoside, gallic 
acid and 2,4,6-trihydroxybenzaldehyde (phlorogluceraldehyde)). Cell viability 
was determined after 24 h using WST-1 cell proliferation reagent. Briefly, 10 
µL of tetrazolium salt WST-1 reagent was added to each well following 
treatment and the soluble formazan dye produced by metabolically active cells 
was monitored every 30 min for 2 h at 440nm on a microplate reader 
(Fluostar, BMG Labtech, UK). 
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The iron-ion reducing capacity of anthocyanins and their metabolites: To 
assess the direct reduction of cytochrome c by anthocyanin metabolites, 2, 
20, 200 and 2000 µM of structure-activity test compounds (mono-hydroxyl 
derivatives: pelargonidin-3-glucoside and 4-hydroxybenzoic acid; catechol 
derivatives:  cyanidin-3-glucoside, protocatechuic acid, vanillic acid, 3-
hydroxy-4-methoxybenzoic acid and the 4’ glucuronide of protocatechuic acid; 
tri-hydroxyl derivatives: delphinidin-3-glucoside and gallic acid) were co-
incubated with 20 µM cytocrome c in PBS at 37 °C as described in previ ously 
for catechols and quinols (Saleem and Wilson 1982). The spontaneous 
reduction of cytochrome c was monitored as a kinetic assay at 550nm 
(Fluostar, BMG Labtech, UK) over 2 h. Cytocrome c reduction was quantified 
using the millimolar extinction coefficient for reduced cytochrome c (29.5 
mM.cm-1). Control/blank samples consisted of the above reaction in the 
absence of phenolic compounds or in the absence of cytochrome c.  
 
Cytochrome c reduction assay for xanthine/xanthine oxidase activity: 
Superoxide production by xanthine/xanthine oxidase was measured using a 
cytochrome c reduction assay optimised from a previously described method 
(Steffen, Gruber et al. 2008). Briefly, the reaction mixture contained xanthine 
(as the primary substrate), cytochrome c (which acted as an indicator of 
superoxide production) and xanthine oxidase (the enzyme source) in a 50 mM 
sodium phosphate buffer (pH 7.4). To optimise the reaction the three primary 
variables were sequentially altered as follows: xanthine oxidase (0, 0.025, 
0.05 and 0.1 U/ml), xanthine (0, 50, 100, 200 and 400 µM) and cytochrome c 
(0, 50, 100 and 200 µM). The reaction was started with the addition of 
xanthine oxidase and incubated at 25 °C. The reduct ion kinetics of 
cytochrome c was followed spectrophotometrically (Fluostar, BMG Labtech, 
UK) at 550 nm in a kinetic assay until the reaction plateaued. Following 
optimisation, the specificity of the reaction for superoxide was ascertained by 
incubating 80 µM cytochrome c, 0.1 U/ml xanthin oxidase and 200 µM 
xanthine both in the presence and absence of SOD (330 U/ml) in a 50 mM 
sodium phosphate buffer (pH 7.4). The superoxide generated was determined 
by subtracting the rate of cytochrome c reduction (increase in absorbance at 
550 nm) in the presence of SOD from those in the absence of SOD. Blanks 
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consisted of samples with heat inactivated xanthine oxidase (heated to 100 °C 
for 5 min). 
 
Ang II induced superoxide production by cultured endothelial cells: To 
measure the release of superoxide from intact endothelial cells, a cytochrome 
c reduction assay was developed and optimised from a previously reported 
method (Steffen, Gruber et al. 2008). Briefly, cells were seeded into 6 well 
culture plates (Nunclon∆ surface, Nunc, UK) at 5000 cells.cm-2 and grown to 
confluence. Confluent cells were equilibrated in 2% FCS supplemented 
Medium 199 for 24 h. Following equilibration, cells were washed in warm PBS 
and re-suspended in phenol free Medium 199 containing 2% (as per the 
findings of method development and optimisation I, above) or 20% FCS, 50 
µM cytochrome c with or without (basal condition) the addition of SOD (400 
U). Blanks consisted of treatment in the absence of cells or in the absence of 
cytochrome c. Cells were incubated for a total of 6 h at 37 °C under a 
humidified atmosphere containing 5% CO2. At 2 and 6 h, 200 ul of cell 
supernatant was transferred to a 96-well plate and the reduced cytochrome c 
measured at 550 nm (Fluostar, BMG Labtech, UK).   
 
To establish a model for vascular oxidative stress (Rueckschloss, Quinn et al. 
2002), HUVECs were treated with various concentrations of Ang II (0.05, 0.1 
or 1 µM; dissolved in 1 mg/ml BSA) and the superoxide production assessed 
as described above with some alterations. Briefly, cells were seeded into 24 
well culture plates (Nunclon∆ surface, Nunc, UK) at 5000 cells.cm-2 and 
grown to confluence. Confluent cells were equilibrated in 2% FCS 
supplemented Medium 199 for 24 hours. Following equilibration, cells were 
washed in warm PBS and re-suspended in phenol free Medium 199 
containing 2% FCS, 20 µM cytochrome c and 0.05, 0.1 and 1 µM Ang II, with 
or without the addition of SOD (400 U). Blanks consisted of treatment in the 
absence of cells or in the absence of cytochrome c. Cells were incubated for a 
total of 6 h at 37 °C under a humidified atmosphere  containing 5% CO2. At 6 
h, 200 µl of cell supernatant was transferred to a 96-well plate and the 
reduced cytochrome c measured at 550 nm (Fluostar, BMG Labtech, UK). 
The superoxide generated was determined by subtracting the absorbance at 
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550 nm in the presence of SOD from those in the absence of SOD. Control 
(basal) condition consisted of cells incubated in the absence of Ang II. All cell 
treatment assays were normalised to total protein concentrations. Protein from 
individual treatment wells were harvested and quantified as described below.  
 
In addition to the above optimised conditions, the following experimental 
design controlled for Ang II binding to plastics, control and basal consistency 
during experimentation; edge effects common to microplate assays; biological 
and technical replicate variation; in plate cell effects on absorbance; path-
length and low volume assay conditions and assay sensitivity. To address the 
afore mentioned assay considerations, the experiment was conducted under 
the following conditions: Ang II losses/inaccuracy due to binding to plastics 
was accounted for by dissolving Ang II and washing all plastics in 1 mg/ml 
BSA solutions; experimental consistency was assessed by including six 
biological replicates for each sample and 3 technical replicates per samples 
(i.e. 6 biological replicates analysed 3 times); edge effects were controlled for 
by plating samples at least one well from the edge of the plate with media in 
the outer most wells; effects of cells on the absorbance variation of samples 
was accounted for by transferring cell free supernatants to a cell-free 96-well 
plate prior to spectroscopic measurement; insensitivity due to shorter light 
path lengths were negated by aliquoting 200 ul of sample into 96 well plate 
wells (6.6 mm path length) and assay sensitivity was assessed by comparing 
optical density between SOD treated and untreated cells with respect to inter-
sample and technical variation (i.e. whether the replicate standard deviations 
were significant and whether this difference was sufficiently great enough to 
measure differences upon compound treatments in later experiments). 
 
NOX4 protein expression. To investigate whether the increase in endothelial 
superoxide release induced by Ang II treatment was due to NOX4 induction, 
protein expression was analysed by Western blot analysis. Briefly, cells were 
seeded into 6 well culture plates (Nunclon∆ surface, Nunc, UK) at 5000 
cells.cm-2 and grown to confluence. Confluent cells were equilibrated in 2% 
FCS supplemented Medium 199 for 24 h. Following equilibration, cells were 
washed in warm PBS and re-suspended in Medium 199 containing 2% FCS 
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and 0.05, 0.1 or 1 µM Ang II. Control treatments were conducted in the 
absence of angiotensin II. Cells were incubated for 6 h at 37 °C and 5% CO 2, 
whereupon total protein was collected and stored at -80 °C until analysis.   
 
Protein was harvested using NP-40 lysis buffer and ulta-sonication. Cell 
treatment media was aspirated and the cell monolayer washed three times in 
cold PBS. Cells were suspended in NP-40 lysis buffer (150 mM NaCl, 20mM 
Tris-EDTA, 10% v/v glycerol, 2% v/v NP-40 and 1x protease inhibitor cocktail) 
at 6.25 µl.cm2 and incubated at 4 °C for 30 min with constant sha king. Cells 
were then scraped off using a rubber policeman and the cell lysate 
suspension stored at -80 °C for 24 h. Cell lysates were thawed at room 
temperature and sonicated on ice for 3x10 sec using a probe sonicator. The 
cell lysates were then centrifuged at 13,000 rpm for 15 min at 4 °C and the 
supernatant retained. Total protein was quantified using a BCA protein assay 
as per the manufacturer’s instructions. Western blot analysis was conducted 
on equal amounts of protein (20 µg), run on 10% SDS polyacrylamide 
resolving gels and the protein transferred to PVDF membranes by semi-dry 
blotting (1h at 15-25v). Equal rates of transfer were confirmed by staining the 
gel with Instant Blue as per the manufacturer’s instructions. Non-specific 
binding was blocked by incubating in Odyssey blocking buffer at room 
temperature for 1 h or overnight at 4 °C. Membranes  were then incubated with 
anti-NOX4 (1/500 dilution) and anti-β-actin (1/10,000 dilution) antibody 
overnight at 4 °C. After washing in 0.1% PBST, memb ranes were incubated 
with anit-rabbit (1/10,000 dilution) and anti-goat (1/10,000 dilution) for 1 h at 
room temperature. Membranes were then imaged using an Odyssey infrared 
imager. Band densities were determined using the Odyssey infrared imager 
software.    
 
NOX4 mRNA expression. To investigate whether the increase in endothelial 
superoxide release induced by Ang II was due to NOX4 induction, mRNA 
expression was measured by qRT-PCR. Briefly, cells were seeded into 6 well 
culture plates (Nunclon∆ surface, Nunc, UK) at 5000 cells.cm-2 and grown to 
confluence. Confluent cells were equilibrated in 2% FCS supplemented 
Medium 199 for 24 h. Following equilibration, cells were washed in warm PBS 
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and re-suspended in Medium 199 containing 2% FCS and 0.05, 0.1 or 1 µM 
Ang II. Control treatments were conducted in the absence of angiotensin II. 
Cells were incubated for 6 h at 37 °C and 5% CO 2, whereupon mRNA was 
collected and analysed. Total RNA was extracted using a GeneElute 
Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, UK) as per the 
manufacturer’s instructions and quantified using a nanodrop RNA 
spectrophotometer (Thermo Scientific, UK). First strand cDNA was 
synthesised from the total RNA. Briefly, 1 mg of total RNA was incubated with 
1 ml of random hexamers at 70 °C for 10 min. Sample s were then transferred 
to ice, allowing the primers to anneal, followed by the addition of master mix 
containing 50 U BioScript, 4 ml 5x reaction buffer (Bioline, UK), 1 ml PCR 
nucleotide mix and 1ml Rnase outTM ribonuclease inhibitor in a final volume 
of 20 ml. Samples were mixed by pipetting and returned to the PCR 200 
Thermal Cycler (MJ Research, UK) for 1 hour at 42 ºC.   
 
NOX4 mRNA quantification was determined by TaqMan using the ABI 7300 
Fast Real-Time PCR System. Primers and the fluorogenic TaqMan probes 
were designed using Primer Express according to human NOX4 sequence 
(Table 5.1). The primers were designed to detect all four NOX4 isoforms. The 
probes were labelled with a 5´ reporter dye (FAM) and 3´ quencher dye 
(TAMRA). Real-time RT-PCR reactions were carried out in a 96-well plate in a 
total volume of 25 µl per well consisting of 5 ng of cDNA, 10 µl Precision 
MasterMix, 100 nM probe, 100 nM forward and 100 nM reverse primers for 
NOX4. Following a 10 min hot start at 95 °C, PCRs w ere performed for 45 
cycles of denaturing at 95 °C for 15s and annealing /extension at 60 °C for 60 
sec using an ABI 7300 machine (Applied Biosystems, Warrington, UK). 
Reactions were carried out in triplicate. Data was normalized against an 
invariant endogenous control, 18S ribosomal RNA. The reaction efficiency 
slope for 18S was determined to be -3.6 and for NOX4 was -3.3. 
Quantification was performed by the standard curve method and ∆∆CT 
method (Nolan, Hands et al. 2006), for comparison. 
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Table 5.1 Primers and Probes Sequences used for qRT-PCR 
   
Gene 
  
Direction 
  
                   Primers  (5’ – 3’)  
NOX4 F 
R 
Probe 
TTCTGGTATACTCATAACCTCT 
 AGCAGCCCTCCTGAAACATG 
CTACATGCTGACGTT 
   
18S F 
R 
Probe 
GGCTCATTAAATCAGTTATGGTTCCT 
GTATTAGCTCTAGAATTACCACAGTTATCCA 
TGGTCGCTCGCTCCTCTCCCA 
  
 
 
5.2.3 Structure-activity studies 
 
Inhibition of xanthine/xanthine oxidase by anthocyanins and their 
metabolites: Superoxide production by xanthine/xanthine oxidase was 
measured using the optimised method described above. Briefly, to a reaction 
mixture containing 200 µM cytochrome c, 0.1 U/ml xanthine oxidase and 200 
µM xanthine, was added 1, 10, 100 and 1000 µM of structure-activity test 
compounds (mono-hydroxyl derivatives: pelargonidin-3-glucoside, 4-
hydroxybenzoic acid and the 4’ glucuronide of 4-hydroxybenzoic acid; 
catechol derivatives:  cyanidin-3-glucoside, protocatechuic acid, vanillic acid 
and the 4’ glucuronide of protocatechuic acid) in 50 mM sodium phosphate 
buffer (pH 7.4). The reaction was started with the addition of xanthine oxidase 
and the reduction kinetics of cytochrome c followed kinetically at 550 nm 
(Fluostar, BMG Labtech, UK) at 25 °C over 15 min (r eaction plateau). The 
superoxide generated was determined by subtracting the rate of cytochrome c 
reduction (increase in absorbance at 550 nm) in the presence of SOD from 
those in the absence of SOD. Blanks consisted of representative samples with 
heat inactivated xanthine oxidase (heated to 100 °C  for 5 min). Controls for 
anthocyanin degradation and direct reaction with cytochrome c consisted of 
samples without the addition of test compounds but with an equivalent 
proportion of DMSO (not exceeding 0.5 % v/v) and incubations with the 
addition of anthocyanins but without cytochrome c and with or without SOD. 
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Modulation of angiotensin II stimulated superoxide release from intact 
cells by anthocyanins and their metabolites: The modulation of Ang II 
induced superoxide production in HUVECs by various anthocyanin 
metabolites (mono-hydroxyl derivatives: pelargonidin-3-glucoside, 4-
hydroxybenzoic acid and the 4’ glucuronide of 4-hydroxybenzoic acid; 
catechol derivatives:  cyanidin-3-glucoside, protocatechuic acid, vanillic acid 
and the 4’ glucuronide of protocatechuic acid) was assessed using the above 
optimised assay condition with the addition of treatment compounds. Briefly, 
cells were seeded into 24 well culture plates (Nunclon∆ surface, Nunc, UK) at 
5000 cells.cm-2 and grown to confluence. Confluent cells were equilibrated in 
2% FCS supplemented Medium 199 for 24 hours. Following equilibration, 
cells were washed in warm PBS and re-suspended in phenol free Medium 
199 containing 2% FCS, 20 µM cytochrome c, 0.1 uM Ang II and 0.1 and 1 
µM structure-activity test compounds (mentioned above), with or without 
(basal condition) the addition of SOD (400 U). Blanks consisted of treatment 
in the absence of cells or in the absence of cytochrome c. Cells were 
incubated for a total of 6 h at 37 °C under a humid ified atmosphere containing 
5% CO2. At 6 h, 200 µl of cell supernatant was transferred to a 96-well plate 
and the reduced of cytochrome c measured at 550 nm (Fluostar, BMG 
Labtech, UK). The superoxide generated was determined by subtracting the 
absorbance at 550 nm in the presence of SOD from those in the absence of 
SOD. Control conditions consisted of cells incubated in the presence of Ang II 
but absence of anthocyanin derived treatment compounds.   
 
 
Modulation of NO release from intact cells by selected anthocyanin 
derived phenolic acid metabolites: Since some of the compounds used in 
the previously described structure-activity relationship studies demonstrated 
some significant effects on cellular superoxide production, effect of these  
anthocyanin metabolites (4-hydroxybenzoic acid, protocatecuic acid, 4’ 
glucuronide of 4-hydroxybenzoic acid and 4’ glucuronide of protocatechuic 
acid) on endothelial cell nitric oxide (NO) production was assessed. Induced 
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NO production was estimated from the primary and non-volatile breakdown 
products of NO, nitrite (NO2) and nitrate (NO3),  as per previously reported 
studies (Cheung, Siow et al. 2001; Pergola, Rossi et al. 2006; 
Wattanapitayakul, Suwatronnakorn et al. 2007). Initially, cells were cultured to 
confluence as previously described and subsequently incubated with 0.1 and 
1 µM 4-hydroxybenzoic acid, protocatecuic acid, 4’ glucuronide of 4-
hydroxybenzoic acid or 4’ glucuronide of protocatechuic acid, respectively, for 
24 h in 2% FCS supplemented Medium 199 (phenol free). Control treatments 
consisted of cells treated in 2% FCS supplemented Medium 199 (phenol free) 
only. Positive control incubations consisted of cells treated with 10 nM PMA or 
100 µM resveratrol, as previously described (Leikert, F. et al. 2002; Wallerath, 
Deckert et al. 2002). Following cell treatments, the culture media was 
collected and cleared by centrifugation at 2,000 rpm for 5 min. The cleared 
supernatant was then assayed for nitrite (NO2) and nitrate (NO3) levels using 
a commercially available kit (R&D Systems, UK), as per the manufacturer’s 
instructions. Briefly, 50 µl of cell supernatant was added to, 50 µl reaction 
buffer and 100 µl of Griess reagent, mixed and incubated at room temperature 
for 10 min. Following incubation, the endogenous nitrite levels were 
determined at 540 nm. To determine total nitrite and nitrate levels, 50 µl of cell 
supernatant was added to 25 µl nitrate reductase and 25 µl NADH, mixed well 
and incubated at 30 °C for 30 min. Following incuba tion, 100 µL of Griess 
reagent was added the total nitrite and nitrate (converted to nitrite by nitrate 
reductase) levels were determined at 540 nm. Since very little or no NO2 was 
found in the cell supernatants (relative to blank samples), differentiation 
between NO2 and NO3 levels were not attempted. Rather, all NO3 was 
enzymatically converted to NO2, where NO was reported as total NO2 and 
NO3. Following the collection of cell supernatants, total cellular protein was 
collected and quantified (as previously described), and all results normalised 
to total protein levels. 
 
 
 
 
 
131 
 
5.2.4 Statistical analysis 
Statistical significance was evaluated by one way ANOVA with Tukey post-
hoc tests (Windows SPSS, version 15) on raw or transformed data (i.e. blank 
corrected and normalisation to total protein where applicable). Significance 
was determined at P<0.05 against control or basal conditions. Unless 
otherwise stated, all experiments were conducted in triplicate and the data 
expressed as % of controls (mean±SD). 
 
5.3 Results and discussion 
 
5.3.1 Method development and optimisations 
 
Cell viability under different treatment conditions: Since previously 
reported cell based flavonoid studies have used either low serum or BSA 
supplemented medium in cell treatment assays (Zhang, Schmeisser et al. 
1999; Steffen, Schewe et al. 2007; Steffen, Gruber et al. 2008), it was 
important in this study to determine whether endothelial cells remained viable 
under different treatment conditions. To assess the effect of reported cell 
treatment conditions on endothelial cell viability, the respiration of confluent 
cells were assessed over 24 and 48 hours under low serum (1, 5 and 10% 
FCS) or BSA (0.1, 0.2, 0.4% BSA) supplemented conditions, without 
additional growth factors (Figure 5.1). All treatment conditions showed a 
significant increase (up to two fold) in cell viability within the first 24 h of cell 
incubation. However, following 48 h of cell incubation, all treatment conditions 
showed a significant loss (p<0.001) in viability compared to complete growth 
medium controls. In the case of serum supplemented media, a dose 
dependent loss in viability was observed, such that an increase in serum 
supplementation inferred an increase in viability. The loss of viability in serum 
supplemented media was 40-85% (1-10% FCS, respectively), while BSA 
supplemented media showed a 60% loss (0.1-0.4% BSA, respectively) in 
viability, across all concentration ranges. This indicated that low levels of 
serum supplementation was the most appropriate treatment medium condition 
for subsequent bioactivity assays. However, microscopic observations 
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showed that at a serum concentration of 1% or less, cells became rounded 
and detached from 6 and 24 well culture plates. This did not occur at 2% 
serum supplementation with 24 h. For these reasons, a serum concentration 
of 2% was adopted in all subsequent bioassays and cell treatments, since this 
was the minimum serum concentration which allowed for adequate cell 
adherence to the culture plates and maintenance of cellular viability.  
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Figure 5.1. Cell viability under different treatment medium conditions (FCS or BSA supplementation). 
To assess the effect of different culture conditions on cell viability, HUVECs were treated with low 
serum (1-10%) or BSA (0.1-0.4%) supplemented medium 199 for 24 (A) and 48 (B) h. Controls 
consisted of cells treated with complete growth medium (basal medium supplemented with 
hydrocortisone, EGF, FGF with heparin and 2% FCS). Negative controls consisted of cells treated with 
PBS. FCS, Foetal calf serum; BSA, bovine serum albumin. *** represents significance at P<0.001 with 
respect to control. Data represented as mean±SD (n=3). 
 
 
Effect of treatment compounds on cell viability: In order to determine the 
structure-activity reationship between different anthocyanins and their 
metabolites (mono-hydroxyl derivatives: pelargonidin-3-glucoside, 4-
hydroxybenzoic acid and the 4’ glucuronide of 4-hydroxybenzoic acid; 
catechol derivatives:  cyanidin-3-glucoside, protocatechuic acid, vanillic acid, 
3-hydroxy-4-methoxybenzoic acid and the 4’ glucuronide of protocatechuic 
acid; tri-hydroxyl derivatives: delphinidin-3-glucoside, gallic acid and 2,4,6-
trihydroxybenzaldehyde (phlorogluceraldehyde)) and cell survival, endothelial 
cell respiration was assayed using WST-1 reagent (Figures 5.2-5.5). In 
addition to structure-activity relationships, this study also determined the 
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optimal compound concentrations to be used in subsequent cell based 
bioassays.  
 
Of the anthocyanins tested, cyanidin-3-glucoside (catechol B-ring) induced a 
significant loss in cell viability at ≥50 µM (P=0.01) (Figure 5.3) and 
pelargonidin-3-glucoside induced a significant loss in cell viability at 100 µM 
(P=0.013) (Figure 5.2). Delphinidin-3-glucoside did not show any significant 
effect on cell viability at ≤100 µM (p>0.05) (Figure 5.4). Of the phenolic 
metabolites tested, only protocatechuic acid (a catechol) induced a significant 
loss in cell viability at 100 µM (p<0.05). All other phenolic compounds did not 
show an effect on cell viability at ≤100 µM (p>0.05). Conjugation of 
protocatechuic acid on the aryl position (3’ or 4’ hydroxyl) with either a 
methoxy or glucuronide conjugate abolished the effect observed for the parent 
(catechol) structure (i.e. loss of cell viability when treated with protocatechuic 
acid). The compounds that most significantly affected cell viability under the 
present assay conditions were shown to be protocatechuic acid and cyanidin-
3-glucoside which both possess a catechol on their benzene ring structure. 
However, since pelargonidin-3-glucoside was more active than delphinidin-3-
glucoside, it cannot be said that an increase in B-ring hydroxyls infers greater 
cellular activity with regards to the loss of cell viability. Although, the poor 
activity observed for delphinidin-3-glucoside may have been due to its 
increased instability under physiochemical conditions, as described in chapter 
3.  
 
It was established that the optimal concentration for structure-activity test 
compounds was between 0 and 10 µM, since no significant effects were 
observed on cell viability at these concentration across all tested compounds. 
To this end, all test compounds did not affect cell viability (respiration) at the 
levels used in subsequent bioactivity assays or at physiologically relevant 
concentrations (0.1-1 µM). 
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Figure 5.2. The effect of different mono-hydroxyl derivatives on endothelial cell viability. To assess 
the effect of different anthocyanin derived structures on cell viability, HUVECs were treated with P3G 
(A; pelargonidin-3-glucoside), HBA (B; 4-hydroxybenzoic acid) and GBA (C; 4’ glucuronide 
conjugate of HBA) for 24 h in 2% FCS in medium 199 and the cellular respiration assayed using WST-
1 reagent. Controls consisted of cells treated with 2% FCS in medium 199. Vehicle control consisted of 
cells treated with 0.05% DMSO in 2% FCS in medium 199. FCS, Foetal calf serum; OGlc, O-glucose; 
OGlcA, O-glucuronic acid. *represents significance at P<0.05 with respect to control. Data represented 
as mean±SD (n=3). 
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Figure 5.3. The effect of different catechol derivatives on endothelial cell viability. To assess the effect 
of different anthocyanin derived structures on cell viability, HUVECs were treated with C3G (A; 
cyanidin-3-glucoside), PCA (B; protocatechuic acid), VA (C; vanillic acid), MePCA (D; 3-hydroxy-4-
methoxybenzoic acid) and 3OH4GBA (E; 4’ glucuronide conjugate of protocatechuic acid) for 24 h in 
2% FCS in medium 199 and the cellular respiration assayed using WST-1 reagent. Controls consisted 
of cells treated with 2% FCS in medium 199. Vehicle control consisted of cells treated with 0.05% 
DMSO in 2% FCS in medium 199. FCS, Foetal calf serum; OGlc, O-glucose; OGlcA, O-glucuronic 
acid. *represents significance at P<0.05 with respect to control. Data represented as mean±SD (n=3). 
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 Figure 5.4. The effect of different trihydroxyl derivatives on endothelial cell viability. To assess the 
effect of different anthocyanin derived structures on cell viability, HUVECs were treated with D3G (A; 
delphinidin-3-glucoside) and GA (B; Gallic acid) for 24 h in 2% FCS in medium 199 and the cellular 
respiration assayed using WST-1 reagent. Controls consisted of cells treated with 2% FCS in medium 
199. Vehicle control consisted of cells treated with 0.05% DMSO in 2% FCS in medium 199. FCS, 
Foetal calf serum; OGlc, O-glucose; OGlcA, O-glucuronic acid. Data represented as mean±SD (n=3). 
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Figure 5.5. The effect of 2,3,4-trihydroxybenzaldehyde acid (PGA) on endothelial cell viability. To 
assess the effect of PGA on cell viability, HUVECs were treated with for 24 h in 2% FCS in medium 
199 and the cellular respiration assayed using WST-1 reagent. Controls consisted of cells treated with 
2% FCS in medium 199. Vehicle control consisted of cells treated with 0.05% DMSO in 2% FCS in 
medium 199. FCS, Foetal calf serum. Data represented as mean±SD (n=3). 
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The iron-ion reducing capacity of anthocyanins and their metabolites: 
Eukaryotic cytochrome c is a constituent of the electron-transport chain 
responsible for transfer of electrons from cytochrome c1 to the terminal 
electron acceptor of the mitochondria (Lemberg and Barret 1973). Reduction 
of cytochrome c by ascorbic acid has been extensively investigated (Al-Ayash 
and Wilson 1979), where it was suggested that dianionic molecules donate 
electrons to the exposed haem edge or bind to the arginine-38 residue of 
cytochrome c, followed by electron transfer to the haem via aromatic residues. 
Therefore, in the present investigation, the direct reduction of cytochrome c by 
anthcyanins and their metabolites (structure-activity study: mono-hydroxyl 
derivatives: pelargonidin-3-glucoside, 4-hydroxybenzoic acid and the 4’ 
glucuronide of 4-hydroxybenzoic acid; catechol derivatives:  cyanidin-3-
glucoside, protocatechuic acid, vanillic acid and the 4’ glucuronide of 
protocatechuic acid; tri-hydroxyl derivatives: delphinidin-3-glucoside and gallic 
acid) was investigated. This was important for several reasons. Firstly, it 
remained essential to determine the ability for these compounds to reduce 
cytochrome c directly, since it would be used as an indicator for superoxide 
production in subsequent structure-activity bioassays. It has been suggested 
that the ability for compounds to reduce cytochrome c is associated with their 
iron-ion reducing/electron donation capacity and, therefore, their ability to 
inhibit proteins such as lipoxygenases (Kemal, Louis-Flamberg et al. 1987; 
Van der Zee, Eling et al. 1989; Laughton, Evans et al. 1991). This property 
may also serve to indicate their antioxidant potential (Bast, Haenen et al. 
1991; Mira, Fernandez et al. 2002), since electron donation potential is crucial 
to direct radical scavenging activity. Secondly, the anthocyanin derived 
compounds are structurally similar, in some respects, to ascorbic acid, 
possessing, in the case of catechols, conjugated enediol-like structures.  
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Figure 5.6. Representative kinetic plot of direct phenolic acid reduction of cytochrome c. In this case, 
gallic acid (GA) was incubated in the presence of cytochrome c in buffer (pH 7.4) at 0-32 µM and the 
rate of cytochrome c reduction (observed as an increase in absorbance) followed kinetically at 550nm 
for 18 min. 
 
In figure 5.6, a representative kinetic curve for the reduction of cytochrome c 
by phenolic acids is shown. In the case of anthocyanins, an increase in B-ring 
hydroxylation inferred a greater potential to oxidise (reduced absorbance at 
550nm) cytochrome c (Figure 5.7). However, anthocyanin co-incubations in 
the absence of cytochrome c also demonstrated a loss in absorbance at 
550nm at neutral pH. Thus, although the cytochrome c reduction experiments 
were blanked to co-incubations in the absence of cytochrome c, it is possible 
that this did not negate the effect of anthocyanin degradation in this 
experiment. Therefore, further investigation should be conducted to elucidate 
the direct cytochrome c reduction potential of anthocyanins, where the 
spectral effects of anthocyanin degradation should be accounted for. 
 
For anthocyanin derived phenolic acids, in keeping with previously reported 
data (Saleem and Wilson 1982), hydroxylated phenolic compounds rapidly 
reduced cytochrome c at physiological pH (increase in absorbance at 550nm). 
The reduction kinetics for hydroxyl substituted benzoic acids (mono-hydroxyl 
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derivatives: 4-hydroxybenzoic acid; catechol derivatives:  protocatechuic acid; 
tri-hydroxyl derivatives: gallic acid)  are shown in figure 5.7, where the rate of 
cytochrome c reduction was dependent on the number of hydroxyls present 
on the aromatic ring, as an increase in hydroxylation inferred an increase in 
the rate of cytochrome c reduction. This activity appeared to be dependent on 
the presence of multiple aryl hydroxyls (two and three B-ring hydroxyls i.e. 
protocatechuic acid and gallic acid), since the mono-hydroxyl, 4-
hydroxybenzoic acid, did not appear to reduce cytochrome c.  
 
In order to further investigate this effect, the direct reduction of cytochrome c 
by the catechol protocatechuic acid and its metabolic substitutes (methoxy or 
glucuronide substituted aryl hydroxyls) was investigated (Figure 5.7). In this 
manner it was shown that substitution of the catechol structure with either a 
methoxy or glucuronide abolished protocatechuic acid’s direct cytochrome c 
reduction potential. Furthermore, substitution with a glucuronide abolished the 
ability for protocatechuic acid to directly reduce cytochrome c to a greater 
extent when compared with methoxy substitution. This effect is likely due to 
differential abilities for methoxy or glucuronide conjugates to withdraw 
electrons from the adjacent ring system.  
 
The finding of this structure-activity relationship study appear to be in keeping 
with the reported antioxidant potentials of flavonoids and phenolic acids, 
where it has been shown that an increase in aromatic hydroxyls infers an 
increase in antioxidant potential (Rice-Evans, Miller et al. 1996), likely due to 
their increased ability to donate electrons. With regards to mechanism, these 
compounds would be de-protonated at neutral pH [with a PKa of 4.4 for 4-
hdroxybenzoic acid, 4.4 for protocatechuic acid and 4.2 for gallic acid 
(Erdemgil, Sanli et al. 2007)], forming either mono or di-anions, in which the 
hydroxyl groups are negatively charged. It is well established that catechols 
and quinols can donate two electrons per molecule, forming stable quinones 
as final products (Patai 1971; Paltai 1988). As it is reported that cytochrome c 
is a one electron acceptor (Lemberg and Barret 1973), it follows that an 
increase in the number of deprotonated hydroxyls would reduce a greater 
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number of cytochrome c molecules, which is in keeping with the present 
findings.  
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Figure 5.7. The rate of direct cytochrome c reduction by anthocyanins and their metabolites. A, the rate 
of cytochrome c reduction by PCA (protocatechuic acid), HBA (4-hydroxybenzoic acid) and GA 
(gallic acid), plotted as the rate of reduction (change in cytochrome c concentration over time at the 
linear range) vs. the log of phenolic acid concentration. B, the rate of cytochrome c reduction by P3G 
(pelargonidin-3-glucoside), C3G (cyanidin-3-glucoside) and D3G (delphinidin-3-glucoside), plotted as 
the rate of reduction (change in cytochrome c concentration over time at the linear range) vs. the log of 
phenolic acid concentration. C, the rate of cytochrome c reduction by PCA and its aryl conjugates, 
mePCA (3-hydroxy-4-methoxybenzoic acid), VA (vinallic acid or 4-hydroxy-3-methoxybenzoic acid) 
and 3OH4GBA (4’ glucuronide conjugate of protocatechuic acid PCA), plotted as rate of reduction 
(change in cytochrome c concentration over time at the linear range) vs. the log of phenolic acid 
concentration. Rate data was based on individual kinetic assays (refer to Figure 5.6 for a representation 
of the individual kinetic assay plots). Data represented as mean±SD (n=3), with a polynomial line of 
regression.     
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In summary, anthocyanin derived phenolic acids acted as direct reductants of 
cytochrome c at physiological pH, under the present assay conditions, where 
an increase in aryl hydroxylation inferred an increase in iron-ion reducing 
capacity. Since conjugation of the catechol structure on protocatechuic acid 
abolished its cytochrome c reduction capacity, it may be surmised that the 
charge on the de-protonated compound must reside on the conjugated sites 
(i.e., the oxygen and aromatic ring system). This effect is likely due to 
withdrawal of electrons from the ring system following substitution of the aryl 
hydroxyl with a methoxy or glucuronide conjugate, causing them to be 
unavailable for reduction reactions. Importantly, the assessment for these 
compounds as reducers of cytochrome c was key to future method/assay 
development, since cytochrome c was to be used in bioassays aimed at 
quantifying superoxide production. From these experiments it was evident that 
all the compounds tested, with the exception of gallic acid, would be suitable 
for use in subsequent superoxide bioassays, without the occurrence of 
extensive direct cytochrome c reduction and, therefore, depletion of the assay 
substrate/marker.     
 
Cytochrome c reduction assay for xanthine/xanthine oxidase activity: 
The enzyme xanthine oxidase catalyses the oxidation of hypoxanthine and 
xanthine to uric acid (Parks and Granger 1986). During the re-oxidation of 
xanthine oxidase, molecular oxygen acts as an electron acceptor, producing 
superoxide radical and hydrogen peroxide. It has been reported that 
flavonoids inhibit xanthine oxidase and that this inhibition is due to their direct 
radical scavenging activities (Cos, Ying et al. 1998). Presently, the structure-
activity relationship of anthocyanins and their metabolites (mono-hydroxyl 
derivatives: pelargonidin-3-glucoside, 4-hydroxybenzoic acid and the 4’ 
glucuronide of 4-hydroxybenzoic acid; catechol derivatives:  cyanidin-3-
glucoside, protocatechuic acid, vanillic acid and the 4’ glucuronide of 
protocatechuic acid)   as inhibitors of xanthine oxidase and scavengers of 
superoxide were investigated. In order to measure the inhibition of xanthine 
oxidase, a cytochrome c reduction assay was developed and optimised from a 
previously reported system (Steffen, Schewe et al. 2007; Steffen, Gruber et al. 
2008).  
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Figure 5.8. Optimisation of a xanthine oxidase catalysed superoxide assay using cytochrome c 
reduction. First, rate of cytochrome c reduction by xanthine oxidase was assessed at different xanthine 
(substrate) concentrations (A). Next, the rate of cytochrome c reduction by xanthine oxidase was 
assessed at different cytochrome c (detector molecule) concentrations (B). Finally, the rate of 
cytochrome c reduction by xanthine oxidase was assessed at different enzyme concentrations (C). Data 
represented as mean±SD (n=3). 
 
Initially, the rate of cytocrome c reduction by a xanthine oxidase catalysed 
reaction was assessed at different concentrations of primary substrate 
(xanthine at 0, 50, 100, 200 and 400 µM). It was shown that the primary 
substrate was in excess abundance, since a change in xanthine concentration 
did not affect the rate of cytochrome c reduction (Figure 5.8). Therefore 
substrate depletion would not be a compounding factor in subsequent 
structure-activity assays and an economical concentration of 200 µM xanthine 
was therefore used in all subsequent xanthine oxidase assays. Subsequently, 
the rate of cytocrome c reduction by a xanthine oxidase catalysed reaction 
was assessed at different concentrations of cytocrome c (0, 50, 100 and 200 
µM). It was shown that a cytochrome c concentration of 200 µM demonstrated 
143 
 
the greatest assay sensitivity, since this concentration had the greatest 
change in absorbance (Figure 5.8). Therefore a cytochrome c concentration 
of 200 µM was used in all subsequent xanthine oxidase assays. Finally, the 
rate of cytocrome c reduction by a xanthine oxidase catalysed reaction was 
assessed at different enzyme concentrations (0, 0.025, 0.05 and 0.1 U/ml). It 
was shown that a xanthine oxidase concentration of 0.1 U/ml produced the 
greatest reduction of cytochrome c, since this concentration demonstrated the 
largest change in absorbance (Figure 5.8). Therefore a xanthine oxidase 
concentration of 0.1 U/ml was used in all subsequent xanthine oxidase 
assays. Thus, the optimal assay parameters were determined to be at a 
xanthine oxidase concentration of 0.1 U/ml, cytochrome c concentration of 
200 µM and xanthine concentration of 200 µM.  
 
Using the above developed cytochrome c reduction assay it was 
demonstrated that SOD significantly attenuated the rate of cytochrome c 
reduction (Figure 5.9), indicating that this assay was specific for superoxide. 
However, SOD did not completely abolish cytochrome c reduction. This was 
likely due to reduction by hydrogen peroxide produced by SOD. Here it was 
demonstrated that when including SOD as a control (co-incubation), 
cytochrome c could be used as an effective assay for xanthine oxidase 
catalyzed superoxide production, since SOD significantly inhibited the 
reduction of cytochrome c. Thus, all subsequent xanthine oxidase bioassays 
included a SOD containing co-incubation (blank), through which the specific 
superoxide production by the optimised xanthine oxidase reaction could be 
assessed.  
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Figure 5.9. SOD inhibition of cytochrome c reduction by xanthine oxidase. The reduction of 
cytochrome c was assessed in the presence and absence of SOD, using an optimised xanthine oxidase 
reaction assay. SOD, superoxide dismutase, mAU, milli-absorbance units. Data represented as 
mean±SD (n=3). 
 
Ang II induced oxidative stress (superoxide production) in cultured 
endothelial cells: Increased levels of angiotensin II (Ang II) has been shown 
to be involved in the development and progression of atherosclerosis (Brasier, 
Recinos et al. 2002; Mehta and Griendling 2007). This hypothesis is 
supported by recent studies with Ang II receptor type 1 (AT1R) inhibitors, 
which show anti-atherosclerotic effects (Rueckschloss, Quinn et al. 2002; 
Gaede, Vedel et al. 2003). A putative risk factor involved in the pro-
atherosclerotic effects of Ang II is increased oxidative stress by an elevated 
formation of ROS, including superoxide. Superoxide rapidly reacts with NO 
and reduces the bioavailability of this vasoprotective mediator of endothelium-
dependent relaxation. Therefore, Ang II stimulated increases in vascular 
superoxide formation likely contributes to the development of endothelial 
dysfunction and atherosclerosis. In the present study, the dose-dependent 
regulation of superoxide production and expression of NAD(P)H oxidase 
(NOX4) subunit  by Ang II in human endothelial cells was investigated and 
subsequently employed as a bioassay to screen the structure-activity 
relationship of anthocyanin derived phenolic acids and metabolites. In order to 
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measure the induction of superoxide by Ang II and conduct a structure-activity 
relationship study, a cytochrome c reduction assay was developed and 
optimised, based on previously reported studies (Rueckschloss, Quinn et al. 
2002; Steffen, Schewe et al. 2007; Steffen, Gruber et al. 2008) and methods 
developed above. This assay was subsequently used to evaluate the 
structure-activity relationship of anthocyanins and their metabolites with 
respect to Ang II induced superoxide production.  
 
Initially, the optimised cytochrome c reduction assay developed for measuring 
xanthine oxidase catalysed superoxide production was adapted to cell culture 
experiments and developed further. First, the optimum incubation time for 
cytochrome c in the presence of endothelial cells was assessed in 2% serum 
supplemented medium (as previously optimised in cell viability assays). In this 
experiment the basal rates of cytochrome c reduction by cultured endothelial 
cells was assessed. Simultaneously, the ability for SOD to inhibit the 
endothelial cell induced reduction of cytochrome c was also assessed. This 
allowed for the evaluation of superoxide specific cytochrome c reduction. 
Thus, it was demonstrated that cultured HUVECs were capable of reducing 
cytochrome c in a superoxide dependent manner (figure 5.10), since a) the 
reduction of cytochrome c was greater in the presence of cells than in their 
absence (blank) and b) the reduction of cytochrome c by cultured endothelial 
cells was significantly inhibited by SOD. Furthermore, when incubated in the 
presence of endothelial cells for 2, 6 and 8 h, the degree of cytochrome c 
reduction was shown to be greatest at 6 h and demonstrated the least degree 
of variation (Figure 5.10 and 5.11).  
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Figure 5.10. The SOD inhibitable reduction of cytochrome c by HUVECs. Cultured endothelial cells 
were exposed to cytocrome c in 2% FCS containing medium 199 in the absence (basal) and presence 
(SOD) of SOD. The reduced cytochrome c was measured at 550nm at 2h (A) and 6h (B). Blanks 
consisted of treatments in the absence of cells. *represents significance at P<0.05 with respect to basal 
levels of cytochrome c reductions. Data represented as mean±SD (n=6). 
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Figure 5.11. The SOD inhibitable reduction of cytochrome c by HUVECs under low and high serum 
conditions. Cultured endothelial cells were exposed to cytocrome c in 2% FCS containing medium 199 
in low (1%) and high (20%) serum supplemented medium 199. The reduced cytochrome c was 
measured at 550nm at 6h (A) and 8h (B). *represents significance at P<0.05 with respect to basal levels 
of cytochrome c reductions. Data represented as mean±SD (n=6). 
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Since it had previously been reported that serum supplementation  increases 
the production of superoxide production and expression of NOX in cultured 
cells (Wingler, Wünsch et al. 2001), it was important to establish the degree of 
serum induced cytochrome c reduction in the current cell culture model. 
Following the stimulation of endothelial cells with 1 and 20% serum 
supplemented medium (Figure 5.11), it was demonstrated that increased 
serum concentrations increase the reduction of cytochrome c. Furthermore, 
the reduction of cytochrome c by serum stimulated endothelial cells was 
significantly inhibited by the addition of SOD. This was consistent with 
previously reported data (Wingler, Wünsch et al. 2001) demonstrating that 
increased serum supplementation induced an increase in basal superoxide 
production by cultured endothelial cells. In addition, no difference in 
cytochrome c reduction by cultured endothelial cells was observed between 6 
and 8 h incubation. Thus, subsequent structure-activity relationship 
experiments were performed in 2% serum supplemented medium in 
accordance with this data and the findings of earlier cell viability experiments.  
 
Following the evaluation of basal superoxide production (above), cultured 
human endothelial cells were exposed to 0.05, 0.1 and 1 µM Ang II 
(Rueckschloss, Quinn et al. 2002) over 6 h in 2% serum supplemented 
medium, as optimised in previously described experiments. It was 
demonstrated that exposure of the cells to Ang II resulted in a dose 
dependent induction of endothelial superoxide production (Figure 5.12). This 
was in agreement with previously reported data at concentrations ≤0.1 µM 
(Rueckschloss, Quinn et al. 2002), although a study by Rueckschloss et al. 
showed a bimodal response, with a decrease in superoxide production at 
concentrations ≥0.1 µM (Rueckschloss, Quinn et al. 2002). The difference in 
Ang II induced superoxide production between this study and that of 
Rueckschloss et al. could be rationalised by previously reported activation and 
un-coupling of eNOS by Ang II (Millatt, Abdel-Rahman et al. 1999; Chalupsky 
and Cai 2005). Thus, it may be hypothesised that methodological differences 
in this study were unable to detect the bi-modal response or that the cells 
were less responsive to Ang II induced eNOS expression/activation. If 
substrates for NO production by eNOS were insufficient under the current 
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assay condition, it could be hypothesised that 0.1 µM Ang II increased 
superoxide production due to increased activity/expression of NOX4, while at 
>0.1 µM, Ang II stimulation resulted in eNOS activity/expression, which was 
“un-coupled” due to substrate (BH4) depletion as discussed elsewhere 
(Chalupsky and Cai 2005). Interestingly others have used Ang II at 1 µM to 
induce superoxide release from HUVECs (Steffen, Schewe et al. 2007; 
Steffen, Gruber et al. 2008). In order to establish a molecular source for the 
dose-dependent induction of endothelial superoxide production by Ang II, the 
expression of a NAD(P)H oxidase (NOX4) was examined in response to Ang 
II stimulation, both at the protein and mRNA level. Stimulation of HUVECs 
with Ang II caused a dose-dependent bimodal induction of NOX4 protein and 
mRNA expression (Figure 5.13), which was consistent with previously 
reported data (Rueckschloss, Quinn et al. 2002), although not statistically 
significant. Based on these findings and in accordance with previously 
reported data, subsequent structure-activity relationship studies were 
conducted using Ang II stimulation at 0.1 µM for 6 h in 2% serum 
supplemented medium, since these parameters appeared to induce 
superoxide production from endothelial cells due to NOX4 up-regulation 
and/or activity.   
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Figure 5.12. The induction of superoxide production by Ang II. Cultured HUVECs were exposed to 
Ang II (angiotensin II) for 6 h in 2% FCS supplemented medium 199 and the production of superoxide 
(difference in reduced cytochrome c in treatments in the presence and absence of SOD) assessed using 
an optimised cytochrome c reduction assay and normalised to total protein content. *represents 
significance at P<0.05 with respect to basal levels of superoxide production (no treatment). Data 
represented as mean±SD (n=3). 
149 
 
0
0.5
1.0
1.5
2.0
2.5
Fo
ld
 
Ex
pr
e
ss
io
n
 
(N
OX
4/
β
-
Ac
tin
)
NOX4
β-Actin
0
1
2
3
Ang II
Ang II
Ang II
Fo
ld
 
Ex
pr
e
ss
io
n
 
(N
OX
4/
18
S)
A)
B)
 
Figure 5.13. The induction of NOX4 protein (A) and mRNA (B) in HUVECs exposed to Ang II 
(angiotensin II) for 6 h in 2% FCS supplemented medium 199. Data represented as mean±SD (n=2). 
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5.3.2 Structure-activity studies 
 
Inhibition of xanthine/xanthine oxidase by anthocyanins and their 
metabolites: The structure-activity relationship of anthocyanins and their 
metabolites (mono-hydroxyl derivatives: pelargonidin-3-glucoside, 4-
hydroxybenzoic acid and the 4’ glucuronide of 4-hydroxybenzoic acid; 
catechol derivatives:  cyanidin-3-glucoside, protocatechuic acid, vanillic acid 
and the 4’ glucuronide of protocatechuic acid) on xanthine oxidase catalysed 
superoxide production was assessed using the above optimised xanthine 
oxidase assay. The B-ring monohydroxyl derived anthocyanin compounds did 
not appear to inhibit superoxide production by xanthine oxidase (Figure 5.14). 
Interestingly, the glucuronide conjugate of pelargonidin-3-glucoside’s primary 
degradation product, 4-hydroxybenzoic acid, appeared to increase superoxide 
production (Figure 5.14C). 
 
The B-ring catechol derived anthocyanin compounds appeared to inhibit the 
production of superoxide by xanthine oxidase. However, substitution of the 
phenolic catechol with a methoxy and glucuronide conjugate appeared to 
eliminate this inhibitory effect (Figure 5.15). This suggests that the inhibition 
of xanthine oxidase catalysed superoxide production was increased with the 
number of B-ring hydroxyls (catechols). This was consistent with their 
antioxidant potential, where radical scavenging capacity has been shown to 
increase with the number of free hydroxyls on the phenolic structure (Rice-
Evans, Miller et al. 1996). This pattern of structure-activity is also consistent 
with their observed electron donor properties as determined from the direct 
iron-ion reducing capacity studies (described above). Therefore, it is likely that 
anthocyanins and their phenolic metabolites inhibit xanthine oxidase through 
their direct radical scavenging activity. This was consistent with previously 
reported findings for other flavonoids (Cos, Ying et al. 1998) and indicates that 
the antioxidant properties of these compounds are retained only as un-
metabolised parent compounds. Thus, the ability for anthocyanins to 
scavenge xanthine oxidase produced superoxide radicals is not likely to occur 
in vivo, since no effect was observed at physiologically relevant 
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concentrations. Therefore, the reported vascular benefits associated with 
these compounds must act via an alternative mechanism. To this end, a 
cellular model was developed in subsequent studies to assess the inhibition of 
superoxide production by these compounds at physiologically relevant 
concentrations (0.1-1 µM (Manach, Williamson et al. 2005)).   
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Figure 5.14. The inhibition of xanthine oxidase catalysed superoxide production by the mono-hydroxyl 
derivatives, P3G (A), HBA (B) and 4GBA (C). The rate of superoxide production (difference between 
the linear rates of cytocrome c reduction in the presence and absence of superoxide dismutase) by 
xanthine oxidase was assessed in the presence of P3G (pelargonidin-3-glucoside), HBA (4-
hydroxybenzoic acid) and 4GBA (4’ glucuronide conjugate of HBA) using an optimised cytochrome c 
reduction assay. OGlc, O-glucose; OGlcA, O-glucuronic acid. * represents significance at P<0.05 with 
respect to control (no test compounds). Data represented as mean±SD (n=3). 
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Figure 5.15. The inhibition of xanthine oxidase catalysed superoxide production by the catechol 
derivatives, C3G (A), PCA (B), VA (C) and 3OH4GBA (D). The rate of superoxide production 
(difference between the linear rates of cytocrome c reduction in the presence and absence of superoxide 
dismutase) by xanthine oxidase was assessed in the presence of C3G (cyanidin-3-glucoside), PCA 
(protocatechuic acid), VA (vinallic acid or 4-hydroxy-3-methoxybenzoic acid) and 3OH4GBA (4’ 
glucuronide conjugate of protocatechuic acid) using an optimised cytochrome c reduction assay. OGlc, 
O-glucose; OGlcA, O-glucuronic acid. *represents significance at P<0.05 with respect to control. Data 
represented as mean±SD (n=3). 
 
  
Modulation of angiotensin II stimulated superoxide release from intact 
cells by anthocyanins and their metabolites: It has been shown that 
numerous compounds from both natural and synthetic sources possess NOX 
inhibitory effects, or at least reduce the production of superoxide within 
cellular environments (Steffen, Schewe et al. 2007; Steffen, Gruber et al. 
2008). Therefore the ability for novel anthocyanin metabolites (mono-hydroxyl 
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derivatives: pelargonidin-3-glucoside, 4-hydroxybenzoic acid and the 4’ 
glucuronide of 4-hydroxybenzoic acid; catechol derivatives:  cyanidin-3-
glucoside, protocatechuic acid, vanillic acid and the 4’ glucuronide of 
protocatechuic acid) to inhibit Ang II stimulated release of superoxide from 
endothelial cell was assessed, using the developed and optimised Ang II 
induced superoxide production assay, described above (optimised primarily 
for Ang II concentration and treatment duration, SOD inhibition, treatment 
medium conditions, cytochrome c concentrations, protein normalisation and 
NOX4 induction).  
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Figure 5.16. The inhibition of Ang II induced superoxide production by the mono-hydroxyl 
derivatives, P3G (A), HBA (B) and 4GBA (C). Superoxide production (difference in reduced 
cytochrome c between treatments in the presence and absence of superoxide dismutase) by cultured 
HUVECs was assessed in the presence of P3G (pelargonidin-3-glucoside), HBA (4-hydroxybenzoic 
acid) and 4GBA (4’ glucuronide conjugate of HBA) using an optimised cytochrome c reduction assay 
and normalised to total protein content. *represents significance at P<0.05 with respect to control (no 
treatment). Data represented as mean±SD (n=3). 
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Cells treated with the B-ring mono-hydroxylated anthocyanin derived family 
(pelargonidin-3-glucoside, 4-hydroxybenzoic acid and its 4’ glucuronide 
conjugate) showed a dose dependent inhibition of Ang II induced superoxide 
production (Figure 5.16). Furthermore, 4-hydroxybezoic acid (33.2±23.3% 
and 71.4±16.2% inhibition at 0.1 and 1 µM, respectively) had a greater effect 
than its precursor pelargonidin-3-glucoside (21.0±24.7% and 22.7±18.8% 
inhibition at 0.1 and 1 µM, respectively). The glucuronide conjugate of 4-
hydroxybenzoic acid (27.9±8.4% and 97.2±15.3% inhibition at 0.1 and 1 µM, 
respectively) showed an even greater effect, at physiologically relevant 
concentrations. This suggests that anthocyanins become more bioactive 
following degradation to phenolic acid constituents and metabolic conjugation. 
Thus, although anthocyanins themselves possess low systemic bioavailability, 
their vasoactive properties may be mediated by their phenolic acid 
metabolites. This is consistent with previously reported hypotheses (Kay, 
Kroon et al. 2009).      
 
Cells treated with the B-ring catechol derived anthocyanin family (cyanidin-3-
glucoside, protocatechuic acid and its 4’ glucuronide conjugate or 3’ methyl 
conjugate, vanillic acid) showed some bimodal responses (i.e. bioactive at 
specific concentrations, which does not show a dose response relationship) 
(Figure 5.17). This bimodal response was consistent with the previously 
reported bioactive characteristics for cyanidin-3-glucoside (Xu, Ikeda et al. 
2004), where cyanidin-3-glucoside induced eNOS expression in endothelial 
cells only at 0.1 µM, with little or no response at 0.01 or 1 µM. The primary 
end stage degradation product of cyanidin-3-glucoside, protocatechuic acid, 
did not appear to attenuate Ang II induced superoxide production at 
physiological concentrations (15.2±16.4% and 16.7±8.8% inhibition at 0.1 and 
1 µM, respectively). However, both the glucuronide (87.9±4.1% and -
1.4±18.9% inhibition at 0.1 and 1 µM, respectively) and methyl (0.5±17.7% 
and 67.6±26.3% inhibition at 0.1 and 1 µM, respectively) conjugates of 
protocatechuic acid did demonstrate significant inhibitory effects. Cyanidin-3-
glucoside demonstrated a 35.8±21.0% and -3.8±22.0% inhibition of Ang II 
induced superoxide production at 0.1 and 1 µM, respectively. Again, this 
suggests that the vasoactive properties of anthocyanins are mediated by their 
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phenolic acid metabolites, since they possess greater bioactivity, in this 
instance, than their anthocyanin precursors. Interestingly, the inhibition of 
superoxide production by cyanidin-3-glucoside and the 4’ glucuronide 
conjugate of protocatechuic acid showed similar responses (i.e. bimodal). 
Future studies should be conducted to assess the degree of structural 
homology between cyanidin-3-glucoside in its chalcone form (at pH 7) and the 
glucuronide conjugates of protocatechuic acid.  
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Figure 5.17. The inhibition of Ang II induced superoxide production by the catechol derivatives, C3G 
(A), PCA (B), VA (C) and 3OH4GBA (D). Superoxide production (difference in reduced cytochrome c 
between treatments in the presence and absence of superoxide dismutase) by cultured HUVECs was 
assessed in the presence of C3G (cyanidin-3-glucoside), PCA (protocatechuic acid), VA (vanillic acid) 
and 3OH4GBA (4’ glucuronide conjugate of protocatechuic acid) using an optimised cytochrome c 
reduction assay and normalised to total protein content. *represents significance at P<0.05 with respect 
to control (no treatment). Data represented as mean±SD (n=3). 
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Modulation of NO production by anthocyanin derived phenolic acid 
metabolites: Since it had been shown that 4-hydroxybenzoic acid, 
protocatecuic acid, the 4’ glucuronide of 4-hydroxybenzoic acid and the 4’ 
glucuronide of protocatechuic acid significantly attenuated the Ang II induced 
release of superoxide from endothelial cells (structure-activity study IV), these 
compounds were subsequently assessed for their ability to induce NO 
release.  Of the compounds tested, only the 4’ glucuronide of 4-
hydroxybenzoic acid showed a significant induction of NO at a concentration 
of 1 µM (Figure 5.18). This appeared similar to the effects of these 
compounds of endothelial superoxide production described above (i.e. the 
compound with the least number of hydroxyls has the greatest effect). This 
may suggest that the vasoactive properties of these compounds are mediated 
through the attenuation of superoxide production rather that a direct 
stimulation of NO production.  However, this study was conducted under basal 
conditions (i.e. not stimulated with Ang II) and since these compounds 
appeared to show bioactivity under stimulated conditions, further structure-
activity relationship studies should be conducted to assess the true bioactive 
properties for these compounds. 
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Figure 5.18. The modulation of NO by selected anthocyanin metabolites. Cultured endothelial cells 
were treated with 0.1 and 1 µM 4-hydroxybenzoic acid (HBA), protocatecuic acid (PCA), 4’ 
glucuronide of 4-hydroxybenzoic acid (GBA) and 4’ glucuronide of protocatechuic acid (3OH4GBA), 
respectively, for 24 h in 2% FCS supplemented medium 199, whereupon NO production was quantified 
as total nitrite and nitrate in cell supernatants. Basal treatment consisted of cells in 2% FCS 
supplemented medium 199 only. Positive control incubations consisted of cells treated with 10 nM 
PMA (phorbol 12-myristate 13-acetate) or 100 µM resveratrol (Resv). *represents significance at 
P<0.05 with respect to basal. Data represented as mean±SD (n=3). NO, nitric oxide. 
 
 
5.4 Conclusion  
 
In summary, this study showed that anthocyanins and their metabolites do 
attenuate Ang II induced endothelial superoxide production and that the 
bioactivity of anthocyanins is enhanced following degradation and metabolism 
to phenolic acid metabolites. With respect to structure-activity relationships, 
mono-hydroxylated anthocyanin derived compounds (pelargonidin-3-
glucoside, 4-hydroxybenzoic acid and the 4’ glucuronide of 4-hydroxybenzoic 
acid) produce a dose dependent reduction of superoxide production while the 
catechol anthocyanin derived compounds (cyanidin-3-glucoside, 
protocatechuic acid, vanillic acid and the 4’ glucuronide of protocatechuic 
acid) show a bimodal inhibition of superoxide production when conjugated to 
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glucose analogous (i.e. glucose or glucuronic acid). Interestingly, the most 
bioactive compounds, with respect to inhibition of Ang II induced superoxide 
production, were those with less B-ring (aryl) hydroxyls. For instance, the 
mono-hydroxyl, 4-hydroxybenzoic acid, showed a greater bioactivity than the 
di-hydroxyl, protocatechuic acid. When the di-hydroxyl, protocatechuic acid, 
was converted to a mono-hydroxyl by substituting one of the aryl hydroxyls 
with a metabolic conjugate (methoxyl or glucuronide), its bioactivity was 
increased. Furthermore, when the aryl hydroxyl on 4-hydroxybenzoic acid was 
substituted with a glucuronide, its bioactivity was further increased.  
 
The ability for phenolic acids to inhibit Ang II induced superoxide production or 
induce NO production by the endothelium appeared to be a) inversely 
associated with the number of aryl hydroxyls such that ↓OH = ↑bioactivity and 
b) this effect is in express opposition to their direct iron-ion reducing capacity 
and direct radical scavenging capacity (↑OH = ↑bioactivity).  
 
Based on this dichotomy between points a and b, it is likely that the biological 
effects of these anthocyanins on the vasculature, at physiological 
concentrations, are not due to their direct radical scavenging properties and 
thus, this study provides evidence in support of epidemiological and animal 
studies that indicate a positive effect of anthocyanins on vascular health. 
Thus, the effects of anthocyanin consumption on the vasculature are likely 
mediated by their phenolic acid degradation products and metabolites. 
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Chapter 6  
General discussion and future research 
perspectives 
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6.1 Overview 
 
Oxidative stress, vascular inflammation, and endothelial dysfunction play a 
central role in the development of cardiovascular diseases. As such, novel 
pharmaceutical and/or dietary strategies have been proposed to prevent the 
development and progression of vascular diseases. Epidemiological 
observations have played a significant part in the development of such dietary 
strategies, which includes the identification of numerous cardio-protective 
phytochemicals. In general, research into the health related benefits of 
flavonoids has been supported by epidemiological studies signifying that 
foods rich in flavonoids provide cardiovascular protection. Reviews of 
numerous flavonoid intervention trials show modest effects on cardiovascular 
risk factors, such as flow mediated dilatation (FMD) and blood pressure 
(Hooper, Kroon et al. 2008). This is particularly evident in foods such as 
chocolate, red wine and purple grape juice. However, the evidence is 
inconsistent for most other biomarkers of cardiovascular disease. This may be 
due to poor interpretation of findings from observational studies to intervention 
trials, non-standardised biomarker analysis and/or difficulties in identifying 
primary bioactive food components. Specifically, anthocyanins are thought to 
possess significant cardio-protective properties and have been proposed as 
potent modulators of vascular disease. However, their true health benefit has 
been thrown into question, since current literature evidence demonstrates that 
anthocyanins possess poor bioavailability (Manach, Williamson et al. 2005). 
To date, studies have failed to fully establish the bioavailability of 
anthocyanins and have been unable to pinpoint their bioactive mechanisms of 
action. Moreover, little is currently known about anthocyanin absorption 
(Figure 6.1), routes of metabolism and excretion (Figure 6.2), formation of 
phenolic degradation products, pH dependent chemical derivatives and the 
pharmacokinetics of anthocyanin metabolites. No studies have yet determined 
their biological mechanisms of action, nor their physiologically relevant 
metabolites. Indeed, much is still unknown about the major sites and modes of 
anthocyanin metabolism.  
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In order to fully appreciate the health related benefits of ingested 
anthocyanins, an understanding of their occurrence, biochemistry, metabolism 
and final bioactive mechanisms is essential. Therefore, within this thesis, the 
experimental gaps in our knowledge of anthocyanin stability, metabolism and 
bioactivity were addressed in a series of experiments designed to evaluate (i) 
the stability of anthocyanins during processing from whole berry (anthocyanin 
rich food source) to commercial juice product (Chapter 2), (ii) the formation of 
phenolic degradation products under simulated physiological and 
experimental conditions and recovery from clinical samples (Chapter 3), (iii) 
the in vitro hepatic conjugation (metabolism) of anthocyanins and their 
phenolic acid degradation products (Chapter 4) and (iv) the in vitro 
cardiovascular related bioactivities of anthocyanins and their novel free or 
conjugated metabolites (Chapter 5).  
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Figure 6.1. Current unknowns for anthocyanin absorption. “?” represent possible sites/modes of 
absorption that are yet to be confirmed. Image modified from Kay, C. D. (2006) Nutr. Res. Rev. 
19:137-146. BLT, bilitranslocase; SGLT, sodium dependent glucose transporters; LPH, lactase 
phloridzin hydrolase; CBG, cytosolic β-glucosidase;  Glc, glucose; Metb, metabolism; MRP, multi-
drug resistance associated proteins.  
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Figure 6.2. Current unknowns for anthocyanin absorption and sites of metabolism. “?” represent 
possible sites/modes of absorption/metabolism that are yet to be confirmed. Figure modified from Kay, 
C. D. (2006) Nutr. Res. Rev. 19:137-146. 
 
 
6.2 Anthocyanins and processed foods (remarks on Chapter 
2) 
 
With regards to evaluating anthocyanin occurrence in processed foods, it 
remained important to establish the stability of anthocyanins during 
commercial juice processing in order to evaluate their availability to the 
general population and their bioactivity within processed food/s. In this study it 
was demonstrated that no significant loss in anthocyanins was observed 
throughout commercial processing. Thus it remains clear that anthocyanins 
are available for consumption by the population in high concentration, where 
the evaluation of anthocyanin interactions with human physiology is clearly 
important. However, from this and other studies (Hollands, Brett et al. 2008) it 
is shown that the levels of anthocyanins found in commercial juice products 
are far below that indicated by the manufacturers. Therefore, anthocyanins 
are likely to degrade during storage of processed juice products and should 
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be the focus of future research in the food and drinks industry. Particularly, 
research should aim to evaluate the degradation of anthocyanins and the 
formation of free phenolic acids or dimerised polymers in processed foods, 
since these products could significantly modulate health or disease upon 
consumption.  Furthermore, since the work presented in this thesis indicates 
that the effects of anthocyanins on the vasculature (in vitro) are enhanced by 
their degradation and metabolism, it may prove beneficial to promote the 
formation of these degradation compounds during fruit processing to 
commercial products.   
 
 
6.3 Anthocyanin bioavailability (remarks on Chapters 3 and 4)  
 
A crucial aspect in modern anthocyanin research is demonstrated by past and 
present bioavailability studies, which confirm that less than 1% of an ingested 
dose is present in the serum and urine, and thus 99% is un-available to the 
systemic circulation (Manach, Williamson et al. 2005). Therefore, it remains 
paramount to this research field that the metabolic fate of the remaining 99% 
of ingested anthocyanins is determined. To account for the metabolic loss of 
anthocyanins, protocatechuic acid, as a by-product of cyanidin-3-glucoside 
degradation has been investigated following (i) thermal or chemical 
degradation, (ii) microbial catabolism, (iii) simulated digestion, (iv) cell culture 
metabolism studies and (v) rodent feeding trials. Also, in one human study, 
protocatechuic acid has been suggested to be the primary degradation 
product or metabolite of cyaniding-3-glucoside (Vitaglione, Donnarumma et al. 
2007). Thus, it remained important to evaluate the physio-chemical stability of 
anthocyanins and their stability following routine sample analysis in order to 
fully account for their poor bioavailability. To this end the study presented in 
Chapter 3 assessed the effect of anthocyanin B-ring hydroxylation on their 
stability under simulated (in vitro) physiological conditions and their 
degradation and recovery following routine pre-analytical sample extraction 
and storage. It was shown that (i) the B-ring hydroxylation status of 
anthocyanins mediated their degradation to phenolic acid and aldehyde 
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constituents, (ii) that successful anthocyanin extraction was dependant on 
both sample preparation technique and anthocyanin structure and (iiI) that 
anthocyanins remain stable through multiple freeze thaw cycles. Importantly, 
these data indicated that significant portions of ingested anthocyanins are 
likely to degrade to phenolic acids and aldehyde and that the poor 
bioavailability of anthocyanins is not due to inappropriate sample extraction or 
clinical sample storage.  
 
An apparent lack of appreciation for the rate and extent of anthocyanin 
degradation under physiological or processing conditions may explain the 
almost complete absence of data aimed at quantifying anthocyanin 
breakdown products and metabolites in humans and the current lack of 
reports concerned with the biological activities of these compounds or their 
metabolites. The studies presented in this thesis have described the 
degradation of anthocyanins to phenolic acids under simulated physiological 
conditions, with the subsequent formation of phenolic acid metabolites, 
particularly glucuronide conjugates. This would indicate that following 
ingestion, anthocyanins may be found in the systemic circulation as free or 
conjugated phenolic acids. However, in order to fully validate this hypothesis, 
further bioavailability should be conducted with the express aim of identifying 
both anthocyanins and phenolic acid conjugated metabolites in humans. 
Further to this, these studies should aim to identify the conjugation position 
and structure of these metabolites, since this may significantly affect their 
bioactivity. Particularly, the study presented in Chapter 4 indicated that the 
primary phenolic glucuronide conjugates were acyl glucuronides (under the 
current experimental conditions). This may be of particular research interest 
since (i) the formation of acyl glucuroides over aryl glucuronides contradicts 
common pharmacological dogma and (ii) it has been well reported that acyl 
glucuronides are able to cross-link proteins and cause adverse drug reactions 
(side affects). These aspects of anthocyanin metabolism require further 
investigation. In addition, it has been reported that protocatechuic acid and 
gallic acid form sulphate and methyl conjugates upon metabolism where it 
may be found that these anthocyanin derived phenolic acids may be found in 
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the systemic circulation as multiply conjugated metabolites (methyl-
glucuronides etc.).  
 
A consistent observation throughout the analysis of anthocyanin degradation 
and metabolism, was the “lag” time between anthocyanin loss and phenolic 
acid formation, particularly under physiologically buffered conditions. It may be 
found that the identification of these intermediate anthocyanin products may 
serve to account for the poor bioavailability of anthocyanins. To date, no 
analystical method has been developed to identify these intermediates (pH 
dependent iso-forms) in buffered/biological samples and should be the focus 
of further studies aimed at elucidating the degradation or “ring opening” of 
anthocyanins under physio-chemical conditions.    
    
 
6.4 Anthocyanin and cardiovascular disease (remarks on 
Chapter 5) 
 
The vascular endothelium plays a fundamental role in the maintenance of 
vascular health, and thus organ function. The fact that our daily diet directly 
and indirectly influences cardiovascular and endothelial function has been 
widely demonstrated. While there is a large body of knowledge on oxidative 
risk for vascular disease, rigorous clinical investigations that establish a link 
between the intake of dietary polyphenols and the improvement of vascular 
function in humans is scarce. However, it has been observed that human 
volunteers ingesting beverages rich in polyphenols exhibit an increase in FMD 
(Hooper, Kroon et al. 2008), which is believed to be largely dependent on 
eNOS and NO activity. While such reports support the notion that polyphenols 
are biologically active compounds, a direct causal link has yet to be 
established. Indeed, which compounds are biologically active at the molecular 
level remains an open question that requires further investigation. 
Nonetheless, some mechanistic observations have lead to a better 
understanding of polyphenol function. The most important of these has lead to 
a paradigm shift in the flavonoid research field where it is now accepted that 
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rather than directly acting as antioxidants per se, certain flavonoids may be 
thought of as bioactive compounds with biological specificity and functionality. 
Indeed, this notion has been demonstrated in the present thesis (Chapter 5) 
where the biological effect of anthocyanins has been shown to be in express 
opposition to their antioxidant potential. In vitro assays clearly demonstrate 
that flavonoids react with free radicals. These and other chemical properties 
related to antioxidant activity can be classified as direct actions, and much 
emphasis has been placed on this in recent years. However, the following 
considerations argue against a direct antioxidant affect in vivo, based on the 
findings of this and other studies; (i) the low concentration of flavonoids in the 
systemic circulation compared with endogenous antioxidant compounds and 
enzymes, (ii) the lack of evidence regarding the efficacy of long term 
antioxidant supplementation and (iii) the high level of metabolism and 
biotransformation that flavonoids undergo, which ultimately reduce their 
antioxidant potential. The latter point represents yet another important 
paradigm shift in recent flavonoid research, namely, the question as to 
whether polyphenols or their metabolites mediate their biological effects? In a 
recent study, an O-methylated metabolite of (-)-epicatechin, 3’-O-
methylepicatechin, was shown to inhibit NADPH oxidase. Importantly, it was 
shown that this (-)-epicatechin metabolite was more effective than its un-
metabolised precursor (Steffen, Schewe et al. 2007; Steffen, Gruber et al. 
2008). The importance and relevance of metabolism is also highlighted here 
(Chapter 5), where it was demonstrated that changes to anthocyanin 
structure following degradation or metabolic conjugation elicited divergent 
effects on endothelial superoxide production. In particular, a reduction in the 
number of aryl hydroxyls was associated with a greater bioactivity. These 
results are in general agreement with other flavonoid structure-activity 
relationship studies. More specifically, this study showed that anthocyanins 
and their metabolites do attenuate Ang II induced endothelial superoxide 
production and that the bioactivity of anthocyanins is enhanced following 
degradation and metabolism to phenolic acid metabolites. Furthermore, the 
ability for phenolic acids to inhibit Ang II induced superoxide production or 
induce NO production by the endothelium was inversely associated with the 
number of aryl hydroxyls (↓OH = ↑bioactivity). This effect is in express 
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opposition to their antioxidant potential (↑OH = ↑bioactivity). Therefore, it is 
likely that the biological effects of these compounds on the vasculature, at 
physiological concentrations, are not due to their direct radical scavenging 
properties. Others have shown that phenolic acids (including protocatechuic 
acid and gallic acid) exert a range of bioactivities in addition to their radical 
scavenging capacity, including the induction of apoptosis. These observations 
therefore support the hypothesis that anthocyanin degradation products and 
metabolites are likely to mediate their biological activity. Thus, future research 
may typify flavonoids as pre-cursors or “pro-drugs” for bioactive metabolites. 
However, considering that cyanidin-3-glucoside is most bioactive at 0.1 µM, a 
physiologically achievable concentration, it may be thought that the low 
bioavailability of anthocyanins may exemplify their biological affects. 
Therefore, future studies should aim to assess the dose dependant effects of 
anthocyanins and other phenolic compounds in bioactivity assays at 
concentration lower than previously considered (i.e. 0.1 µM), in order that a 
“therapeutic window” for these bi-modally active compounds is established.    
 
Although it has here been demonstrated that anthocyanins and their 
metabolites modulate vascular functions at physiological concentrations, the 
mechanisms of this action remains to be assessed. To this end, initial studies 
should aim to assess the ability for these compounds to modulate the protein 
and gene expression of superoxide associated enzymes, particularly in the 
relation to Ang II and other inflammatory stimulators. Among these targets 
should be included NOX (NOX4) and eNOS. Furthermore, the effects of 
anthocyanins and their metabolites should be assessed in both acute and 
prolonged inflammatory environments in which gene/protein expression as 
well as activation (phosphorylation) and translocation (i.e. the association of 
NOX4 with its intracellular and membrane bound components including 
p22phox). With regards to protein activation, since NOX and eNOS are 
primarily subject to the MAP kinase pathway (including Erk and AKT 
associated pathways) it may prove likely that anthocyanins and their 
metabolites modulate the production of superoxide and NO through the 
upstream modulation of the afore mentioned pathways, as has been shown 
for procyanidins and VEGF receptor signalling.  
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6.5 Concluding remarks 
 
Overall, the findings of this thesis emphasize the importance of investigating 
the health related benefits associated with flavonoid consumption and the 
significance of stability and metabolism in elucidating the mechanisms by 
which flavonoids may modulate human health and disease. The concepts of 
metabolism (metabolic structural alterations), bioavailability and mechanisms 
of action should be regarded as vitally important when conducting and 
interpreting past and future research associated with the health benefits of 
flavonoids.   
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Appendix A: Anthocyanins and juice products 
 
A.1. Analysis of commercial juice products my HPLC 
 
Preparation of GSK berry products 
 
Ribena blackcurrant (tetrapack): 10 µl of single strength Ribena (tetrapack) 
was injected directly on to the HPLC system. 
 
Ribena blackcurrant concentrate: 10 µl of Ribena concentrate was injected 
directly onto the HPLC system. 
 
Eurovit Anthocyanin (grape skin) additive: An aliquot of Eurovit Anthocyanin 
additive was diluted 1:9 with 5% aq. formic acid. 10 µl of the diluted sample 
was injected onto the HPLC system.  
 
Blackcurrant berries: A portion of frozen blackcurrants were extracted (see 
below) and injected (10 µl) onto the HPLC system. 
 
 
Anthocyanin/phenolic acid extraction method 
 
Materials 
 
Frozen blackcurrant were provided by GSK and stored at -18oC. Degraded 
blackcurrants were prepared as described below. Anthocyanin standards 
were purchased from Extrasynthese (France) or provided by GSK. Phenolic 
acid standards were purchased from Sigma Aldrich (UK). 
 
Extraction conditions 
 
Anthocyanins and phenolic acids were extracted from a 25g sample of frozen 
blackcurrants.  Berry sample were blended in 100ml 80:20 Acetonitrile:dH2O 
and 5% formic acid for 3 min. The resulting ‘slurry’ (100 ml) was then 
sonicated in a bath sonicator at 40oC for 30 min. The sonicated sample was 
then centrifuged at 4000 rpm (4x25 ml samples) for 20 min on a bench top 
centrifuge. The supernatants were then filtered through 0.45 µm syringe 
filters, diluted in 5% aq. formic acid (1:4 and 1:3 dilution for fresh and 
degraded berry samples respectively) and analysed by HPLC.    
 
Degradation of whole berries 
 
In order to determine if anthocyanin derived phenolic acids were present and 
extracted from whole berries, a sample of whole blackcurrants (25g) was 
submerged in 50 ml dH2O (titrated to pH 8 with 0.1 M NaOH) and heated to 
70oC for 24 h under vacuum). The remaining dH2O was evaporated on a 
rotary evaporator and the anthocyanins and phenolic acids extracted as 
described above. 
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HPLC method 
 
HPLC analysis was performed on an Agilent 1200 series HPLC equipped with 
a diode array detector (DAD) and a 4 µm, 250 x 4.6 mm Synergi Max-RP 
reverse phase column (Phenomenex, Macclesfield, UK) with a SecurityGuard 
guard cartridge (Phenomenex AJO-6074). The column temperature was set at 
30 °C with an injection volume of 10 µL and mobile phases consisting of 5% 
formic acid (v/v) in water (solvent A) and 5% formic acid (v/v) in acetonitrile 
(solvent B). The solvent gradient consisted of 8% B at 0 min, 10% B at 5 min, 
18% B at 25 min and 100% B at 27-33 min; at a flow rate of 1 mL/min. 
Absorbance was recorded at 520, 360 and 260 nm. 
 
Analysis of Eurovit. anthocyanin colouring additive 
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Compound Rt (min) Peak Area Dilution f. Concentration (g/L) 
Delphinidin-3-glucoside 9.3 1181.5 10 1.198 
Cyanidin-3-glucoside 11.9 180 10 0.063 
Cyanidin-3-rutinoside 13.9 1187 10 1.010 
Peonidin-3-arabinoside 18.9 3274.2 10 1.405 
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Compound Rt (min) Peak Area Dilution f. Concentration (g/L) 
Gallic acid 3.9 3722 10 1.493 
Protocatechuic acid 6.0 427.3 10 0.118 
Vanillic acid 11.6 172.8 10 0.049 
 
 
 
Analysis of Ribena tetra-pack (no added colour) 
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Compound Rt (min) Peak Area Dilution f. Concentration (ug/mL) 
Delphinidin-3-glucoside 9.4 36.7 1 3.721 
Delphinidin-3-rutinoside 10.6 219.5 1 19.953 
Cyanidin-3-glucoside 12 16.7 1 0.585 
Cyanidin-3-rutinoside 13.5 173.1 1 14.731 
 
 
173 
 
min4 5 6 7 8 9 10
mAU
0
100
200
300
400
500
600
700
G
a
llic
 
ac
id
Pr
o
to
ca
te
ch
u
ic
ac
id
 
 
Compound Rt (min) Peak Area Dilution f. Concentration (ug/mL) 
Gallic acid 3.9 56.3 1 2.258 
Protocatechuic acid 5.7 9.4 1 0.260 
 
 
Analysis of Ribena Concentrate 
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Compound Rt (min) Peak Area Dilution f. Concentration (ug/mL) 
Delphinidin-3-glucoside 9.4 482.0 1 48.875 
Delphinidin-3-rutinoside 10.6 2826.0 1 256.883 
Cyanidin-3-glucoside 12 238.5 1 8.348 
Cyanidin-3-rutinoside 13.5 2228.9 1 189.679 
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Compound Rt (min) Peak Area Dilution f. Concentration (ug/mL) 
Gallic acid 3.9 292.7 1 11.737 
 
 
Analysis of frozen blackcurrants  
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Compound Rt (min) Peak Area Berry content (mg/100g FW) 
Delphinidin-3-glucoside 9.4 365.5 74.1234 
Delphinidin-3-rutinoside 10.6 1429.5 259.8831 
Cyanidin-3-glucoside 12 124.8 8.736 
Cyanidin-3-rutinoside 13.5 920.0 156.584 
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Compound Rt (min) Peak Area Berry content (mg/100g FW) 
Gallic acid 3.6 26.0 2.0852 
Protocatechuic acid 0 0.0 0 
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Compound Rt (min) Peak Area Berry content (mg/100g FW) 
Delphinidin-3-glucoside 9.4 44.4 5.402592 
Delphinidin-3-rutinoside 10.6 158.8 17.321904 
Cyanidin-3-glucoside 12 15.4 0.6468 
Cyanidin-3-rutinoside 13.6 117.7 12.019524 
 
 
176 
 
min4 6 8 10 12
mAU
-10
0
10
20
30
40
50
G
al
lic
 
ac
id
Pr
ot
oc
at
ec
hu
ic
ac
id
 
 
Compound Rt (min) Peak Area Berry content (mg/100g FW) 
Gallic acid 3.6 110.8 5.331696 
Protocatechuic acid 6.3 116.5 3.87246 
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A.2. Design of Experiment (DOE) 1: Factors influencing the 
loss of anthocyanins during berry concentrate processing. 
 
Overview: 
 
In order to identify key point for anthocyanin losses during routine industrial 
scale blackcurrant processing, samples of processed blackcurrant were 
analyse pre and post significant processing steps in a previous experiment. In 
order to elucidate the relationship between anthocyanin loss and various 
processing influence and potentially improve processed berry concentrate 
anthocyanin content, a DOE (design of experiment) was conducted using a 
simulated blackcurrant processing system. The key influences on anthocyanin 
content investigated were milling method, SO2 concentration, pectinaze 
enzyme concentration, enzyme treatment time and concentration 
temperature.  
 
DOE design matrix: 
 
 Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 
Run 
A 
Method of Milling 
(fine/coarse) 
B 
SO2  
(mg/Kg) 
C 
Enzyme  
(ul/Kg) 
D 
Enzyme time  
(h) 
E 
Concentration temp. (°C)  
1 Method 1 150 0.8 3.25 65 
2 Method 1 300 1.5 6 40 
3 Method 1 300 1.5 0.5 90 
4 Method 1 300 0.1 0.5 40 
5 Method 2 0 1.5 6 40 
6 Method 2 150 0.8 3.25 65 
7 Method 1 150 0.8 3.25 65 
8 Method 2 300 0.1 0.5 90 
9 Method 2 0 1.5 0.5 90 
10 Method 1 150 0.8 3.25 65 
11 Method 2 0 0.1 6 90 
12 Method 1 0 0.1 0.5 90 
13 Method 1 300 0.1 6 90 
14 Method 2 300 0.1 6 40 
15 Method 2 150 0.8 3.25 65 
16 Method 1 0 0.1 6 40 
17 Method 2 300 1.5 6 90 
18 Method 1 0 1.5 0.5 40 
19 Method 1 0 1.5 6 90 
20 Method 2 300 1.5 0.5 40 
21 Method 2 0 0.1 0.5 40 
22 Method 2 150 0.8 3.25 65 
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Appendix B: Compound purity and structure 
 
B.1. HPLC purity of synthesised compounds 
 
 
 
4-(1-carboxyphenyl) β-D-glucuronic acid (HBA-GlcA) = >99% pure 
 
4-(1-carboxy-3-hydroxyphenyl) β-D-glucuronic acid (PCA-GlcA) = 99% pure 
 
3-(1-carboxy-4-hydroxyphenyl) β-D-glucuronic acid (3OH4GlcABA) = 98% 
pure 
 
 
 
 
 
(Purity based on % peak area at <33 min. see chromatographs below) 
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B.2. NMR spectra for synthesised compounds 
 
4-(1-carboxyphenyl) β-D-glucuronic acid 
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4-(1-carboxy-3-hydroxyphenyl) β-D-glucuronic acid 
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B.3. MS Method development 1: Glucuronide Fragmentation 
Parameters: Injection Flow Analysis (IFA) of 7-Hydroxy-4-
Methylcoumarin-D-Glucuronide (4MUG) 
 
 
Brief Method: 
 
In order to determine the cone-voltage (fragmentor voltage) required to produce both parent 
and aglycone (a-glucuronide) fragments an injection flow analysis (IFA ) of a common 
glucuronide standard (4MUG) was performed under various cone-voltage conditions,  in both 
negative and positive ionisation modes (sample and LC/MS conditions for each experiment 
are described intern in the experimental section below). 
 
 
  
 
 
 
 
 
 
 
 
 
Overall Summery of Results 
 
It was found that cone voltage conditions significantly affect the fragmentation of the 
glucuronide standard 4MUFGA. Figures A and B illustrate the influence of cone-voltage on 
4MUFGA fragmentation, where an increase in cone-voltage yields an increase in the relative 
abundance of the “aglucuronide” fragment ion and a decrease in the glucuronide fragment 
ion.  
 
Fragmentor: 110v Fragmentor: 150v
Fragmentor: 270v Fragmentor: 300v
 
 
 
7-Hydroxy-4-Methylcoumarin-D-Glucuronide 
(Mass = 352 Da) 
 
 
7-Hydroxy-4-Methylcoumarin 
(Mass = 176 Da) 
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Figure A. Mass fragmentation patterns for 4MUFGA at cone-voltages (fragmentor) of 110v, 
150v, 270v and 300v. Ionization performed in negative full scan mode [100-500Da]. Circled 
are the masses of interest (“aglycone” = 175 Da; Glucuronide = 351 Da [M-1]-). Additional 
fragment ions were observed. 
Fragmentor: 100v Fragmentor: 150v
Fragmentor: 190vFragmentor: 160v
 
 
Figure B. Mass fragmentation patterns for 4MUFGA at cone-voltages (fragmentor) of 100v, 
150v, 2600v and 190v. Ionization performed in positive full scan mode [100-500Da]. Circled 
are the masses of interest (“aglycone” = 177 Da; Glucuronide = 353 Da [M+1]+). Additional 
fragment ions were observed. 
 
 
Overall Conclusions 
 
The glucuronide 4MUG, representing a phenolic glucuronide structure, may be ionized and 
fragmented under both positive and negative LC/MS conditions. Should negative mode 
ionization be used for phenolic glucuronide fragmentation, it is recommended that a cone-
voltage of 270v be utilized under these MS conditions, described in the experimental section. 
Likewise, should positive mode ionization be used for phenolic glucuronide fragmentation, it is 
recommended that a cone-voltage of 180-190v be utilized under these MS conditions, 
described in the experimental section. The above stated cone-voltage parameters should  
yield glucurinide and a-glucuronide fragments in equal relative abundances. 
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Experimental Section: 
 
The following section describes a series of experiments designed to determine the cone-
voltage (fragmentor voltage) required to produce both parent and aglycone (a-glucuronide) 
fragments from a phenolic glucuronide standard. 
 
Experiment 1: 
 
In order to determine the initial cone voltage required to fragment 4MUFGA, an injection flow 
analysis was performed, under the below stated MS conditions, with varying cone voltages 
(50-300v). 
 
Sample concentration: 0.1mg/ml in water 
 
LC Conditions: 
Flow rate: 0.4ml/min 
Solvent conditions: isocratic run with 75% solvent A (0.1% formic acid in water) and 25% 
solvent B (0.1% formic acid in actetonitrile). 
Injection volume: 20ul 
 
MS Conditions: 
Sim mode: positive mode, ion 1 = 353, ion 2 = 177 
Gain: 1 
Threshold: 150 
Drying gas flow: 13 l/min 
Nebulizer pressure: 30psig 
Drying gas temperature: 350 
Capillary voltage: 4000 
Ionization mode: API-ES 
 
Results: 
 
As showing in figure 1 below, several 4MUFGA injections were performed (each peak 
represents an injection at 0.8 min intervals), each at different (increasing) cone-voltages 
(fragmentor settings). Fragmentation of 4MUFGA appeared to occur between 180 and 190 
cone volts, as illustrated below in figures 2 and 3, showing the mass fragmentation patterns 
for 4MUFGA at fragmentor settings 180v and 190v. 
 
 
 
Figure 1. Mass chromatograph of 4MUFGA at cone voltages of 50-300v, increasing in 10v 
increments (positive sim mode [353Da; 177Da]). 
190 
 
 
 
Figure 2. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 180v (positive 
sim mode [353Da; 177Da]). 
 
 
 
Figure 3. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 190v (positive 
sim mode [353Da; 177Da]). 
 
 
Experiment 2: 
 
As it was observed that fragmentation  of 4MUFGA occurred between 180-190 cone volts, an 
injection flow analysis was performed, under the below stated MS conditions, with varying 
cone voltages (180-190v).  
 
Sample concentration: 0.1mg/ml in water 
 
LC Conditions: 
Flow rate: 0.4ml/min 
Solvent conditions: isocratic run with 75% solvent A (0.1% formic acid in water) and 25% 
solvent B (0.1% formic acid in actetonitrile). 
Injection volume: 20ul 
 
MS Conditions: 
Sim mode: positive mode, ion 1 = 353, ion 2 = 177 
Gain: 1 
Threshold: 150 
Drying gas flow: 13 l/min 
Nebulizer pressure: 30psig 
Drying gas temperature: 350 
Capillary voltage: 4000 
Ionization mode: API-ES 
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Results: 
 
Several 4MUFGA injections between 180 and 190 cone volts were performed (each peak 
represents an injection at 0.8 min intervals), each at different (increasing) cone-voltages 
(fragmentor settings), as shown in figure 4. Fragmentation of 4MUFGA appeared to occur 
between 185 and 186 cone volts, as illustrated below in figures 5 and 6, showing the mass 
fragmentation patterns for 4MUFGA at fragmentor settings 185v and 186v. 
 
 
Figure 4. Mass chromatograph of 4MUFGA at cone voltages of 180-190v, increasing in 1v 
increments (positive sim mode [353Da; 177Da]). 
 
 
 
 
 
 
 
 
Figure 5. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 195v (positive 
sim mode [353Da; 177Da]). 
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Figure 6. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 186v (positive 
sim mode [353Da; 177Da]). 
 
 
 
 
 
 
Experiment 3 
 
Although fragmentation appeared to occur at 186 cove volts in positive sim mode, it was 
necessary to assess the fragmentation 4MUFGA in full scan mode (as would be performed 
for experimental samples). In order to assess varying cone voltages to the fragmentation of 
4MUFGA in full scan positive mode, an injection flow analysis was performed, under the 
below stated MS conditions, with varying cone voltages (170-200v). 
 
Sample concentration: 0.1mg/ml in water 
 
LC Conditions: 
Flow rate: 0.4ml/min 
Solvent conditions: isocratic run with 75% solvent A (0.1% formic acid in water) and 25% 
solvent B (0.1% formic acid in actetonitrile). 
Injection volume: 10ul 
 
MS Conditions: 
Full scan mode: positive mode, 100-1000Da 
Gain: 1 
Threshold: 150 
Drying gas flow: 13 l/min 
Nebulizer pressure: 30psig 
Drying gas temperature: 350 
Capillary voltage: 4000 
Ionization mode: API-ES 
 
Results: 
 
Injections of 4MUFGA, fragmented at cone voltages between 180 and 190v in full scan 
positive mode are shown in figure 7. The fragmentation patterns produced under these 
conditions are shown in figure 8. Although our masses of interest were identified, their 
abundance appeared to be significantly lower than the “background” fragments, due to the 
decreased sensitivity of full scan mode. Subsequent experiments were performed in more 
concentrated solutions.   
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Figure 7. Mass chromatograph of 4MUFGA at cone voltages of 170-200v, increasing in 10v 
increments (positive full scan mode [100-1000Da]). 
 
 
 
Figure 8. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 170v (positive 
full scan mode [100-1000Da]). Circled are the masses of interest (aglycone and glucuronide). 
Significant proportions of additional fragments are observed. 
 
 
 
Experiment 4 
 
The fragmentation of 4MUFGA was again assessed in positive full scan mode (100-500Da) 
with a more concentrated sample. Injection flow analysis was performed under the below 
stated MS conditions. 
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Sample concentration: 1mg/ml in water 
 
LC Conditions: 
Flow rate: 0.4ml/min 
Solvent conditions: isocratic run with 75% solvent A (0.1% formic acid in water) and 25% 
solvent B (0.1% formic acid in actetonitrile). 
Injection volume: 10ul 
 
MS Conditions: 
Full scan mode: positive mode, 100-500Da 
Gain: 1 
Threshold: 150 
Drying gas flow: 13 l/min 
Nebulizer pressure: 30psig 
Drying gas temperature: 350 
Capillary voltage: 4000 
Ionization mode: API-ES 
 
Results: 
 
 
Injections of 4MUFGA, fragmented at cone voltages between 100 and 200v in full scan 
positive mode are shown in figure 9. The fragmentation patterns produced under these 
conditions are shown in figure 10-13. Increasing cone voltages resulted in an increase in 
“aglycone” ion formation, were about equal abundances of “aglycone” and glucuronide 
fragments occurred at 190v.   
 
 
 
 
 
 
 
Figure 9. Mass chromatograph of 4MUFGA at cone voltages of 100-200v, increasing in 10v 
increments (positive full scan mode [100-500Da]). 
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Figure 10. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 100v (positive 
full scan mode [100-1000Da]). Circled is the glucuronide mass of interest. Additional mass 
fragments are observed. 
 
 
 
Figure 11. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 150v (positive 
full scan mode [100-1000Da]). Circled are the glucuronide masses of interest. Additional 
mass fragments are observed. 
 
 
 
Figure 12. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 160v (positive 
full scan mode [100-1000Da]). Circled are the glucuronide masses of interest. Additional 
mass fragments are observed. 
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Figure 13. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 190v (positive 
full scan mode [100-1000Da]). Circled are the glucuronide masses of interest. Additional 
mass fragments are observed. 
 
 
 
 
Experiment 5 
 
In order to determine the cone voltage required to fragment 4MUFGA in full scan negative 
mode, an injection flow analysis was performed, under the below stated MS conditions, with 
varying cone voltages. 
 
Sample concentration: 1mg/ml in water 
 
LC Conditions: 
Flow rate: 0.4ml/min 
Solvent conditions: isocratic run with 75% solvent A (0.1% formic acid in water) and 25% 
solvent B (0.1% formic acid in actetonitrile). 
Injection volume: 10ul 
 
MS Conditions: 
Full scan mode: negative mode, 100-500Da 
Gain: 1 
Threshold: 150 
Drying gas flow: 13 l/min 
Nebulizer pressure: 30psig 
Drying gas temperature: 350 
Capillary voltage: 3000 
Ionization mode: API-ES 
 
 
Results: 
 
Several 4MUFGA injections were performed (each peak represents an injection at 0.8 min 
intervals), each at different (increasing) cone-voltages (fragmentor settings) (Figure 14). 
Fragmentation under these conditions occurred at 150 cone volts as shown in figures 15-17. 
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Figure 9. Mass chromatograph of 4MUFGA at cone voltages of 100-200v, increasing in 10v 
increments (negative full scan mode [100-500Da]). 
 
 
 
Figure 15. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 110v (negative 
full scan mode [100-500Da]). Circled is the mass of interest. Additional mass fragments are 
observed. 
 
 
 
Figure 16. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 150v (negative 
full scan mode [100-500Da]). Circled are the masses of interest. Additional mass fragments 
are observed. 
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Figure 17. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 200v (negative 
full scan mode [100-500Da]). Circled are the masses of interest.  
 
 
 
 
 
Experiment 6 
 
Although fragmentation occurred at >186 cone volts in negative full scan mode, fragmentation 
did not yield equal “aglycone” and glucuronide ion abundances. Therefore, it was nessesary 
to assess the fragmentation 4MUFGA at an increased cone voltage (200-300v). An injection 
flow analysis was performed, under the below stated MS conditions, with varying cone 
voltages (200-300v). 
 
Sample concentration: 1mg/ml in water 
 
LC Conditions: 
Flow rate: 0.4ml/min 
Solvent conditions: isocratic run with 75% solvent A (0.1% formic acid in water) and 25% 
solvent B (0.1% formic acid in actetonitrile). 
Injection volume: 10ul 
 
MS Conditions: 
Full scan mode: negative mode, 100-500Da 
Gain: 1 
Threshold: 150 
Drying gas flow: 13 l/min 
Nebulizer pressure: 30psig 
Drying gas temperature: 350 
Capillary voltage: 3000 
Ionization mode: API-ES 
 
Results: 
 
Several 4MUFGA injections were performed (each peak represents an injection at 0.8 min 
intervals), each at different (increasing) cone-voltages (fragmentor settings) (Figure 18). 
Fragmentation patterns under these are shown in figures 19-21. 
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Figure 18. Mass chromatograph of 4MUFGA at cone voltages of 200-300v, increasing in 10v 
increments (negative full scan mode [100-500Da]). 
 
 
 
Figure 19. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 200v (negative 
full scan mode [100-500Da]). Circled are the masses of interest.  
 
 
Figure 20. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 270 (negative 
full scan mode [100-500Da]). Circled are the masses of interest.  
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Figure 21. Mass fragmentation pattern for 4MUFGA at a fragmentor setting of 300v (negative 
full scan mode [100-500Da]). Circled are the masses of interest.  
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Glossary, Definitions and Abbreviations 
 
°Brix - unit representative of the sugar content of an aqueous solution. One degree Brix 
corresponds to 1 gram of sucrose in 100 grams of solution and thus represents the strength 
of the solution as a percentage by weight (% w/w)  
 
1H - common isotope of hydrogen, namely protium. 
 
4GBA - synthesised 4-(1-carboxyphenyl) β-D-glucuronic acid. 
 
3-O-Glucoside – glucose conjugate on the 4' position via an ether bond. 
 
3OH4GBA - synthesised 4-(1-carboxy-3-hydroxyphenyl) β-D-glucuronic acid. 
 
4OH3GBA - synthesised 3-(1-carboxy-4-hydroxyphenyl) β-D-glucuronic acid. 
 
ABCA - ATP-binding cassette transporter.  
 
Acyl – functional group derived by the removal of one or more hydroxyl groups from an acid 
containing oxygen (oxoacid). 
  
Acylation - process of adding an acyl group to a compound. 
 
ADME - acronym in pharmacokinetics and pharmacology for Absorption, Distribution, 
Metabolism, and Excretion. 
 
Aglycone - non-sugar compound remaining after replacement of the glycosyl group from a 
glycoside by a hydrogen atom. 
 
Aldehyde - with the structure R-CHO. 
 
Amine/Amino - functional group that contains a basic nitrogen atom with a lone pair. 
 
Ang II  - angiotensin II. 
 
ANOVA – analysis of variance. 
 
ApoA-1 - protein that has a specific role in lipid metabolism. 
 
-ara – arabinose conjugate. 
 
Aryl - functional group or substituent derived from a simple aromatic ring. 
 
AT1R – angiotensin II receptor type 1. 
 
BCA - Bicinchoninic acid assay is a biochemical assay for determining the total level of 
protein in a solution, similar to Lowry protein assay, Bradford protein assay or biuret reagent.  
 
BH4 – tetrahydrobiopterin. 
 
Bioavailability - Describe the fraction of an administered dose of unchanged xenobiotic that 
reaches the systemic circulation. 
 
BSA – Bovine Serum Albimin. 
 
Callistephin - pelargonidin-3-O-glucoside chloride. 
 
Carboxyl - functional group consisting of a carbonyl and a hydroxyl, which has the formula –
COOH. 
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Catechol - organic phenol having two adjacent hydroxyl groups attached to a benzene ring. 
 
CD40 - Type I transmembrane protein present on mature B cells, monocytes, dendritic cells, 
and epithelial cells involved in signal transduction leading to cell activation, proliferation, 
adhesion, and/or differentiation 
 
CD40L - a ligand for CD40 that induces activation, proliferation, and/or differentiation of 
CD40-expressing cells. 
 
cGMP - cyclic guanosine monophosphate. 
  
Chalcone -  aromatic ketone like compounds. 
 
c-Jun - gene and protein that forms the activator protein 1 (AP-1) early response transcription 
factor. 
 
COMT - catechol-O-methyltransferase. 
  
CVD – cardiovascular. 
 
Cy – cyanidin 
 
Cytochrome - membrane-bound hemoproteins that contain heme groups and carry out 
electron transport. 
 
CZE – capillary zone electrophoresis. 
 
DAD – photodiode array detector 
 
DMEM - Dulbecco’s modified Eagle's medium. 
 
DMSO - dimethyl sulfoxide. 
 
DMSO d6 - deuterated DMSO. 
  
DOE - design of experiments (DOE) or experimental design is the design of any information-
gathering exercises. 
 
Dp – delphinidin. 
 
DPPH - 2,2-diphenyl-1-picrylhydrazyl. 
 
DUOX – NADPH oxidase isoform. 
 
EDTA - ethylenediaminetetraacetic acid. 
 
Electron delocalisation - when electrons are not associated with one atom but are spread 
over several atoms. 
 
eNOS/NOS3 – endothelial nitric oxide synthase. 
 
Enteric - general term for the intestines. 
 
Enterocyte - simple columnar epithelial cells found in the small intestines and colon. 
 
ER – endoplasmic reticulum. 
 
Erk - extracellular-signal-regulated kinases. 
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ESI – electrospray ionisation. 
 
ESR - electron spin resonance.  
 
EtOAc – ethylacetate. 
 
FAD - flavin adenine dinucleotide. 
 
FasL - type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. 
 
FCS - Foetal Calf Serum. 
 
Ferricytochrome - cytochrome containing oxidized (ferric) iron. 
 
Fission - splitting of something into two parts. 
 
Flavin - organic compounds based on pteridine, formed by the tricyclic heteronuclear organic 
ring isoalloxazine. 
 
Flavonoid - group of compounds containing a characteristic aromatic nucleus and widely 
distributed in higher plants, often as pigments. 
 
Flavylium - 2-phenylchromenylium that is the basis of the anthocyanins. 
 
FW – fresh weight. 
 
GA – gallic acid. 
 
-gal – galactose conjugate. 
 
GIT – gastrointestinial tract. 
 
-glu/-glc – glucose conjugate. 
  
Glucuronide - substance produced by linking glucuronic acid to another substance via a 
glycosidic bond. 
 
Glycoside - molecules in which a sugar is bound to a non-carbohydrate moiety. 
 
GSH – glutathione. 
 
GSK – GlaxoSmithKline. 
 
GSSG - glutathione disulfide. 
 
GTP - guanosine-5'-triphosphate. 
  
HBA – 4-hydroxybenzoic acid. 
 
Hemiketal - carbonyl compound that results from the addition of an alcohol to the carbonyl 
group of a ketone. 
 
Homolytic/homolysis - chemical bond dissociation of a neutral molecule generating two free 
radicals. 
  
HPLC – high performance liquid chromatography. 
 
HUVEC – human umbilical vein endothelial cells. 
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Hydrolysis - chemical process in which a molecule is split into two parts by the addition of a 
molecule of water. 
 
Hydroxyl - compound containing an oxygen atom bound covalently with a hydrogen atom (-
OH). 
 
Imine - functional group or chemical compound containing a carbon–nitrogen double bond, 
with the nitrogen attached to a hydrogen atom or an organic group. 
 
IFN-γ - Interferon-gamma. 
 
I-κB - inhibitor of nuclear factor kappa-B. 
 
JAK/STAT - signalling pathway that transmits information from chemical signals outside the 
cell, through the cell membrane, and into gene promoters on the DNA in the cell nucleus. 
 
JNK - c-Jun N-terminal kinases. 
 
K – campferol. 
 
Kuromanin – cyaniding-3-glucoside chloride. 
  
LC – liquid chromatography. 
 
M –  morin. 
 
m/z – mass to charge ratio. 
 
MAPK - mitogen-activated protein (MAP) kinases.  
 
MCP - monocyte chemotactic protein. 
 
Metabolite - intermediates and products of metabolism. 
 
Methoxyl -  functional group consisting of a methyl group bound to oxygen. 
 
Microsome - vesicle-like artefacts formed from the endoplasmic reticulum (ER) when 
eukaryotic cells are broken-up in the laboratory. 
 
MPLC – medium pressure liquid chromatography. 
 
MS – mass spectrometry. 
 
Mv  - melvidin. 
 
My - myricetin. 
 
Myrtillin – delphinidin-3-glucoside chloride. 
 
NF-κB - nuclear Factor Kappa B. 
 
NMR  - nuclear magnetic resonance. 
  
NO – nitric oxide. 
 
NOX – NADPH oxidase. 
 
NP-40 – detergent (nonyl phenoxypolyethoxylethanol). 
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Nucleophilic/nucleophile - reagent that forms a chemical bond to its reaction partner (the 
electrophile) by donating both bonding electrons. 
 
OH – hydroxyl. 
  
OH• - hydroxyl radical. 
 
ORAC - oxygen radical absorbance capacity. 
 
- oxo - a ketone functional group. 
   
P38 - p38 mitogen-activated protein kinases, a class of phosphorylating enzymes. 
  
PBS – phosphate buffered saline. 
 
PBST – phosphate buffered saline with tween. 
 
PCA – protocatechuic acid. 
 
PCR – polymerase chain reaction. 
 
PDGF – platelet derived growth factor. 
 
Pectinolytic – degradation of pectin. 
 
PGA – phloroglucinaldehyde (2,4,6-trihydroxybenzaldehyde). 
 
Phenolic acid - consists of a phenyl bonded to a hydroxyl (-OH) and carboxylic acid (-
COOH). 
 
Phenotype - observable characteristic or trait of an organism. 
 
Phytochemical - chemical compounds that occur naturally in plants. 
 
PKa - negative logarithm of the ionization constant (K) of an acid. 
  
PKC – protein kinase C. 
 
Plasma – cell free liquid component of blood containing with fibrinogen present.  
 
PMA - phorbol 12-myristate 13-acetate. 
 
Pn – peonidin. 
 
Polyphenol - chemical substances found in plants characterized by the presence of more 
than one phenol unit. 
  
prep-LC – preparative liquid chromatography. 
 
Pt – petunidin. 
 
PVDF - polyvinylidene fluoride. 
 
Pyrylium – any derivative of a conjugated 6-membered carbon ring system with one carbon 
atom replaced by a positively charged oxygen atom. 
 
Q – queretin. 
  
qRT-PCR - qualtitative real-time polymerase chain reaction. 
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Quinonoidal – pertaining to organic compounds that are formally derived from aromatic 
compounds by exchanging an even number of –CH= groups with –C(=O)– groups, with any 
necessary rearrangement of double bonds. 
 
Radical - atoms, molecules, or ions with unpaired electrons on an open shell configuration. 
 
Redox – reduction/oxidation state. 
 
Resinosis - reoccurrence of a narrowing of a blood vessel. 
 
ROS – reactive oxygen species. 
 
RT-PCR – reverse transcription polymerase chain reaction. 
 
-rut – rutinoside conjugate. 
 
SA – salicylic acid. 
  
SBS – sodium bisulphite. 
 
Serum - cell free liquid component of blood containing without fibrinogen present. 
 
SOD – superoxide dismutase. 
 
SPE – solid phase extraction. 
 
Src - family of proto-oncogenic tyrosine kinases. 
 
Stoichiometry - quantitative relationships that exist among the reactants and products in 
chemical reactions. 
 
TAA - total antioxidant activity. 
  
TEAC - trolox equivalent antioxidant activity. 
  
THF - Tetrahydrofuran 
 
TLC – thin layer chromatography. 
 
TNF-α - tumour necrosis factor. 
  
TR – retention time. 
 
TRAF - tumour necrosis factor receptor associated factor. 
 
UDP - uridine diphosphate. 
 
UDP-GA - uridine 5'-diphospho-glucuronic acid. 
  
UGT - uridine 5'-diphospho-glucuronosyltransferase. 
  
UPLC – ultra-performance liquid chromatography. 
  
UV – ultraviolet.  
 
VA – vanillic acid. 
 
VEGF - vascular endothelial growth factor. 
  
Vis – visible. 
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Vit C – vitamin C. 
 
XO – xanthine oxidase. 
 
Diketone - a molecule containing two carbonyl groups.  
 
λmax – maximum absorbance wavelength.  
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